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RESUMO 
 
No contexto dos desafios globais nos cuidados de saúde, o desenvolvimento de 
sistemas de cuidados de saúde primários tem tido prioridade, enquanto a avaliação do 
desempenho na prestação de cuidados de saúde primários se assume como uma das 
direções centrais de investigação. Não existe, no entanto, uma forma padronizada sob a 
qual o desempenho dos prestadores de cuidados primários possa ser medido, tendo em 
conta a diversidade de definições para o termo “desempenho” em relação a esses 
mesmos prestadores. Além disso, não é claro que a investigação empírica nesta área 
tenha estado associada, com sucesso, à prática e política de cuidados de saúde. 
A este respeito, o primeiro artigo incluído nesta tese pretende alcançar os dois 
objetivos seguintes: (1) explorar as dimensões e indicadores de desempenho principais 
das avaliações dos cuidados primários, ao efetuar uma revisão sistemática da literatura 
que adota um enquadramento concetual abrangente para a avaliação de desempenho dos 
prestadores de cuidados primários; e (2) examinar o potencial das avaliações dos 
cuidados primários em relação à melhoria de desempenho na prática e política de 
cuidados de saúde, através do prisma do envolvimento das partes interessadas 
(stakeholders) em três diferentes fases da avaliação de desempenho, tal como proposto 
por Smith (1996). Desenvolvemos um enquadramento concetual que inclui três fases de 
avaliação de desempenho (medição, análise, e ação) e que captura quatro dimensões de 
desempenho (acessibilidade, equidade, eficiência, e eficácia). Aplicámos este 
enquadramento para uma revisão sistemática de 166 artigos empíricos dedicados à 
avaliação de desempenho de prestadores de cuidados primários. Os resultados da 
revisão mostram que uma ampla variedade de medições de desempenho foi utilizada 
para avaliar prestadores de cuidados primários, as quais são sistematizadas em tabelas 
sumárias para auxiliar a seleção de um conjunto apropriado de indicadores de 
desempenho para futuras avaliações de cuidados primários. Também concluímos que as 
quatro dimensões têm sido maioritariamente exploradas de forma separada na literatura 
empírica analisada. Levando em conta as relações existem entre as diferentes dimensões 
de desempenho, pensamos que os futuros estudos de investigação devem aplicar 
maiores esforços para avaliar simultaneamente várias dimensões de desempenho e para 
explorar de forma mais profunda as relações existentes entre elas. Os resultados da 
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revisão mostram também um envolvimento insuficiente por parte dos interessados no 
processo de avaliação de desempenho, indicando o impacto potencialmente limitado da 
investigação analisada. Na maioria dos casos, as partes interessadas envolvidas nas 
avaliações de cuidados primários foram membros de staff, legisladores, e gestores, 
sendo que apenas uma pequena minoria de estudos relata o envolvimento de outras 
partes interessadas relevantes, como pacientes e cidadãos. Por conseguinte, aconselha-
se que estudos futuros tenham o intento de envolver partes interessadas cruciais no 
processo de avaliação de cuidados primários, incluindo pacientes e cidadãos, entre 
outros, para garantir que os modelos e resultados têm validade aparente (face validity) e 
que consigam também fortalecer o impacto que a investigação empírica tem na prática e 
política de cuidados de saúde.  
O segundo artigo incluído nesta tese explora o potencial da Análise Envoltória de 
Dados (DEA), uma técnica não paramétrica para a avaliação relativa de desempenho 
proposta por Charnes, Cooper e Rhodes (1978), a fim de melhorar delinear programas 
de pagamento por desempenho (pay-for-performance ou P4P) nos cuidados de saúde 
primários. Os programas de pagamento por desempenho são atualmente vistos como 
uma ferramenta promissora para melhorar a prestação de cuidados de saúde, e não 
existem dúvidas de que a conceção dos programas P4P tem um papel crucial na forma 
como os seus objetivos são cumpridos. Neste artigo pretendemos investigar um 
elemento fundamental na conceção destes programas que não tem recebido muita 
atenção na literatura P4P – o método para a avaliação de desempenho. Acreditamos que 
a utilização da DEA permite uma avaliação mais justa dos prestadores no contexto do 
P4P quando comparada com a análise de proporção (ratio analysis), que é mais 
tradicional nos programas P4P. Uma das principais vantagens da DEA, quando 
comparada com a análise de proporção, é que ela permite que cada unidade seja 
avaliada com uma maior ênfase nos indicadores de desempenho, nos quais a unidade 
avaliada teve um melhor desempenho, levando simultaneamente em conta as relações 
entre os diferentes indicadores e dimensões de desempenho. A DEA também compara 
cada unidade com um grupo de outras unidades que operam sob condições similares e 
com prioridades de desempenho iguais, identificando aqueles prestadores que são os 
melhores executantes e identificando metas para a melhoria de desempenho das 
unidades que obtêm um resultado inferior a 100% na avaliação da DEA. 
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A este respeito, este artigo tem dois objetivos de investigação: (1) desenvolver 
uma abordagem metodológica com base na DEA para a avaliação de desempenho de 
prestadores de cuidados de saúde primários em Portugal; e (2) propor uma metodologia 
alternativa para a contratualização de P4P por parte destes prestadores, com base nos 
resultados da avaliação da DEA. Para alcançar o primeiro objetivo, modificámos o 
modelo básico da DEA ao adotar a abordagem de benefício da dúvida (the benefit-of-
the-doubt approach) e ao introduzir uma combinação única de restrições de pesos – um 
parâmetro que regula o nível de disparidade entre os pesos virtuais ideais que está 
combinado com restrições de pesos virtuais proporcionais e ordinais. Na nossa 
perspetiva, tal combinação de restrições de pesos faculta o melhor equilíbrio entre as 
preferências derivadas exogenamente a partir da relevância relativa de cada indicador de 
desempenho e de cada dimensão e o nível de disparidade acessível definido 
endogenamente na atribuição dos pesos virtuais. As restrições estabelecidas permitem 
ainda um grande grau de flexibilidade na atribuição dos pesos, em oposição a qualquer 
sistema fixo de pesos, preservando dessa forma uma das principais vantagens da DEA. 
A abordagem proposta com base na DEA também tem explicitamente em conta a 
influência de fatores ambientais no alcançar das metas estabelecidas pelo sistema P4P. 
Em particular, ao termos analisado os índices de Malmquist propostos por Camanho e 
Dyson (2006) e os coeficientes de correlação de Pearson, identificámos quatro fatores 
ambientais relevantes – o número de anos em operação das unidades prestadoras de 
serviços, a densidade populacional, a percentagem de utentes inscritos com 65 ou mais 
anos de idade, e a percentagem de utentes inscritos com diabetes – e efetuámos uma 
análise de clusters para classificar os prestadores em relação às suas condições 
ambientais. Como resultado desta análise de clusters, identificámos um pequeno grupo 
de prestadores que operam em condições menos favoráveis e um grande grupo de 
prestadores que operam em condições mais favoráveis. Depois, efetuámos uma 
avaliação da DEA, em que cada prestador foi comparado somente com os pares que 
operam nos mesmos ou em piores ambientes, como sugerido por Löber e Staat (2010). 
Para alcançar o segundo objetivo deste estudo, propomos uma nova metodologia 
para a contratualização de P4P que liga os resultados da avaliação da DEA com as 
metas absolutas para as unidades que obtiveram um resultado inferior a 100% na 
avaliação da DEA e com um sistema de incentivos graduados para as unidades que 
obtiveram um resultado relativamente alto nesta avaliação. Também definimos uma 
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metodologia para a avaliação do alcançar absoluto das metas por parte das unidades que 
mostram um potencial para a melhoria de desempenho e desenvolvemos um sistema 
distinto de incentivos graduados associado a esta avaliação. Foi efetuada uma análise 
exploratória dos resultados atuais, das metas contratualizadas e das metas DEA 
sugeridas para algumas das unidades, sublinhando as vantagens da metodologia DEA 
proposta, quando comparada com a metodologia de avaliação atualmente implementada 
no programa P4P português. Também se sugere a implementação de um programa de 
benchmarking entre os prestadores com caraterísticas similares e prioridades de 
desempenho iguais, a fim de contribuir para a disseminação das melhores práticas. 
Os estudos futuros são encorajados a explorar um leque mais vasto de indicadores 
relacionados com o desempenho dos prestadores de cuidados primários portugueses, a 
fim de permitir uma avaliação abrangente desses prestadores e também são encorajados 
a investigar a influência de outros fatores ambientais, como as caraterísticas 
socioeconómicas da população, na alcançabilidade das metas do P4P. Recomenda-se 
também a análise de possíveis efeitos não intencionais do programa P4P implementado. 
Além disso, propõe-se que um modelo de DEA baseado em indicadores de volume seja 
utilizado em futuras avaliações dos prestadores de cuidados primários portugueses, pois 
esse modelo tem em conta potenciais diferenças de recursos entre os prestadores.  
Palavras-chaves: avaliação de desempenho, prestadores de cuidados primários, 
pagamento por desempenho, Análise Envoltória de Dados. 
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ABSTRACT 
 
This thesis consists of two research articles. The first article addresses two 
research questions: (1) what have been the main performance dimensions and measures 
used for primary care assessment? And (2) to what extent have key stakeholders been 
involved in primary care assessment? To answer these questions, we developed a 
conceptual framework that includes three stages of performance assessment 
(measurement, analysis, and action) and captures four performance dimensions 
(accessibility, equity, efficiency, and effectiveness). We applied this framework for a 
systematic review of the 166 empirical articles devoted to performance assessment of 
primary care providers. The results of the review show that a wide variety of 
performance measures has been used to assess primary care providers, and also that the 
four dimensions have mostly been explored separately. Furthermore, the results of the 
review reveal an insufficient involvement of stakeholders in the performance 
assessment process, indicating the potentially limited impact of the reviewed research 
on health care policy and practice. 
The second article aims two objectives: (1) to develop a DEA methodology for 
performance assessment of primary care providers in Portugal; and (2) to propose an 
alternative methodology for P4P contracting based on the DEA assessment results. To 
achieve the first objective, we modified the standard DEA model to account for the 
necessary relations between the weights attributed to each performance indicator and 
domain and to account for the effect of the relevant environmental variables. To achieve 
the second objective, we combined relative and absolute performance assessments in 
the elaboration of several bases for reward, and each of these two assessments is 
proposed to be linked to a system of graduated rewards. For underperforming units, we 
suggest establishing absolute targets derived from the relevant benchmarks, identified 
by DEA. We also recommend the creation of a benchmarking programme that will 
contribute to the dissemination of best practices among the providers.  
Keywords: performance assessment, primary care providers, pay-for-
performance, Data Envelopment Analysis. 
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Chapter 1 
INTRODUCTION 
 
1.1 Introduction  
In the context of global health care challenges, the development of primary care 
systems has been prioritised (WHO, 2008), while performance measurement in primary 
health care becomes one of the central research directions (Schäfer, Groenewegen, 
Hansen and Black 2011). This is due to the fact that primary health care has unique 
characteristics that may contribute to the improvement of the overall performance of the 
health systems worldwide (WHO, 2008). In particular, it has been recognised that a 
well-functioning primary care system has the potential to prevent the occurrence of 
common diseases up to 70% (WHO, 2008) and also to assist their early detection and 
management (e.g. Gorey, Luginaah, Holowaty, Fung and Hamm 2009; Campbell, 
Ramirez, Perez and Roetzheim, 2003; Roetzheim, Pal, Durme, Wathington, Ferrante, 
Gonzalez and Krischer, 2000). Primary care interventions, unlike specialist care 
services, are not usually limited to a particular disease or type of diseases, being more 
“generic” and “patient-oriented” rather than “disease-oriented”. This property of 
primary care is particularly valuable in the context of an ageing population that 
struggles with increasing multiple morbidities (WHO, 2008). 
Countries with strong primary care systems also report to have lower health care 
expenditure, possibly due to more effective disease prevention and lower hospitalisation 
rates (Starfield, Shi and Macinko, 2005; Starfield and Shi, 2002). This is a critical 
advantage of the health systems with an explicit focus on primary care, since most 
OECD countries are expected to spend more than 20% of their GDP on health care by 
2050, if current trend in health care expenditure persists (Drouin, Hediger, Henke, 
Kanzler, Leydon and De Santis, 2008). To counteract the ongoing growth of health care 
costs, a series of fundamental health care reforms are urgently needed, including further 
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development of primary care systems that in many situations, as argued by Starfield et 
al. (2005), serve as a less expensive but equally effective alternative to specialist care. 
Primary-care oriented health systems are also known to have fewer inequities in 
health service delivery (Starfield, 2009). For instance, it has been concluded that a 
higher supply of primary care physicians is associated with reductions in racial 
disparities related to referral-sensitive procedures (Basu and Clancy, 2001) and with 
decreased mortality among racial and ethnic minority groups (Shi, Macinko, Starfield, 
Politzer and Xu, 2005). The beneficial impact of primary health care is also confirmed 
in relation to the areas with high income inequality (Shi, Starfield, Kennedy and 
Kawachi, 1999). 
In this context, the importance of performance measurement in primary health 
care should not be underestimated. In particular, performance measurement helps to set 
health policy goals and priorities and to design health care reforms; to ensure the 
providers are functioning efficiently and effectively and to control that money is being 
spent in line with taxpayers’ expectations; to monitor whether appropriate health care 
services are accessible when needed and whether all patients are experiencing the same 
level of quality of health care delivery (Smith, Mossialos, Papanicolas and Leatherman 
2009).  
However, to date, there is no standardised way in which performance of primary 
care providers is measured due to the variation in the definition of “performance” of 
these providers. Furthermore, to our knowledge, there is no study that has explored the 
linkage between the empirical research on primary care assessments and health care 
policy and practice. In this respect, one of the broad aims of this thesis is to contribute 
to the understanding of the conceptual basis that underlies a comprehensive 
performance measurement of primary care providers and to explore the potential of the 
undertaken primary care assessments for improving health care policy and practice.  
At a broader perspective, besides the above described objectives, performance 
assessment is crucial for promoting accountability relationships with multiple 
stakeholders, such as the government, health care managers and policy makers, 
taxpayers, purchaser organisations, providers, patients, and the general public (Smith et 
al., 2009). Within the context of these relationships, performance measurement is 
usually seen as a part of the management system, in which the embedded measurement 
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helps to trigger appropriate organisational responses and changes in behaviour (Smith et 
al., 2009; Smith, 1996). In order to provide a greater motivation for desired responses 
from the providers, the measurement of performance is frequently linked to incentive 
mechanisms, such as pay-for-performance (P4P) programmes. As pointed out by 
Cromwell, Trisolini, Pope, Mitchell and Greenwald (2011),  
“P4P is intended to bring incentives for improving quality of 
care directly into the payment system. By paying for specified 
standards of quality care, P4P may help equalize quality across 
different regions of the country and among different providers 
in the same region.” (Cromwell et al., 2011: 12) 
P4P progammes are now seen as a promising tool for improving quality of health 
care delivery. For this reason, methodological and practical issues related to the 
development and implementation of P4P programmes have attracted much attention in 
the research literature (e.g. Eijkenaar, 2011; Conrad, 2009). Nevertheless, there is still 
significant potential for improvement of P4P programme design, including the 
methodology for performance assessment and subsequent target setting among other 
aspects. 
In particular, we believe that Data Envelopment Analysis (DEA), a non-
parametric frontier technique for relative performance assessment proposed by Charnes, 
Rhodes and Cooper (1978), opens up new opportunities for P4P programme design in 
what concerns the methodology for performance assessment and subsequent target 
setting. The exploration of these opportunities presents the second broad aim of this 
thesis. 
To date, the DEA applications in the context of P4P and incentive regulation have 
been scarce (e.g. Shwartz, Burgess and Zhu, 2016; Gök and Altındağ, 2015; Prior and 
Surroca, 2007; Agrell, Bogetoft and Tind, 2002) and, to our knowledge, none of the 
existing P4P programmes in health care has implemented DEA as a principal 
performance assessment methodology. However, if applied to P4P, DEA has a number 
of advantages, including the following: 
1) DEA allows to assess multiple inputs (i.e. resources) and outputs (i.e. goods or 
services produced from the inputs) simultaneously, recognising the existence 
of trade-offs between different production factors, by contrast to a ratio 
analysis that is more traditionally used in P4P;  
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2) DEA suggests relative performance assessment, so that it stimulates continual 
performance improvement rather than encourages the achievement of 
determined targets;  
3) DEA recognises the existence of providers’ preferences in assigning relative 
importance to each of the explored performance indicators (PIs) by adopting a 
flexible weighting system; 
4) DEA aims to show each provider in the best possible light by maximising its 
relative performance score under the incorporated model restrictions;  
5) DEA can be effectively combined with value judgements and prior views 
regarding the relative importance of the explored PIs, as well as with the 
methods that allow to account for the effect of environmental factors (i.e. 
factors that are beyond the control of the providers); 
6) DEA identifies realistic individual targets and benchmarks for each unit that 
shows the potential for performance improvement. 
At the same time, DEA has some limitations, including the following: 
1) DEA requires all units under assessment to be homogenous in order to 
produce realistic performance scores;  
2) DEA has proved to be sensitive to the number of input and output variables in 
the presence of a small number of units, since a higher number of variables 
leads to a lower discriminating power of the technique; 
3) DEA may provide biased results if data regarding inputs or outputs are 
missing for some providers; 
4) DEA results are sensitive to model specification, since DEA assumes that the 
production process can be fully characterised by the inputs and outputs 
included into the analysis that in practice is not always possible. 
We consider these limitations in our thesis and provide specific solutions and directions 
for future research in order to overcome them. 
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1.2 Research objectives 
This thesis has four research objectives: 
1. To explore the main performance dimensions and measures of primary care 
assessments by undertaking a systematic literature review that adopts a 
comprehensive conceptual framework for performance evaluation of primary 
care providers. 
 
2. To examine the potential of primary care evaluations for the targeted 
improvement in health care policy and practice through the prism of 
stakeholders’ involvement at three different stages of performance assessment– 
measurement, analysis, and action – as proposed by Smith (1996). 
 
3. To develop a DEA-based methodological approach for performance assessment 
of primary care providers in Portugal that allows a fairer comparison of the 
providers in the context of P4P. This approach estimates the relative 
performance scores of the providers, considering the maximum possible 
performance level under the current technology identified for each provider 
individually, both providers’ preferences and health care authorities’ judgements 
regarding the relative importance of each PI, and the effect of environmental 
variables on P4P target attainment. 
 
4. To propose an alternative methodology for P4P contracting with primary care 
providers in Portugal based on the DEA assessment results. This methodology 
allows us to effectively combine relative performance assessment with absolute 
performance assessment in the elaboration of several bases for reward for 
providers with different performance levels. Furthermore, the DEA assessment 
allows benchmarking programmes to be implemented between the providers 
with similar characteristics and strategic priorities in order to contribute to the 
dissemination of best practices among these providers. 
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1.3 Thesis outline 
This introductory chapter provided an overview of the thesis context and set up 
research objectives. The remaining part of the thesis comprises two scientific papers, 
each of which is presented in the form of a chapter, followed by general conclusions. 
In particularly, Chapter 2 investigates the conceptual basis for performance 
assessment of primary care providers and explores the potential of the undertaken 
primary care assessments for performance improvement in health care policy and 
practice. A conceptual framework for primary care assessments is developed. This 
framework is used for analysis of the empirical studies included into the systematic 
literature review to explore the main dimensions, sub-dimensions, and PIs of primary 
care assessments and to conclude about the level of stakeholders’ involvement at 
different stages of organisational performance assessment. A functional classification of 
the explored PIs is also provided. 
Chapter 3 explores the potential of DEA for enhancing performance assessment 
and subsequent target setting in the context of P4P. Firstly, we develop a DEA-based 
methodology for performance assessment of primary care providers in Portugal. In 
doing so, we modify the standard DEA model in order to account for the necessary 
relations between the relative weights attributed to each PI and each performance 
domain and in order to account for the effect of the relevant environmental factors. 
Secondly, we propose a new methodology for P4P contracting with the Portuguese 
primary care providers that links the DEA assessment results with absolute targets for 
the underperforming units and with a system of graduated rewards for the units that 
scored relatively high in this DEA assessment. We also set up a methodology for the 
assessment of absolute target attainment of the underperforming units and develop a 
distinct system of graduated rewards associated with this assessment. An exploratory 
analysis of the actual results, the contracted targets and the suggested DEA targets for 
some of the providers is performed, outlining the advantages of the proposed DEA 
methodology compared to the assessment methodology currently implemented in the 
Portuguese P4P programme. 
Chapter 4 draws conclusions from the two papers and identifies the main 
suggestions for further research.   
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Chapter 2 
ORGANISATIONAL PERFORMANCE 
ASSESSMENT IN PRIMARY HEALTH CARE:  
A SYSTEMATIC LITERATURE REVIEW AND A 
CONCEPTUAL FRAMEWORK 
 
2.1 Introduction 
Nowadays, more than ever, governments worldwide face increased pressure to 
ensure that their health systems deliver the best performance results. This is mainly due 
to the global demographic changes that are causing the average patient to be older and 
poorer in health (WHO, 2011), and also because of stringent resource constraints that 
contrast heavily with the persistent growth of health care expenditure (Drouin et al., 
2008). Alerted by these tendencies, both researchers and policymakers have started to 
look for innovative solutions in organising the work of health systems in a more 
efficient, effective, equitable, and accessible manner. The search for new solutions has 
caused a fundamental shift in the health care research agenda by moving the focus away 
from hospitals and onto primary care providers (Schäfer et al., 2011). In particular, it 
has been recognised that a strong and well-established primary care system has great 
potential to cope with the challenges related to the quality of health care delivery. As a 
result, performance improvement in primary care provision has been acknowledged by 
several international entities, including the World Health Organisation (WHO) (2008), 
as one of the central priorities for future research.  
Performance assessment in the primary care context plays a vital role. It facilitates 
the control of the performance results achieved by primary care organisations and 
provides valuable information for performance improvement. However, no single 
framework for this purpose exists due to the variety of views on what is meant by 
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performance in primary health care and how to measure it in the most appropriate way. 
Moreover, it is unclear whether empirical research in this area has been successfully 
linked to health care policy and practice. In order to provide further and more 
conclusive evidence on these issues, our study aims to present a critical and updated 
review of the empirical research devoted to performance assessment of primary care 
providers. In doing so, we aim to answer two important research questions: 
1. What have been the main performance dimensions and measures used for 
primary care assessment? By exploring this research question, we aim to 
systematise the main aspects of primary care performance that are crucial for the 
development of a performance measurement system in this context. 
2. To what extent have key stakeholders been involved in the performance 
assessment process in primary health care? By answering this research question, 
we aim to reveal whether the level of stakeholders’ involvement has been 
sufficient to ensure a formative evaluation of primary care providers in order to 
encourage subsequent performance improvement. 
To date, several authors have performed literature reviews in the context of 
performance assessment in primary health care. Amado and Dyson (2008) reviewed the 
methods and measures that have been developed to compare primary care providers 
with particular reference to the use of the non-parametric technique known as Data 
Envelopment Analysis. Pelone, Kringos, Romaniello, Archibugi, Salsiri and Ricciardi 
(2015) reviewed the studies that have used DEA to compare primary care providers in 
developed countries. Kringos, Boerma, Bourgueil, Cartier, Hasvold, Hutchinson, 
Lember, Oleszczyk, Pavlic, Svab, Tedeschi, Wilson, Windak, Dedeu and Wilm (2010a) 
and Kringos, Boerma, Hutchinson, van der Zee and Groenewegen (2010b) explored 
performance dimensions and indicators related to this research topic, limiting the 
analysis of the literature within a five-year period. Hollingsworth, Dawson and 
Maniadakis (1999) and Hollingsworth (2008, 2003) conducted reviews of non-
parametric and parametric applications in health care, including primary health care, 
focusing solely on efficiency measurement.  
Whilst these studies have improved our understanding regarding different aspects 
related to the assessment of primary care providers, our review extends and 
complements this literature in several important ways. Firstly, this review offers a 
9 
 
conceptual framework for primary care evaluation and a functional classification of 
indicators within each performance dimension discussed. These theoretical 
developments may have important benefits for researchers, policymakers, and health 
care managers who are searching for effective tools in the design of a balanced 
performance measurement system. In particular, the proposed framework and 
classification can help to reveal the relationships between major conceptual elements 
related to primary care assessment. They can also facilitate the choice of appropriate 
dimensions and corresponding measures sensitive to specific aspects of primary care 
delivery. Secondly, this review provides one of the most exhaustive analyses of the 
literature in this research area until now, since in this study we do not limit our attention 
to any particular performance dimension, analytical technique, or time period. This 
allows us to provide a complete view on the state of the art in the referred area and also 
to reflect on how to best capture the performance of primary care providers. Thirdly, 
this review explores the level of stakeholders’ involvement in the process of primary 
care assessment, an issue that has not been thoroughly studied before. In doing so, we 
aim to conclude whether the previous studies’ research findings have been (or can be) 
used formatively to guide subsequent improvement in the performance of primary care 
providers. This is an important piece of knowledge, since it is recognised that formative 
evaluations are fundamental to successful translation of research evidence into relevant 
changes in policy and practice (Amado and Dyson, 2008). In the health care context, 
this is vital to enhance the health-related quality of life of the population. 
The remainder of this paper is organised as follows. Section 2 sets out the 
conceptual framework developed for performance assessment of primary care 
providers. This framework provides the basis for analysing the studies included in this 
literature review. Section 3 discusses the protocol used for literature search and 
selection of studies. Section 4 presents a synthesis of the reviewed studies, including a 
functional classification of the indicators used, and offers suggestions for future 
research. Section 5 concludes by systematising the main findings of the review and 
discussing its main limitations. 
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2.2 Conceptual framework 
Performance assessment in health care is a complex undertaking that involves 
several stages. According to Smith (1996), who investigated the peculiarities of 
performance assessment in the public sector, these stages can be broadly identified as 
the measurement stage, the analysis stage, and the action stage. Particularly, the 
measurement stage aims to create a methodological basis for the whole assessment 
process. In the pursuit of this objective, the most relevant dimensions of performance 
must be selected and the indicators that allow performance assessment must be defined. 
In addition, the most appropriate method to measure performance must also be chosen. 
Then, at the analysis stage, the results regarding the chosen sets of indicators are 
interpreted to provide an idea about the level of performance achieved in relation to 
each of the defined dimensions. The relationships between the results observed in the 
different performance dimensions should also be analysed at this stage. Overall, the 
main objective of the analysis stage is to derive learning regarding the performance of 
the system. Finally, the action stage suggests appropriate organisational responses to the 
results of the analysis of performance data, including the discussion and elaboration of 
plans, implementation of actions, and monitoring towards performance improvement 
among other activities. Given that performance assessment is a continuous process, the 
action stage also offers opportunities to reflect on the objectives of the system in order 
to return to the measurement stage. 
As we mentioned earlier, the development of a conceptual basis is fundamental to 
the measurement stage. The conceptual basis for health care assessment has been 
extensively explored and one of the most significant contributions in this respect 
belongs to Donabedian (1980). In particular, Donabedian (1980) proposed a framework 
for quality assessment consisting of three key elements: structure, process, and 
outcome. Structure refers to the organisational characteristics of health care providers, 
including human, physical, and financial resources and tools used in the delivery of 
health care services, representing the inputs in health care provision. Process refers to 
the activities that go on within and between health care practitioners and patients, 
focusing on conformity to technical and ethical norms of good care. And, finally, 
outcome refers to the impact of these activities on a patient’s current and future health 
status. Most of the subsequently developed conceptual models in this area include the 
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components of the framework developed by Donabedian (1980). Among other models, 
Maxwell (1992) described how six dimensions of health care quality – effectiveness, 
acceptability, efficiency, access, equity, and relevance – can be assessed in relation to 
structure, process, and outcomes. Starfield (1998), in turn, proposed a model based on 
four structural elements and two process features to measure the most important 
attributes of quality in primary health care: first-contact care, longitudinality, 
comprehensiveness, and coordination. Afterwards, Campbell, Roland and Buetow 
(2000) analysed the most widely used approaches to measuring the quality of health 
care delivery, including the models developed by Maxwell (1992) and Starfield (1998), 
and concluded that a comprehensive health care assessment model incorporates the 
measurement of four performance dimensions: accessibility, equity, efficiency, and 
effectiveness.  
Inspired by the works of Smith (1996) and Campbell et al. (2000), we propose a 
conceptual framework for performance assessment in primary health care. This 
framework involves the three stages of performance assessment (measurement, analysis, 
and action) and captures the four basic dimensions of performance (accessibility, equity, 
efficiency, and effectiveness). Figure 2.1 presents this conceptual framework.  
There are two important aspects to be emphasised about this framework. Firstly, it 
recognises the influence of environmental factors in the performance assessment 
process. Control of these environmental factors can be made through, for example, case-
mix adjustment. This type of adjustment aims to account for variations in the observed 
performance results of the providers that are caused by intrinsic patient characteristics 
(Iezzoni, 2009). Beyond patient attributes, there are other non-controllable factors that 
may impact the performance of primary care providers, such as, for example, health 
care regulations and the performance of other providers of health care services. 
Secondly, the framework acknowledges that performance has different meanings across 
multiple groups of stakeholders. In this respect, it is of paramount importance to 
identify the relevant stakeholders, whose objectives will underlie the whole 
performance assessment process. Furthermore, as defended by several authors (e.g. 
Amado and Dyson, 2008; Smith, 1996), it is essential to involve the key stakeholders in 
the three stages of the process. This involvement is critical for the performance 
measurement system to generate results that act as a trigger for discussion among   
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Figure 2.1 Conceptual framework for performance assessment of primary care providers 
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targeted stakeholder groups, fostering learning and promoting performance 
improvement. Stakeholders’ involvement is also essential to guarantee face validity of 
the assessment results (that is, results that are recognised as valid by the stakeholders) 
and to contribute to subsequent implementation of the developed improvement 
strategies and plans. 
In what concerns the measurement stage, our framework relates the four 
performance dimensions to five basic elements of primary health care delivery (needs, 
resources, receipt of services, patient-provider interpersonal interactions, and 
outcomes). Each of the performance dimensions has been divided into several sub-
dimensions. Accessibility can take the form of organisational accessibility, economic 
accessibility, geographical accessibility, service availability, and realised accessibility. 
Equity can be analysed from two perspectives: horizontal equity and vertical equity. In 
each of these perspectives, equity can assume three forms: equity of access (potential 
and realised), equity of treatment (including both clinical treatment and interpersonal 
treatment), and equity of outcomes. Efficiency can take the form of technical efficiency 
and allocative efficiency. Finally, effectiveness can take the form of clinical 
effectiveness, effectiveness of interpersonal care, and outcomes achievement.  
In order to clarify the meaning of the terms used in the conceptual framework, 
below we provide a discussion regarding each of the four performance dimensions and 
of their sub-dimensions.  
Accessibility in the context of primary health care may have different 
interpretations. One of the most common definitions suggests that accessibility 
measures the possibility of potential or actual entry of an individual into the health care 
system (Andersen, McCutcheon, Aday, Chiu and Bell, 1983). Therefore, an accessible 
health care system removes the barriers to the initiation and maintenance of 
relationships between the individual and the provider (Gulliford, Figueroa-Munoz, 
Morgan, Hughes, Gibson, Beech and Hudson, 2002). Considering the existence of 
various barriers to access, Campbell et al. (2000) proposed the measurement of 
accessibility in terms of geographical (or physical) access, service and provider 
availability, and the affordability of health care expressed in monetary costs. We find 
this definition useful for analysing the accessibility dimension and thus we identified 
four corresponding sub-dimensions: organisational accessibility, economic accessibility, 
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geographical accessibility, and service availability. In particular, organisational 
accessibility measures the extent to which the organisation of health care delivery 
corresponds to patients’ needs. Economic accessibility evaluates the acceptability of 
costs paid by the users of health care services. Geographical accessibility concerns the 
efforts needed to physically access a health care provider. Finally, service availability 
reflects whether a range of available services is adequate to satisfy patients’ needs. 
Following the distinction between potential and realised access, first discussed by 
Andersen and Aday (1978), we decided to introduce an additional fifth sub-dimension 
entitled realised accessibility. This sub-dimension includes the performance indicators 
that show whether an individual or local population has succeeded in gaining access to 
primary care services. 
Regarding equity, there are two different perspectives that underlie its definition. 
In particular, horizontal equity requires the same treatment of individuals with identical 
health care needs, regardless of their individual characteristics. Vertical equity supports 
the idea of preferential treatment of those who have greater health care needs. Given the 
existence of these two distinct ideological perspectives, it is essential to choose one of 
them for the evaluation of equity. Furthermore, the evaluation of equity also requires the 
concept of need to be defined. In the health care context, need has been most commonly 
viewed as the capacity to benefit from the consumption of health care (Allin, 
Hernández-Quevedo and Masseria, 2009).  
Concerning the equity sub-dimensions, there are equity of access, equity of 
treatment, and equity of health care outcomes (Whitehead, 1990; Goddard and Smith, 
2001). In the following discussion we will define the concepts using the perspective of 
horizontal equity, considering that this is the most commonly studied perspective. 
However, the definitions of the three forms of equity can be easily adjusted to refer to 
the perspective of vertical equity. 
Equity of access implies equal entitlement to health care services for everyone, a 
fair distribution of resources, and the removal of all barriers to access (Whitehead, 
1990). Equity of treatment, in turn, is frequently viewed as the absence of restricted use 
of health care services caused by any kind of patient disadvantage (Whitehead, 1990). 
However, we use this term in a broader sense to cover both clinical and interpersonal 
aspects in the delivery of health care, as proposed by Donabedian (1988). Finally, 
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equity of health care outcomes implies the same high standard in relation to outcomes 
achievement for everyone. 
Efficiency is one of the four dimensions captured by the framework. The 
achievement of an efficient health care provision is targeted by most health care systems 
worldwide, as it ensures a balanced distribution of available resources among and 
within the systems. For the purpose of efficiency analysis, the economic literature 
considers that health care providers consume various inputs (human resources, capital, 
etc.) in order to produce valued outputs (consultations, home visits, etc.). The 
conceptual literature also distinguishes between several types of efficiency. In 
particular, the achievement of technical efficiency means that an increase in any output 
or input is not feasible without decreasing some other output(s) or input(s) (Cooper 
Seiford and Zhu, 2011). When price data for inputs are available, we can estimate the 
allocative efficiency of providers, which reflects the ability to mix resources in optimal 
proportions, given current input prices (Farrell, 1957). The achievement of both 
technical and allocative efficiency results in cost-efficiency, which reflects the ability to 
deliver a certain quantity of outputs at minimum cost. If only information on cost 
indicators is available, one may estimate cost-efficiency without being able to 
disentangle between technical and allocative efficiency. 
Regarding efficiency measurement, it is common to evaluate efficiency in relative 
terms, by comparing the performance of several providers. One may compare the 
relative efficiency of providers using a ratio of a single output over a single input. In 
this case, this tends to result in a partial measure of efficiency. In order to estimate a 
comprehensive measure of efficiency, we must use a technique that allows the 
consideration of multiple inputs and outputs.  
Stochastic Frontier Analysis (SFA) and Data Envelopment Analysis (DEA) are 
the two most commonly used analytic techniques for measuring relative efficiency in 
health care. In particular, SFA is a parametric technique that estimates the cost (or 
production) frontier based on a prior specification of its functional form. DEA, in turn, 
is a non-parametric technique that constructs a frontier by a linear combination of the 
best practice providers that “envelop” underperforming providers. In addition, as 
opposed to SFA, DEA does not require a priori assumptions with regards to the weights 
attached to input and output variables. The flexible weighting system adopted in DEA 
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aims to represent the provider under evaluation in the best possible light. An added 
advantage of DEA, when compared with SFA, is that it allows the simultaneous 
inclusion of multiple inputs and multiple outputs. A detailed description of SFA and 
DEA can be found elsewhere (Cooper et al., 2011; Kumbhakar and Lovell, 2003). 
The fourth dimension included in our framework is effectiveness. According to 
Campbell et al. (2000), effectiveness in health care provision is defined as “the extent to 
which care delivers its intended outcome or results in a desired process, in response to 
need” (Campbell et al., 2000: 1616). This definition implies that effectiveness can be 
measured by process assessment and/or by outcomes assessment. 
When a process assessment is undertaken, it is assumed that certain characteristics 
of health care delivery, measured by process indicators, are directly linked to targeted 
health care outcomes. Process assessment also distinguishes between the clinical 
effectiveness and effectiveness of interpersonal care that are associated with two key 
elements of the health care process – clinical management and management of 
interpersonal care (Donabedian, 1988). In particular, clinical effectiveness focuses on 
conformity to evidence-based practice or any health care standards and norms that are 
considered to be legitimate (Campbell et al., 2000). Effectiveness of interpersonal care 
reflects the quality of interpersonal interactions between the provider and the patient 
that is considered to have influence on patient health status and patient satisfaction 
(Beaulieu, Haggerty, Beaulieu, Bouharaoui, Lévesque, Pineault, Burge and Santor, 
2011).  
When an outcomes assessment is undertaken, data regarding the impact of health 
care delivery is collected (e.g. indicators regarding the improvement in health care 
status). Several authors have argued that outcomes assessment should play a central role 
in the investigation of effectiveness in primary care delivery (e.g. Amado and Dyson, 
2008). However, the challenges involved in accurately measuring outcomes 
achievement in the health care context have also been acknowledged. The major 
challenges include the difficulty in attributing outcomes to specific actions carried out 
by health care providers, the existence of considerable time lags between certain health 
care processes and outcomes, and the interference of environmental factors (Lester and 
Roland, 2009). In this respect, it is essential that outcomes measurement accounts for all 
these aspects.  
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Having presented the conceptual framework that served as a basis for the analysis 
of the reviewed studies, we will now discuss the protocol used for the systematic review 
of the literature.  
 
2.3 Methods 
The article search and selection process adopted in this study followed the 
protocol of a systematic literature review. As stated by Petticrew and Roberts (2006), 
systematic reviews aim to provide a comprehensive and reliable overview of the 
evidence with regards to the specified research questions by following strict scientific 
protocols in the selection and analysis of the studies. For the article search we initially 
selected six keywords, namely, “performance”, “*efficiency”, “productivity”, 
“*equity”, “accessibility”, and “*effectiveness” (an asterisk is used for searching related 
terms, e.g. “cost-efficiency” and “inefficiency”). These keywords were then 
successively combined with each of the following sets of terms: “measur*”, “manag*”, 
“assess*”, “evaluat*”, “Data Envelopment Analysis”, “Stochastic Frontier Analysis” 
(an asterisk is used for searching a noun and a verb, e.g. “measurement” and “measure”) 
and with “primary care”, “primary health care”, “health centre*”, “health center*”, 
“health care centre*”, and “health care center*” (an asterisk is used for searching plural 
forms of the keywords) (Figure 2.2).  
We searched for these keyword combinations in the title, abstract, and subject 
terms of the papers published between January 1968 and December 2014 and indexed in 
the EBSCOhost electronic databases, including Academic Search Complete, CINAHL 
Plus, and Medline. 
As shown in Figure 2.3, we found 7527 papers that met the search criteria. After 
screening the titles, 2040 duplicates were removed, resulting in 5487 potentially 
relevant papers for further analysis. We then read the abstracts of these articles and 
excluded from further review those papers that did not meet the inclusion criteria 
indicated in Table 2.1. This resulted in 340 papers being selected for full-text screening. 
After reading the full text, we excluded those papers that did not meet the inclusion 
criteria. As a result, from the initial 7527 entries derived from the electronic database 
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search 130 papers were included in our review. Thirty-six additional papers were 
retrieved by means of reference mining. In total, 166 studies were included in this 
literature review. 
 
Figure 2.2 Search criteria tree 
 
 
 
 
 
 
 
 
 
Figure 2.3 Flow chart of the systematic paper search and selection 
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Table 2.1 Inclusion and exclusion criteria  
Study 
characteristic 
Inclusion criteria Exclusion criteria 
Study objective Studies that aim to assess the 
performance of primary health care 
organisations 
Studies that focus solely on performance 
assessment in secondary or tertiary 
health care 
Studies that report on national health 
strategy assessment; information health 
system evaluation; staff knowledge, 
attitudes, satisfaction, and workforce 
development; diagnostic and treatment 
innovations within the context of 
primary health care 
Study population The units of analysis include primary 
health care organisations of any type 
and dimension; they might be 
aggregated at a higher level (e.g. 
municipalities or district authorities) 
or decomposed into constituents (e.g. 
specific services provided, individual 
practitioners within a general 
practice)  
The units of analysis only include 
hospitals and/or specialty care providers 
 
Study design Empirical studies with an application 
using real data 
Observational and experimental studies 
reporting findings on the evaluation of 
medical interventions and programmes; 
validation studies that aim to test 
questionnaires or performance 
measurement systems without applying 
real data; theoretical and discussion 
papers, editorials, literature reviews, 
policy documents 
Study publication Peer-reviewed papers written in 
English and published between 
January 1968 and December 2014 
Papers not written in English; papers not 
peer-reviewed 
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2.4 Results 
2.4.1. Characteristics of the studies 
Before discussing the results of the literature review, we will provide summary 
statistics of the sample of the articles selected for the study. A detailed description of 
each study reviewed is presented in Table A1 in Appendix A. 
Figure 2.4 shows the distribution of the papers according to the year of 
publication. As can be observed, only four papers of the sample were published prior to 
1990, which can be partly explained by the widespread political unacceptance of any 
kind of organisational performance assessment in health care until the nineties (Lester 
and Roland, 2009). After 1990, we can distinguish three chronological periods based on 
the average number of publications per year: from 1991 to 1998 (on average 2 papers 
published per year), from 1999 to 2010 (on average 8 papers published per year), and 
from 2011 to 2014 (on average 13 papers published per year). This generally increasing 
trend indicates the growing relevance of the research topic over the recent years, an 
issue that was also brought into sharp focus by one of the WHO reports (WHO, 2008). 
 
Figure 2.4 Number of selected papers by year of publication 
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As for the geographical distribution of the studies, the 166 papers explored the 
performance of primary care providers from 42 countries across the world. As shown in 
Figure 2.5, more than half of the studies (96 studies) were conducted in the United 
States of America (USA), Canada, and the United Kingdom (UK), three countries that 
have highly developed health care systems. At the same time, we also found a 
significant number of papers focusing on primary care assessments in developing 
countries of Africa and Asia.  
Finally, we looked at the medical conditions explored in the papers. Of the 166 
articles analysed, 123 papers examined primary health care in general, without focusing 
on a particular disease or by studying the management of different medical conditions. 
Fourteen studies of the sample were devoted to the assessment of maternal and child 
care. Eleven studies focused on chronic disease management (diabetes, asthma, 
hypertension, coronary heart disease, and congestive heart failure). The remaining 18 
papers were devoted to the examination of dental care (7 studies), acute/non-acute 
infectious disease management (sinusitis, otitis, tuberculosis, HIV) (6 studies), mental 
health care (3 studies), and preventive care (diagnostic screening and vaccination) (2 
studies). 
 
2.4.2 Performance dimensions and indicators used in primary 
care assessment 
 
2.4.2.1 Accessibility 
From the 166 reviewed papers, there are 59 that focused on the measurement of 
accessibility. As shown in Table 2.2, 50 studies have measured organisational 
accessibility. Access via telephone/ease of contact, ability to get an appointment when 
needed/waiting time, and working hours/out-of-hours service were the most commonly 
explored provider characteristics (e.g. Llanwarne, Abel, Elliott, Paddison, 
Lyratzopoulos, Campbell and Roland, 2013; Tourigny, Aubin, Haggerty, Bonin, Morin, 
Reinharz, Leduc, St-Pierre, Houle, Giguère, Benounissa and Carmichael, 2010; 
Montgomery, Irish, Wilson, Chang, Li, Rogers and Safran, 2004). In essence, these 
measures aim to reflect when and how a health care provider can be accessed. Staff 
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Figure 2.5 Number of selected papers by country studied 
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Table 2.2 Classification of accessibility measures 
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Economic accessibility 
Insurance coverage among patients                                                              
Payment requirements and policies                    X                         X           X  
Additional direct costs     X                                                       
Opportunity costs      X                                                   X  
Geographical 
accessibility 
Convenience of provider location     X                           X                           
Transportation to/from medical consultations     X                                                       
Travel distance/time to provider   X         X X             X       X   X         X X X     
Organisational 
accessibility 
Access via telephone/ease of contact         X X                   X X X X     X X   X       X  
Adequacy and availability of premises, 
equipment, and medication 
    X               X X X X           X                 X  
Ability to get an appointment when needed/ 
waiting time 
    X     X                   X X X X     X     X       X  
Existence of language barriers             X X                                             
Staff availability  X       X   X X       X X X X       X   X         X X X X  
Working hours/out-of-hours service         X X     X   X         X X X X           X       X  
Service availability 
(comprehensiveness) 
Range of health care services         X X     X   X X       X X     X     X X         X  
Range of social support services     X                                                       
Realised accessibility 
Presence of unmet health care needs       X                                                     
Rate of avoidable hospital admissions                                                           X 
Utilisation rate of health care services     X X           X                   X       X             
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Table 2.2 Classification of accessibility measures (continued) 
Sub-dimension Classification of PIs 
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Economic accessibility 
Insurance coverage among patients                    X         X                       X     3 
Payment requirements and policies        X           X   X X                           X     8 
Additional direct costs                                                           1 
Opportunity costs                                                            2 
Geographical 
accessibility 
Convenience of provider location                       X X               X                 5 
Transportation to/from medical consultations                                                     X     2 
Travel distance/time to provider X X           X                                           12 
Organisational 
accessibility 
Access via telephone/ease of contact       X X       X     X X     X X X     X X       X   X X 23 
Adequacy and availability of premises, 
equipment, and medication 
    X                     X                   X X         11 
Ability to get an appointment when 
needed/waiting time 
    X X X             X X     X X X X   X X     X X   X X 24 
Existence of language barriers                                 X X       X         X     6 
Staff availability  X X                 X     X X       X           X         21 
Working hours/out-of-hours service     X   X X X   X     X X     X X X     X X   X     X     24 
Service availability 
(comprehensiveness) 
Range of health care services     X   X                       X X       X       X X   X 19 
Range of social support services                                 X                 X X   X 5 
Realised accessibility 
Presence of unmet health care needs                             X                             2 
Rate of avoidable hospital admissions           X X       X                                     4 
Utilisation rate of health care services                   X                   X     X X     X     10 
  
25 
 
availability, another parameter of organisational accessibility, was measured by 
population-to-provider ratios (e.g. Teach, Guagliardo, Crain, McCarter, Quint, Shao and 
Joseph, 2006), the presence of staff members at health facilities (e.g. Macinko, Almeida 
and de Sá, 2007), and the number of providers accepting new patients (e.g. Hall, 
Lemak, Steingraber and Schaffer, 2008). Less representative in this group were 
indicators related to the adequacy and availability of physical resources (facilities, 
equipment, and medication) (e.g. Geboers, Mokkink, van Montfort, van den Hoogen, 
van den Bosch and Grol 2002) and related to the existence of language barriers (e.g. 
Weiss, Haslanger and Cantor, 2001). 
Service availability is another component of accessibility that has been frequently 
discussed in the reviewed literature. More specifically, it has been analysed in 20 
reviewed papers. The importance of this sub-dimension and the reason why service 
availability is frequently seen as a part of accessibility derives from the assumption that 
a large supply of services makes the provider more accessible to people with different 
health care needs. In a number of studies, service availability was also used as an 
equivalent to comprehensiveness of health care (e.g. Tsai, Shi, Yu, Hung and Lebrun, 
2010; Breyer, 1977). According to these studies, a comprehensive health care system 
provides a range of services that is wide enough to meet the common needs of the 
population. 
Geographical accessibility has, in turn, been explored in 18 papers. This 
performance sub-dimension has frequently been measured in combination with 
organisational accessibility, given that a number of the reviewed studies used composite 
indicators that account for provider availability and travel distance/time to provider (e.g. 
Bell, Wilson, Bissonnette and Shah, 2013; Bissonette, Wilson, Bell and Shah, 2012; 
Luo and Wang, 2003). According to McGrail and Humphreys (2009), this approach 
allows researchers to extend the use of simple population-to-provider ratios to more 
sophisticated accessibility measures. Specifically, these advanced measures estimate 
provider availability within the population catchment areas defined by provider 
proximity to its potential users rather than on the basis of administrative division of the 
studied territories. However, the application of this approach becomes limited when 
individuals are not eligible to select primary care providers outside their residential 
areas, particularly, if these providers are practicing in the public sector. 
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A distinct subset of indicators has been used in 15 papers out of the 166 papers 
reviewed. These indicators aim to measure realised accessibility and they provide 
evidence of the extent to which access to primary care services has actually been 
realised. For example, Tilley and Chalkley (2005) estimated the number of patients that 
have received any kind of treatment in the UK General Dental Service within a six-year 
period as a measure of realised accessibility. This measure, along with other similar 
ones, such as the number of home visits (Arakawa, Arcêncio, Scatolin, Scatena, 
Ruffino-Netto and Scatena Villa, 2011; Varatharajan, Thankappan and Jayapalan, 2004) 
and the average number of visits per period (Lewis and Holcomb, 2012; Edward, 
Kumar, Kakar, Salehi, Burnham and Peters, 2011; Weiss et al., 2001), represent the 
utilisation rates of health care services and have commonly been used to evaluate 
realised accessibility. Other examples of indicators related to the measurement of 
realised accessibility include the presence of unmet health care needs (Aysola, Bitton, 
Zaslavsky and Ayanian, 2013) and the rate of avoidable hospital admissions (e.g. 
Manzoli, Flacco, De Vito, Arcà, Carle., Capasso, Marzuillo, Muraglia, Samani and 
Villari, 2014). Both indicators provide evidence of patients not having accessed a 
primary care provider despite needing to. In analysing unmet health care needs, this is 
done by direct investigation of unsatisfied demand in the receipt of health care services. 
The high rate of avoidable hospital admissions is believed to reflect poor access to high-
quality primary care for patients with ambulatory sensitive conditions, given that these 
conditions could effectively be managed in the outpatient setting. However, the 
relationship between performance in primary care and hospital care should be explored 
further, as suggested by the results of some studies (e.g. Dusheiko, Gravelle, Martin, 
Rice and Smith, 2011). 
Concerning economic accessibility, it mainly matters for those countries where 
the delivery of health care is not free at the point of use. We believe that this is the 
reason why its assessment is not very common among the reviewed studies. 
Specifically, only 10 papers have included this sub-dimension in their analysis. Without 
universal health coverage, the access to health care is secured by public and private 
insurance programmes, such as in the case of the USA. In this situation uninsured and 
low-income populations may experience difficulties in accessing health care systems, 
and the implementation of special payment requirements and policies aims to mitigate 
this problem (e.g. Radford, Pink and Ricketts, 2007; Montgomery et al., 2004). The 
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study of the influence of payer mix among patients also contributes to the understanding 
of economic accessibility among individuals covered by different health care plans and 
the uninsured population (e.g. Weiss et al., 2001). However, it is important to recognise 
that financial barriers may exist even if health care delivery is free of charge. These 
include costs directly associated with the access to a health care system (e.g. 
transportation expenses to arrive at a health care facility (Arakawa et al., 2011)) and 
opportunity costs due to losses in earnings (e.g. working days missed due to medical 
consultations (Arakawa et al., 2011; Macinko et al., 2007)). 
To synthesise, the literature dealing with the measurement of accessibility to 
primary care services allows us to draw several conclusions. Firstly, it suggests that the 
measurement of accessibility can focus on the potential and/or on the realised access to 
health care providers. The former concept assesses the level of potential accessibility to 
services and corresponds to the prospective approach to measuring accessibility. The 
latter concept focuses on the actual use (or non-use) of health care services rather than 
on the possibility of such use, and it corresponds to the retrospective approach to 
measuring access to services. Secondly, although realised accessibility is highly 
correlated with potential accessibility, this relationship has not been captured by the 
indicators proposed in the reviewed studies. The conceptual economic literature 
suggests that potential access to a provider will be realised as long as the expected 
benefits from the consumption of health care services exceed the cost and time 
investments to be incurred by contact with the health system. This means that the 
decision to access a health care provider largely depends on the patients’ personal 
valuations and priorities. In the particular case of primary health care, it is hypothesised 
that the influence of these factors may result in routine check-ups, preventive services, 
and health education sessions being placed in a less favourable position, given that these 
kinds of services do not normally produce immediate health improvements. However, 
this hypothesis should be carefully verified in future empirical research. 
 
2.4.2.2 Equity 
Equity has been assessed in 33 studies of the 166 studies included in the review. 
Concerning the equity perspective, most reviewed studies have concentrated on the 
measurement of horizontal equity. We believe that this can be explained by the fact that 
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the assessment of vertical equity in health care is difficult to perform accurately (Sutton, 
2002). In our review only one out of the 33 studies that assessed equity has attempted to 
measure vertical equity. Specifically, Dahrouge, Hogg, Tuna, Russell, Devlin, Tugwell 
and Kristjansson (2010) explored vertical inequities in primary health care delivery for 
male and female patients in Canada. However, since the authors have not specified their 
judgements about the extent to which health care use should vary between men and 
women, the results of the vertical equity evaluation in this study should be treated with 
caution. Below we discuss each of the equity sub-dimensions analysed in the reviewed 
studies. 
Equity of access has been analysed in 23 studies. As one can see by comparing 
Table 2.3 with Table 2.2, equity of access shares identical groups of indicators with 
accessibility. However, the main distinction of an equity analysis from an accessibility 
analysis is that the former considers the needs of specific patient groups rather than all 
individuals at once.  
Similarly to the analysis of accessibility, the organisational characteristics of 
primary care providers has attracted the most attention in the study of equity of access, 
being explored in 17 studies (e.g. Toda, Opwora, Waweru, Noor, Edwards, Fegan, 
Molyneux and Goodman, 2012; Gesler, Sherman, Spencer, Preisser, Arcury and Perin, 
2006). In particular, staff availability was the most explored provider characteristic, 
followed by the ability to get an appointment when needed/waiting time, working 
hours/out-of-ours service, access via telephone/ease of contact, and, finally, the 
adequacy and availability of physical resources. Disparities in staff availability raised 
the greatest interest in geographical context among the reviewed studies, since more 
deprived and rural areas are frequently known to have shortages of health care 
professionals.  
Realised equity of access has also been commonly studied in the reviewed papers. 
This was done via the assessment of disparities in unmet health care needs (Aysola et 
al., 2013), avoidable hospital admissions (e.g. Gusmano, Weisz, Rodwin, Lang, Qian, 
Bocquier, Moysan and Verger, 2013), and health services’ utilisation rates (e.g. Ridde, 
Haddad and Heinmüller, 2013). Overall, ten studies have analysed various patient-
related parameters that may cause a disadvantage in gaining access to primary care 
providers. Most commonly, the evaluation of equity in realised access aimed to explore  
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Table 2.3 Classification of equity measures 
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Equity of 
access 
Ability to get an appointment when 
needed/waiting time 
      X X       X  X            X X    6 
Access via telephone/ease of contact       X X      X                X    4 
Additional direct costs                  X                 1 
Adequacy and availability of 
premises, equipment, and medication 
                              X   1 
Convenience of provider location              X X  X            X     4 
Opportunity costs                  X                 1 
Payment requirements and policies             X X                    2 
Presence of unmet health care needs   X                               1 
Range of health care services                              X X   2 
Rate of avoidable hospital admissions            X                X      2 
Staff availability  X       X X   X  X  X    X  X  X    X  X X X 13 
Travel distance/time to provider          X   X    X        X       X X 6 
Utilisation rate of health care services   X     X  X     X      X X  X  X        8 
Working hours/out-of-hours service       X X      X X               X    5 
Equity of 
treatment 
Management of chronic diseases X     X X   X       X           X X 
 
X             X     
  
    9 
Patient-provider interaction             X X             X   X                       X X   
  
6 
Receipt of preventive care and health 
promotion services 
    X   X X X X                                     X             6 
Equity of 
outcomes 
Health status parameters                     X         X   X X X             X             6 
Health-related quality of life      X                                                             1 
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the influence of patients’ race/ethnicity, socio-economic status of individuals and of 
residence areas on the utilisation rates of health care services. 
The exploration of disparities in geographical access has been addressed in nine 
studies (e.g. Lemos, Alves, Oliveira, Rodrigues, Martins and Croda, 2014; Idzerda, 
Adams, Patrick, Schrecker and Tugwell, 2011). This characteristic was mainly 
measured through travel time/distance to providers and convenience of providers’ 
location among patients of different race/ethnicity and patients residing in areas of 
differing degrees of rurality. The relevance of such focus can be explained by the fact 
that, on the one hand, racial/ethnic minorities frequently experience sociocultural 
barriers in accessing health care providers due to linguistic isolation and cultural 
differences. On the other hand, the rural population may also be placed in a 
disadvantaged position in comparison to urban citizens, as it is common to observe 
asymmetrical distribution of health care providers within the countries.  
Disparities in economic access to primary care services have not received much 
attention from researchers, as only three studies have focused on this issue (Lemos et 
al., 2014; Idzerda et al., 2011; Kelaher, Dunt, Day and Feldman, 2006). At the same 
time, the ability to pay for the receipt of health care services is directly linked to the 
socio-economic status of individuals, a characteristic which has been commonly 
considered in the context of equity analysis.  
In what concerns disparities in service availability, only two papers have assessed 
these types of disparities. Specifically, Stevens and Shi (2002) explored the differences 
in the range of services available for children of different race/ethnicity, whereas Toda 
et al. (2012) analysed the availability of services across areas with different socio-
economic status. 
Concerning equity of treatment, we have identified 11 studies that have made an 
assessment of this sub-dimension. Most equity studies belonging to this group have 
assessed racial and/or ethnic disparities in the treatment provided to patients. In 
particular, the reviewed studies have assessed the discrepancies in compliance with 
chronic disease management protocols (e.g. Lemos et al., 2014; Gray, Millett, Saxena, 
Netuveli, Khunti and Majeed, 2007) and in the delivery of preventive care and health 
promotion services (e.g. Aysola et al., 2013; Coughlin, Leadbetter, Richards and 
Sabatino, 2008) in relation to patients of different race/ethnicity. In both cases the 
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studies aimed to reveal whether racial/ethnic minorities tend to receive a different 
volume of health care services compared to non-minorities. However, beyond simple 
utilisation rates, which are frequently used to evaluate the level of realised accessibility, 
appropriateness and completeness of the treatment provided to patients has also been 
considered. In addition, equity of clinical treatment has also been assessed with regards 
to patients’ age (Buja, Damiani, Gini, Visca, Federico, Donato, Francesconi, Marini, 
Donatini, Brugaletta, Baldo and Donata Bellentani, 2014), gender (Dahrouge et al., 
2010), level of income and education (Dahrouge, Hogg, Ward, Tuna, Devlin, 
Kristjansson, Tugwell and Pottie, 2013; Carrier, Schneider, Pham and Bach, 2011), and 
residence (Amado and Dyson, 2009).  
In the context of patient-provider interpersonal interactions, disparities in 
treatment may result from differences in the perceptions, valuations, and prejudices held 
by health care staff in relation to certain patient groups. The reviewed studies have 
addressed this issue for patients of different race/ethnicity (Lemos et al., 2014; Shi, 
Lebrun-Harris, Parasuraman, Zhu and Ngo-Metzger, 2013; Stevens and Shi, 2002), 
gender (Dahrouge et al., 2010), level of income and education (Dahrouge et al., 2013), 
insurance coverage (Shi et al., 2013), and for patients living in areas with differing 
degrees of rurality (Lamarche, Pineault, Haggerty, Hamel, Levesque and Gauthier, 
2010). 
Finally, equity of health care outcomes has been analysed in seven studies. The 
relatively lower number of the reviewed papers in this category can possibly be 
explained by the significant challenges involved in the measurement of this sub-
dimension, most commonly associated with the need for rigorous case-mix control. All 
studies belonging to this group have investigated racial/ethnic disparities in health care 
outcomes. This was done via the assessment of racial/ethnic disparities in health status 
parameters for patients with chronic conditions (e.g. Gray et al., 2007) and for newborns 
(Lebrun, Shi, Zhu, Sharma, Sripipatana, Hayashi, Daly and Ngo-Metzger, 2013) and the 
assessment of these disparities in health-related quality of life indicators for children 
with asthma (Aysola et al., 2013). 
In conclusion, several important issues must be taken into consideration in the 
analysis of equity. The first issue relates to the fact that it is essential to choose an 
appropriate perspective on equity measurement. The empirical studies undertaken until 
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now have mostly been concentrated on the assessment of horizontal inequities in 
primary health care. However, it might be the case that certain patient-related 
parameters should be considered from the vertical perspective. In particular, in the 
reviewed studies we found evidence of discrepancies in treatment and health care 
outcomes in relation to racial/ethnic minority groups in the UK and the USA, 
suggesting that some unobserved factors associated with racial/ethnic origin may affect 
the use and the outcomes of primary health care. If these factors are inherent, such as 
cultural differences related to health behaviours or genetic predisposition to certain 
diseases, then the application of the vertical perspective is more relevant for the analysis 
of racial/ethnic disparities. From this standpoint, patients’ race/ethnicity can be viewed 
as a discriminating parameter for the purpose of equity analysis. Therefore, an 
appropriate distinction between discriminating and non-discriminating parameters that 
can (or cannot) affect the need for health care is another important issue to consider in 
future studies of equity in health care. 
 
2.4.2.3 Efficiency 
We identified 75 studies that reported the results of efficiency analysis (Table 
2.4). To facilitate the analysis of these studies, we divided them into two broad 
categories depending on the approach used to measure the efficiency of health care 
providers.  
The first category of studies has applied a single measure of input or output to 
develop partial ratio-based measures of efficiency. A total of 10 studies are included in 
this category (please refer to Table A1 in Appendix A). The partial measures of 
efficiency used relate to the number of consultations per patient (Lewis and Holcomb, 
2012; Varatharajan et al., 2004; Abrams, Savela, Trinity, Falik, Tutunjian and Ulmer, 
1995), total/average cost per visit (Heard, Nath and Loevinsohn, 2013; Radford et al., 
2007; Venning, Durie, Roland, Roberts and Leese, 2000; Utriainen and Widström, 
1990), and the number of patients seen per hour (Baker, 1992; Breyer, 1977) among 
other ratios.  
The second category of studies has assessed relative efficiency of a sample of 
providers by incorporating simultaneously multiple inputs and multiple outputs in the  
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Table 2.4 Classification of efficiency measures 
  GROUP 1 
Input/output group Classification of PIs 
A
m
ad
o
 &
 S
an
to
s 
(2
0
0
9
) 
A
n
d
es
 e
t 
al
. 
(2
0
0
2
) 
B
u
ck
 (
2
0
0
0
) 
C
o
ll
ie
r 
et
 a
l.
 (
2
0
0
6
) 
D
ra
p
er
 e
t 
al
. 
(2
0
0
0
) 
H
u
an
g
 &
 M
cL
au
g
h
li
n
 (
1
9
8
9
) 
F
er
re
ir
a 
et
 a
l.
 (
2
0
1
3
) 
K
ir
ig
ia
 e
t 
al
. 
(2
0
0
1
) 
K
ir
ig
ia
 e
t 
al
. 
(2
0
0
4
) 
K
ir
ig
ia
 e
t 
al
. 
(2
0
0
8
) 
K
ir
ig
ia
 e
t 
al
. 
(2
0
1
1
) 
K
o
n
to
d
im
o
p
o
u
lo
s 
et
 a
l.
 (
2
0
0
6
) 
K
o
n
to
d
im
o
p
o
u
lo
s 
et
 a
l.
 (
2
0
0
7
) 
M
ar
at
h
e 
et
 a
l.
 (
2
0
0
7
) 
(M
1
) 
M
as
iy
e 
et
 a
l.
 (
2
0
0
6
) 
(M
1
) 
M
as
iy
e 
et
 a
l.
 (
2
0
0
6
) 
(M
2
) 
O
se
i 
et
 a
l.
 (
2
0
0
5
) 
(M
1
) 
O
se
i 
et
 a
l.
 (
2
0
0
5
) 
(M
2
) 
P
el
o
n
e 
et
 a
l.
 (
2
0
1
2
) 
R
ah
m
an
 &
 C
ap
it
m
an
 (
2
0
1
2
) 
R
am
ír
ez
-V
al
d
iv
ia
 e
t 
al
. 
(2
0
1
1
) 
(M
1
) 
R
am
ír
ez
-V
al
d
iv
ia
 e
t 
al
. 
(2
0
1
1
) 
(M
2
) 
R
en
n
er
 e
t 
al
. 
(2
0
0
5
) 
R
o
ll
in
s 
et
 a
l.
 (
2
0
0
1
) 
R
o
se
n
m
an
 &
 F
ri
es
n
er
 (
2
0
0
4
) 
(M
1
) 
R
o
se
n
m
an
 &
 F
ri
es
n
er
 (
2
0
0
4
) 
(M
2
) 
S
ch
m
ac
k
er
 (
2
0
0
8
) 
S
eb
as
ti
an
 &
 L
em
m
a 
(2
0
1
0
) 
S
zc
ze
p
u
ra
 e
t 
al
. 
(1
9
9
3
) 
T
h
an
as
so
u
li
s 
et
 a
l.
 (
1
9
9
5
) 
Z
av
ra
s 
et
 a
l.
 (
2
0
0
2
) 
(M
1
,M
2
) 
Labour resources (I) 
Administrative, technical, support staff P P     C P P P P   P   P   P C P P         P C P C P   P   P 
Medical staff P P P P C P P P P P P P P P P C P P P P C C P C P C P P P P,C P 
Health care services and 
ancillary resources (I) 
Ambulatory procedures                                                               
Diagnostic and laboratory tests                                                               
Materials and equipment                                                               
Medications/prescriptions                                                               
Referrals to specialists                                                               
Visits                                                               
Capital assets (I) Square footage/depreciation/total assets   P                                             C P P         
Total, operating, and 
other costs (I) 
Operating costs                                       C   C                   
Other costs         C       C                             C C             
Total costs             C                                                 
Other inputs (I) 
Hospital care related inputs         C       P     P           P           C               
Atypical and specific inputs                                                             P 
Health care services (O) 
Ambulatory procedures                                                 P P           
Deliveries/abortions               P                 P P         P         P   P   
Diagnostic and laboratory tests     P                   P                       P P     P  P 
Health education sessions     P       P       P                       P         P      
Other health care services provided P           P     P P P                               P      
Vaccinations and immunisations P           P   P P P           P P P       P           P    
Visits/episodes of care P   P   P P P P P P P P P P P P P P   P P P P P     P P   P P 
Total health care services provided   C   C                               P                      
Patients (O) 
Registered patients                                                         P    
Treated patients                                                       P   P   
Quality indicators (O) 
Indicators on accessibility                                     P                         
Composite quality indicators                                                               
Indicators on effectiveness       R                                                    P   
Other outputs (O) 
Hospital care related outputs         P             P           P P         P               
Atypical and specific outputs                                                          P  P   
I – input, O – output, P – physical units, C – costs/monetary units, R – percentage, S – index, M1-M5 – order number of a model specification in a study (if applicable) 
 
34 
 
Table 2.4 Classification of efficiency measures (continued) 
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Table 2.4 Classification of efficiency measures (continued) 
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development of efficiency models (Table 2.4). A total of 65 studies are included in this 
category. A significant number of studies in this category combine in a single model 
two types of inputs: inputs in terms of the quantities of resources used and inputs in 
terms of costs, making it difficult to identify which type of efficiency is analysed. 
Nevertheless, considering that the authors of these studies have used different 
combinations of inputs and outputs, we consider it helpful to cluster the studies into six 
main groups. In what follows, we discuss the main characteristics of the approaches 
used to measure efficiency in the studies belonging to each of the groups. 
Group 1. The most common approach to measuring the efficiency of primary 
care providers involves relating the quantity (or cost) of human resources with the 
quantity (or value) of services delivered. The indicators related to the quantity of human 
resources are mainly expressed by the number of employed staff members, frequently 
separated by professional type into medical and non-medical categories. In some of the 
studies, full-time equivalents (FTEs) have been used to account for full and part-time 
employees (e.g. Rosenmann and Friesner, 2004; Andes, Metzger, Kralewski and Gans, 
2002). Alternatively, total working time devoted to specific health care activities has 
been estimated (e.g. Thanassoulis, Boussofiane and Dyson, 1995). However, as noted 
by Thanassoulis et al. (1995), the distribution of working time between different 
activities is often difficult to measure accurately, since it is rarely recorded in routine 
practice. The costs of labour resources have usually been measured by the compensation 
paid to health care staff. 
In addition to labour inputs, some authors have included capital inputs, expressed 
by square footage of practices (Schmacker and McKay, 2008; Rosenman and Friesner, 
2004; Andes et al., 2002) and total assets (Rosenman, Siddharthan and Ahern, 1997). 
Depreciation of equipment has also been considered (Marschall and Flessa, 2011). From 
a theoretical perspective, this approach is in line with the classical definition of 
production factors.  
The output measures used in the studies of this group refer to the different health 
care services provided. They have been most frequently measured by the number of 
visits (i.e. episodes of care), followed by the number of vaccinations and immunisations 
(e.g. Pelone, Kringos, Valerio, Romaniello, Lazzari, Ricciardi and Giulio de Belvis, 
2012; Amado and Santos, 2009), deliveries/abortions (e.g. Renner, Kirigia, Zere, Barry, 
37 
 
Kirigia, Kamara and Muthuri, 2005; Thanassoulis et al., 1995), diagnostic and 
laboratory tests (e.g. Buck, 2000; Szczepura, Davies, Fletcher and Boussofiane, 1993), 
health education sessions (e.g. Kirigia, Sambo, Renner, Alemu, Seasa and Bah, 2011; 
Sebastian and Lemma, 2010), and ambulatory procedures (e.g. Rosenman and Friesner, 
2004). Other indicators of health care services include indicators related to the provision 
of more specific actions undertaken by health care staff, for example, a measure of the 
assistance provided to patients with systematic arterial hypertension (Rabetti and 
Freitas, 2011) or the number of special examinations undertaken (Luoma, 1996). 
Group 2. The studies that belong to this group have also used the total number of 
visits as the main output measure. However, these studies can be distinguished from 
those in group 1 by the types of inputs considered. The studies in group 2 complement 
labour inputs with other measures of inputs. Specifically, inputs related to the use of 
ancillary services, such as diagnostic and laboratory tests (García, Marcuello, Serrano 
and Urbina, 1999; Defelice and Bradford, 1997), inputs related to referrals to specialists 
(García et al., 1999), inputs related to materials and equipment (Linna, Nordblad and 
Koivu, 2003), and inputs related to medications (e.g. Cordero-Ferrera, Crespo-Cebada 
and Murillo-Zamorano, 2011; Pina and Torres, 1992). The inclusion of these input 
variables aims to make a fairer assessment of relative efficiency, considering that a 
higher number of visits may be easier to secure for some providers if more ancillary 
services and resources are available. However, it is important to point out that there is 
no unique pattern in the treatment of different health conditions that could justify, for 
example, identical needs in medications or diagnostic tests for all patients seen by a 
provider. For this reason, combining this type of inputs with outputs related to the total 
number of visits could be potentially misleading without an appropriate case-mix 
adjustment. This adjustment is essential to control for factors affecting the intensity of 
use of ancillary services and resources. 
An aspect that is relevant for the majority of studies in groups 1 and 2 is that a 
larger volume of health care services does not necessarily indicate higher quality of 
care. To overcome this shortcoming, some of the studies that belong to group 1 and 2 
include measures related to the quality of care provided, such as the rate of avoidable 
hospital admissions (Pelone et al., 2012), patient satisfaction indicators (Collier, Collier 
and Kelly, 2006; Thanassoulis et al., 1995), survival rate among newborns 
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(Thanassoulis et al., 1995), and composite quality indicators (Murillo-Zamorano and 
Petraglia, 2011; García et al., 1999).  
Group 3. This group includes models that estimate the efficiency of health 
maintenance organisations (HMOs) and other managed care providers in the USA. 
Attempting to restrain health care costs, HMOs have implemented the capitation-based 
system, according to which contracted physicians receive a fixed payment for each 
registered patient (Zuvekas and Cohen, 2010). At the same time, HMO patients have 
gained access to comprehensive primary health care in exchange for a membership fee 
(Chilingerian and Sherman, 1997). Under such circumstances, registered patients 
generate revenues for HMOs, even if they never visit a physician, and an efficient HMO 
would use fewer health care services (inputs) to provide coverage for a certain number 
of enrolled patients (outputs) (Siddharthan, Ahern and Rosenman, 2000; Chilingerian 
and Sherman, 1996). Clearly, this approach to measuring efficiency does not fit other 
models of primary care delivery, in which a prepaid basis for the use of health care 
services is not adopted. 
Group 4. The papers included in this group have considered a patient-related 
output variable, which is the number of patients treated. As implied by its name, this 
measure takes into account only those patients that have actually received treatment. In 
the reviewed studies, this variable has commonly been concentrated on specific 
conditions, such as diabetes (Amado and Dyson, 2009), dental health problems (Linna 
et al., 2003), otitis media (Ozcan, 1998), sinusitis (Ozcan, Jiang and Pai, 2000; Pai, 
Ozcan and Jiang, 2000), and mental illnesses (Tyler, Ozcan and Wogen, 1995; 
Schinnar, Kamis-Gould, Delucia and Rothbard, 1990). With regards to the inputs 
included in these studies, the most frequently used inputs were the costs of labour 
resources and/or the cost of health services provided and ancillary resources consumed. 
Overall, the patient-related outputs used in groups 3 and 4 have frequently been 
controlled for case-mix factors, such as patients’ age, gender, insurance type, residence 
status, residence in deprived/non-deprived areas, and disease severity.  
Group 5. In this group of studies, the health care inputs have been reduced to a 
single measure of costs. In general, the use of total costs as a unique input measure is 
considered to be particularly useful whenever detailed information on the quantities of 
consumed resources and respective prices is not available. This justifies the fact that the 
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components of total costs have not been specified in some studies (e.g. Linna et al., 
2003). In some of the reviewed studies, it is possible to find some variation in terms of 
the cost components included in the calculation of total costs. For instance, Giuffrida 
and Gravelle (2001) included the GPs’ costs and the prescription costs, while Milliken, 
Devlin, Barham, Hogg, Dahrouge and Russell (2011) included medical and non-medical 
staff incomes, operating costs, and capital costs, expressed in rent and depreciation 
values. However, regardless of the nature of the cost components to be included, the 
aggregation of inputs into a single cost variable may also limit the potential of 
efficiency analysis. In particular, the use of a single input will not allow the analyst to 
disentangle between technical and allocative efficiency. The output side of the models 
used in this group of studies does not follow any particular pattern, presenting different 
combinations of the outputs discussed above.  
Group 6. The sixth group of studies includes atypical efficiency models and 
models with specific inputs/outputs. In most cases, these models have been used due to 
specific study objectives. For example, Giuffrida (1999) and Giuffrida and Gravelle 
(2001) developed efficiency models which, among other variables, incorporated outputs 
on the achievement of quality targets by English Family Health Services Authorities in 
order to conclude about the effectiveness of the NHS organisational reforms. We also 
found inputs and outputs that do not fall into the categories discussed above. For 
example, a number of studies have combined the evaluation of primary health care with 
hospital care and, therefore, they have added hospital care related variables into the 
efficiency models (e.g. Bryce, Engberg and Douglas, 2000; Draper, Solti and Ozcan, 
2000).  
Overall, the specifications discussed above constitute the main basis for defining 
inputs and outputs in primary health care. Each of the specifications has its own 
advantages and drawbacks, which make their application dependant on the research 
context and aims. After identification of both inputs and outputs, the evaluation of 
efficiency requires the definition of appropriate weights to each of the selected variables 
and, according to the production theory, the establishment of a clear relationship 
between inputs and corresponding outputs. However, these tasks are far from 
straightforward in a complex setting such as primary health care. In this respect, SFA 
and DEA provide different solutions to both issues, as briefly discussed in Section 2. 
Despite the fact that each method has its own strengths and limitations, we found a 
40 
 
more frequent use of DEA in the reviewed efficiency studies in comparison with 
regression-based methods such as SFA. This can be partly explained by the fact that 
DEA does not require parametric assumptions regarding the relationship between the 
selected inputs and outputs. At the same time, as noted by Jacobs, Smith and Street 
(2006b), the efficiency scores derived from either of the techniques should not be 
treated as accurate efficiency estimates, given their high sensitivity to the choice of 
model specification. 
 
2.4.2.4 Effectiveness 
Effectiveness has been studied in 57 of the 166 papers reviewed (Table 2.5). 
Among all the effectiveness sub-dimensions, the investigation of clinical effectiveness 
has attracted the greatest attention in the reviewed literature, being explored in 39 
papers.  
The achievement of clinical effectiveness is commonly viewed as compliance 
with clinical practice guidelines that comprise a set of standardised algorithms in the 
management of common diseases. For example, an effective diabetes management has 
been defined as the accomplishment of the following activities: eye examination 
performed, foot and leg inspection undertaken, weight/BMI recorded, smoking status 
inquired, blood pressure checked, glycated haemoglobin level tested, cholesterol level 
recorded, kidney function checked, appropriate medications prescribed, treatment 
offered to improve diabetes control (if needed), self-management plan provided (if 
needed), and follow-up scheduled (e.g. Amado and Dyson, 2009; Campbell, Reeves, 
Kontopantelis, Middleton, Sibbald and Roland, 2007; Ulmer, Lewis-Idema, Von 
Worley, Rodgers, Berger, Darling and Lefkowitz, 2000).  
Overall, there are five categories of health care activities that have mostly been 
explored in the management of different medical conditions: diagnostic and laboratory 
tests, health education and counselling, medication management, physical examination, 
and preventive screening, vaccination, and immunisation. Less frequently, clinical 
effectiveness has been measured through the indicators related to characteristics of 
medical history taking, follow-up visits, medical records, symptom relief, and referrals 
to specialists.  
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Table 2.5 Classification of effectiveness measures  
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A
m
ad
o
 &
 S
an
to
s 
(2
0
0
9
) 
A
m
ad
o
 &
 D
y
so
n
 (
2
0
0
9
) 
A
y
so
la
 e
t 
al
. 
(2
0
1
3
) 
B
ar
b
ar
o
 e
t 
al
. 
(2
0
1
4
) 
B
re
y
er
 (
1
9
7
7
) 
C
am
p
b
el
l 
et
 a
l.
 (
2
0
0
7
) 
C
o
ll
ie
r 
et
 a
l.
 (
2
0
0
6
) 
E
d
w
ar
d
 e
t 
al
. 
(2
0
1
1
) 
F
er
re
ir
a 
et
 a
l.
 (
2
0
1
3
) 
F
ri
ed
b
er
g
 e
t 
al
. 
(2
0
0
7
) 
F
u
rt
ad
o
 e
t 
al
. 
(2
0
1
3
) 
G
eb
o
er
s 
et
 a
l.
 (
2
0
0
2
) 
G
iu
ff
ri
d
a 
(1
9
9
9
) 
G
iu
ff
ri
d
a 
&
 G
ra
v
el
le
 
(2
0
0
1
) 
H
ab
ib
 e
t 
al
. 
(2
0
1
1
) 
H
ag
g
er
ty
 e
t 
al
. 
(2
0
0
7
) 
H
ag
g
er
ty
 e
t 
al
. 
(2
0
0
8
) 
H
ea
rd
 e
t 
al
. 
(2
0
1
3
) 
H
ed
ee
n
 e
t 
al
. 
(2
0
0
2
) 
Ja
ak
k
im
ai
n
en
 e
t 
al
. 
(2
0
1
1
) 
Ja
co
b
s 
et
 a
l.
 (
2
0
0
6
a)
 
Ja
iv
ee
r 
et
 a
l.
 (
2
0
0
6
) 
K
el
le
r 
et
 a
l.
 (
2
0
1
4
) 
K
er
n
 e
t 
al
. 
(2
0
1
4
) 
K
le
m
en
c
-K
et
is
 e
t 
al
. 
(2
0
1
4
) 
L
ee
 e
t 
al
. 
(2
0
0
9
) 
L
ew
is
 &
 H
o
lc
o
m
b
 (
2
0
1
2
) 
L
la
n
w
ar
n
e 
et
 a
l.
 (
2
0
1
3
) 
M
ac
in
k
o
 e
t 
al
. 
(2
0
0
7
) 
Clinical 
effectiveness 
Diagnostic and laboratory tests   X       X       X                 X X   X X X     X     
Follow-up visits                         X                   X     X       
Health education and counselling   X       X   X     X       X             X X     X   X   
History taking               X             X                             
Medication management   X       X       X X               X X   X X X     X     
Physical examination   X     X X   X   X         X       X X   X X X X         
Preventive screening, vaccination, and 
immunisation 
    X             X     X X         X X   X X X X X X     
Record of health-related behaviours            X                               X               
Record of standard health status parameters    X       X                               X               
Record of symptoms           X                                               
Referral to specialists           X                                               
Symptom relief           X                                     X         
Other clinical activities           X           X                                   
Effectiveness of 
interpersonal 
care 
Continuity of care       X             X         X X                   X X X 
Quality of patient-provider communication                     X X                         X X   X X 
Length of consultations                     X                           X       X 
Staff behaviour/attitude towards patients       X             X X                         X X   X X 
Patient attitude towasrds health care staff                                                   X   X   
Psychosocial support/distress relief                       X     X                   X         
Whole-person/family-focus orientation       X             X         X                 X X     X 
Outcomes 
achievement  
Health care needs met                                                           
Health-related behaviours                                         X                 
Health-related quality of life     X                                                     
Health status parameters   X       X                         X X   X X       X     
Patient knowledge   X       X                       X                       
Patient satisfaction X X         X X X                                   X X   
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Table 2.5 Classification of effectiveness measures (continued) 
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Clinical 
effectiveness 
Diagnostic and laboratory tests X     X         X   X   X   X       X         X     X X 19 
Follow-up visits X     X           X   X             X     X             9 
Health education and counselling         X X     X X X   X X     X X           X     X X 21 
History taking                   X                                     3 
Medication management       X             X   X X       X X     X   X     X X 20 
Physical examination   X   X X X     X X     X           X     X             21 
Preventive screening, vaccination, and 
immunisation 
            X   X     X   X     X                       17 
Record of health-related behaviours                              X       X         X         5 
Record of standard health status 
parameters  
X                 X                 X         X       X 8 
Record of symptoms X                                   X                   3 
Referral to specialists                         X                 X             3 
Symptom relief                                                         2 
Other clinical activities X                                                       3 
Effectiveness of 
interpersonal 
care 
Continuity of care   X X   X X     X   X   X       X X             X   X   18 
Quality of patient-provider communication   X X   X X     X X X   X         X       X         X   17 
Length of consultations X X X   X X     X   X   X               X           X   13 
Staff behaviour/attitude towards patients   X X   X X     X   X   X       X X       X X   X X X   21 
Patient attitude towards health care staff   X     X X         X                                   6 
Psychosocial support/distress relief                                           X             4 
Whole-person/family-focus orientation   X X   X X     X   X   X       X X             X   X   17 
Outcomes 
achievement 
Health care needs met               X                                         1 
Health-related behaviours                                                         1 
Health-related quality of life                                                         1 
Health status parameters       X       X X     X       X       X       X         14 
Patient knowledge                   X                                     4 
Patient satisfaction                               X         X X             10 
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The accomplishment of specific activities is not the unique parameter captured by 
these types of indicators. Since most health care activities have to be repeated regularly 
within the time frames defined by clinical guidelines, the measurement of clinical 
effectiveness also considers the regularity at which these activities should be 
undertaken. In general, timeliness, appropriateness, and completeness of health care 
delivery are the attributes of care that are essential to consider in the assessment of 
clinical effectiveness.  
Effectiveness of interpersonal care has been studied in 28 of the 166 papers we 
have reviewed. There are five categories of measures that have been most commonly 
explored in the studies: staff behaviour/attitude towards patients, quality of doctor-
patient communication, length of consultations, continuity of care, and whole-
person/family-focus orientation (Table 2.5). Concerning staff behaviour and attitude 
towards patients, the reviewed studies have emphasised the importance of various 
characteristics that are crucial for establishing trustful patient-provider relationships. 
These characteristics include helpfulness, friendliness, caring, respect, patience, 
kindness, courtesy, and concern for patients demonstrated by health care staff (e.g. 
Sequist, Schneider, Anastario, Odigie, Marshall, Rogers and Safran, 2008; Geboers et 
al., 2002; Safran, Wilson, Rogers, Montgomery and Chang, 2002). The quality of 
patient-provider communication, in turn, has been assessed via the evaluation of the 
following characteristics: thoroughness of doctor’s questions about symptoms and 
health-related concerns, attention to what the patient says, allowing time for questions, 
discussion of treatment options, clarity of explanations and instructions, and advice in 
making decisions about care (e.g. Klemenc-Ketis, Kravos, Poplas-Susič, Svab and 
Kersnik, 2014; Safran, Taira, Rogers, Kosinski, Ware and Tarlov, 1998). In addition, 
length of consultations has been used as a proxy measure to estimate the time 
potentially available for interpersonal interactions between the patient and the doctor 
(e.g. Macinko et al., 2007; Venning, Durie, Roland, Roberts and Leese, 2000). 
Continuity of care, another aspect in the measurement of effectiveness of interpersonal 
care, has been related to the patient’s ability to see a designated doctor (e.g. Lewis and 
Holcomb, 2012; Macinko et al., 2007) and the length of patients’ enrolment in the 
practice (e.g. Safran et al., 2002). Finally, whole-person and family-focused orientation 
in service provision has been defined as an important attribute of an effective health 
care delivery (e.g. Furtado, Braz, Pina, de Mello and de Lima, 2013; Montgomery et al., 
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2004), as it ensures the consideration of a patient’s personal and familial characteristics 
in the treatment provided. 
Regarding outcomes achievement, this has been analysed in 25 papers. We found 
that control of health status parameters and patient satisfaction were the most commonly 
explored outcomes of primary care delivery, being assessed in 14 and 10 papers 
respectively. The measurement of health status parameters has often been limited to a 
restricted number of indicators in the reviewed studies. For example, outcomes of 
diabetes control were typically measured by the level of blood pressure, cholesterol 
level and glycated haemoglobin level (e.g. Campbell et al., 2007), despite the fact that 
diabetes management covers a broader range of health issues associated with this 
chronic disease. The measurement of patient satisfaction, in turn, has been used to 
assess the quality of health care delivery as perceived by patients (e.g. Amado and 
Santos, 2009; Collier et al., 2006). Other outcomes of primary care delivery include 
patient knowledge as a result of contacts with the provider (Heard et al., 2013; Amado 
and Dyson, 2009), changes (or their absence) in health-related quality of life (Aysola et 
al., 2013), changes (or their absence) in health-related behaviours (Jacobs, Martin, 
Goddard, Gravelle and Smith, 2006a), and the extent to which health care needs are met 
(Schinnar et al., 1990). 
In summary, several concluding remarks regarding the measurement of 
effectiveness in health care can be provided. As we discussed in Section 2, effectiveness 
in health care can be measured in two distinct ways: directly, by observing the achieved 
outcomes of health care, and indirectly, by investigating the quality of the health care 
process. The selection of an appropriate approach is context-dependant and, despite the 
investigation of outcomes achievement being generally preferred for assessing the 
effectiveness of health care delivery and frequently being viewed as the gold standard, it 
is often impossible to perform or is limited to a restricted number of indicators. 
Moreover, whatever approach is selected, it is essential to guarantee validity of the 
observed performance results. Particularly, attributional validity is crucial to ensure that 
the observed outcomes can be attributed to the health care provided, while causal 
validity reflects the capacity of certain health care processes to produce specified 
outcomes under stipulated conditions (Donabedian, 1980).  
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2.4.2.5 Discussion of the main results regarding the different 
performance dimensions 
Our review allows us to conclude that past studies of performance assessment in 
primary health care have focused on the four dimensions of performance included in the 
framework (accessibility, equity, efficiency, and effectiveness). Specifically, we have 
concluded that efficiency has been the dimension most commonly analysed (75 studies), 
followed by accessibility (59 studies), and effectiveness (57 studies). Despite its 
relevance, only 33 of the reviewed studies have focused on equity.  
The majority of the studies have focused on a single dimension (please refer to 
Table A1 in Appendix A). Nevertheless, it is also possible to find some studies that 
have analysed several dimensions (e.g. Barbaro, Lettiere and Nakano, 2014; Aysola et 
al., 2013; Amado and Dyson, 2009; Amado and Santos, 2009). Given that trade-offs are 
likely to exist between the different performance dimensions, we consider that future 
research studies should make efforts to evaluate several performance dimensions within 
a single framework in order to explore the evidence of trade-offs between them.  
Below we synthesise some of the key features to be considered in the assessment 
of each performance dimension and discuss other directions for future research. 
Accessibility is a prerequisite for contacts to be established between the individual 
and the health care provider. In the health care context the measurement of accessibility 
can be performed from two different perspectives: by investigating the potential 
accessibility of health care providers and by measuring the level of realised access.  
The potential accessibility of health care organisations reflects the presence or 
absence of geographical, economic, and organisational obstacles that may prevent 
potential users from entering into health systems, and also refers to the 
comprehensiveness of available health care services. Despite potential accessibility 
being relatively easy to assess by observing certain provider characteristics, the 
influence of different groups of accessibility factors on each other has not been well-
studied. For example, it might be the case that a smaller range of health care services 
may result in a better organisation of their delivery and, consequently, this may lead to 
the reduction of organisational barriers to access, such as the shortening of waiting lists, 
at the expense of service availability. At the same time, the question about which 
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characteristics possess greater importance in forming an overall level of potential 
accessibility remains unanswered.  
Realised accessibility, in turn, reflects the success or failure in gaining access to a 
primary care provider. In the measurement of realised accessibility it is important to 
consider whether the possibility to access a provider really exists and those 
environmental factors that influence an individual’s decision not to access a provider, 
despite having such an opportunity and recognising the need for health care. We found 
that both issues are relevant for further analysis in order to develop more valid and 
reliable measures on realised accessibility. 
Equity deals with a fair treatment of individuals at every stage and in every aspect 
of health care delivery. A comprehensive assessment of equity demands the analysis of 
all three sub-dimensions – equity of access, equity of treatment, and equity of health 
care outcomes. Furthermore, in order to investigate equity, it is essential to choose 
either a horizontal or vertical perspective on equity measurement as well as to define 
discriminating/non-discriminating patient-related parameters that should (or should not) 
influence the need for health care. The exploration of vertical inequities might be 
relevant in relation to some patient groups. However, its assessment is associated with 
certain challenges that should be explored in future research. In particular, it is 
important to establish criteria on how to appropriately differentiate the volume of health 
care services that is demanded by individuals with different levels of health care needs. 
The relationship between the three sub-dimensions of equity is another important issue 
to consider in the assessment of this dimension. In particular, disparities in access for 
certain patient groups result in hidden inequities in their treatment, since those patients 
that have not succeeded in gaining access to a health care provider automatically do not 
receive the necessary treatment. Similarly, disparities in treatment should, in principle, 
cause disparities in corresponding health care outcomes. If this correlation is not 
confirmed, a more careful control for case-mix factors should be carried out and the 
check of the attributional/causal validity between clinical processes and outcomes 
should be performed.  
Efficiency aims to optimise the use of available resources for the production of 
targeted output levels. In this review we have distinguished six common specification 
patterns that are used for the evaluation of efficiency of primary care providers. 
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Independently of the pattern, the input side of the models is usually measured by the 
quantity (or costs) of labour resources, complemented (or not) with the amount (or 
costs) of ancillary resources, with measures of capital assets, and with other cost 
measures. Some models summarise all inputs in the form of total costs, which is 
considered to be particularly advantageous when the attribution of multiple inputs for 
the production of observed/expected outputs is particularly difficult to perform. 
Regarding the output variables of the models, these frequently include the volume of the 
health care services provided to patients or, alternatively, the number of 
registered/treated patients as an aggregate measure of an expected/performed volume of 
health care services. In some models these outputs are complemented with quality 
measures to account for those provider characteristics that are considered to be 
important attributes of a high-quality primary health care. This is essential to prevent 
activities being performed whenever they can adversely impact the quality of the health 
care provided. Overall, regardless of the choice of the efficiency measurement models 
to adopt, there is still no consensus on how to define the relative importance of the 
multiple outputs produced. It is also unclear how to associate the specific contribution 
of each input with the production of each output. The DEA technique provides one of 
the most commonly adopted solutions to both issues and its application has become 
more frequent for the assessment of efficiency of primary care providers. Nevertheless, 
questions on how to select the most appropriate models and on how to derive robust 
efficiency estimates should be further explored. 
Effectiveness is concerned, in turn, with the accomplishment of the objectives of 
health care, which is usually captured by outcomes achievement. At the same time, the 
assessment of clinical effectiveness and the effectiveness of interpersonal care aim to 
present alternative approaches of effectiveness measurement in health care by exploring 
the quality of two core aspects of the health care process. In particular, clinical 
effectiveness assumes that a targeted impact of health care is likely to occur if health 
care processes correspond to the requirements of evidence-based practice or any 
legitimate health care standards and norms. Effective interpersonal care, in turn, is 
believed to be a good predictor of improved health care outcomes. Yet, the 
correspondence between outcomes and processes of care has to be carefully verified, 
since predicted outcomes may significantly differ from observed consequences of the 
health care provided. For this reason, outcomes measurement remains an essential 
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element in assessing the effectiveness of health care provision, which directs attention 
towards the impact of health care services rather than their attributes and volume. 
Indeed, future empirical research on the evaluation of effectiveness of primary care 
providers should pay more attention to the development of patient-reported outcome 
measures, such as indicators on health-related quality of life, as their measurement can 
provide evidence of the impact of health care on patients’ life beyond standard clinical 
parameters. This will contribute to balancing the functioning of health care systems to 
equally target the achievement of both clinical and non-clinical outcomes. 
 
2.4.3 Exploring stakeholders’ involvement at different stages of 
organisational performance assessment  
As discussed in Section 2, in order to promote performance improvement as a 
response to assessment results, it is fundamental that targeted stakeholders are involved 
during the three stages of the performance assessment process: measurement, analysis, 
and action. Supporting this idea, we analysed in this review how common it has been to 
involve stakeholders in primary care assessment.  
We have summarised the results of our analysis in Table 2.6. Only 17 out of the 
166 studies reviewed provided clear evidence of stakeholders’ involvement at the 
measurement and/or analysis stages. This involvement occurred through discussions 
(Gusmano et al., 2013), focused interviews (Abrams et al., 1995), workshops (Amado 
and Dyson, 2009), expert consultations (Ramírez-Valdivia, Maturana and Salvo-
Garrido, 2011; García et al., 1999) and other forms of collaboration. Judging by the 
evidence provided in the reviewed papers, one may conclude that the development of 
conceptual frameworks and/or the interpretation of the observed performance results 
have rarely been done with the participation of stakeholders. We also found a limited 
amount of evidence demonstrating that the research results have been distributed to the 
targeted groups of stakeholders in order to link the findings to specific actions in 
practice. This information was presented only in 11 studies. It is still possible that some 
studies may have involved the targeted stakeholders in the assessment process, but have 
not reported this fact in the paper. However, we believe that this is the exception rather 
than a common feature of the majority of the reviewed studies. 
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Table 2.6 Evidence of stakeholders’ involvement 
Paper's reference 
Evidence of stakeholders’ involvement at the measurement and/or 
analysis stages 
Evidence of stakeholders’ involvement at the action stage 
Abrams et al. (1995) Yes. Focused interviews were undertaken with health care executives to 
address the impact of community health centres (CHCs) on accessibility in 
primary care and to discuss CHCs’ performance 
No 
Amado and Santos (2009) Yes. Comments were received from nine doctors of the Portuguese national 
health service regarding the conceptual framework used and the results 
obtained 
Yes. The article was sent to several professionals involved in the 
management and delivery of primary care in Portugal, having the potential 
to have impact in practice 
Amado and Dyson (2009) Yes. Workshops were undertaken with some of the Board members of the 
participating Primary Care Groups and Trusts to develop the conceptual 
framework for analysis and to validate the results 
Yes. Meetings were held with eight general practices, with the performance 
manager and three Board members of one of the participating Primary Care 
Groups in order to discuss the results and to potentiate their use in practice 
Breyer (1977) Yes. On-site interviews were held with the health centres’ managers and 
staff members to determine the attributes of the selected performance 
indicators 
No 
Collier et al. (2006) Yes. Interviews were held with three part-time physicians to identify the 
importance of an accurate part-time-equivalent estimate 
No 
García et al. (1999) Yes. The choice of the output variables was made by a group of experts 
(managers in primary care units) among other methods employed in the 
study 
No 
Geboers et al. (2002) Yes. "A panel of five experts defined 27 indicators on quality for six 
dimensions of the quality of care." (Geboers et al., 2002: 52) 
Yes. "After the assessment took place, 20 practices participated in an 
intervention study in which they set priorities and performed concrete 
improvement projects." (Geboers et al., 2002: 52) 
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Table 2.6 Evidence of stakeholders’ involvement (continued) 
Paper's reference 
Evidence of stakeholders’ involvement at the measurement and/or 
analysis stages 
Evidence of stakeholders’ involvement at the action stage 
Gusmano et al. (2013) Yes. Four meetings were held with the key stakeholders to present the 
developed indicators and methods and to discuss the local factors that may 
explain variations in the performance results 
Yes. Preliminary findings of the study were discussed with the key 
stakeholders 
Lee et al. (2009) Yes. "A nine expert panel was assembled for [conceptual] tool 
development." (Lee et al., 2009: 103) 
No 
Macinko et al. (2007) Yes. "The project described here was carried out in close collaboration with 
municipal health authorities." (Macinko et al., 2007: 168) 
Yes. "Discussions with municipal managers in Petrópolis revealed that the 
results of the provider and user surveys were easily understood and, 
perhaps more importantly, readily linked to specific actions to improve the 
organization and delivery of care at both the clinic and district levels." 
(Macinko et al., 2007: 174) 
Mosquera et al. (2013) No Yes. The findings of this study were reported to the District Health 
Secretariat 
Nuti et al. (2011) Yes. “Chief executive officers from the 12 Local Health Authorities in the 
Tuscany Region worked with the research team to select the variables to be 
used in this study.” (Nuti et al., 2011: 325) 
Yes. "Although data envelopment analysis has been accepted by the chief 
executive officers as a valid tool to measure efficiency, it proved to be a 
complicated tool to manage efficiency. Indeed, the chief executive officers 
found it problematic to translate the efficiency scores into specific actions 
to be taken in order to improve their performance." (Nuti et al., 2011: 328) 
Pina andTorres (1992) No Yes. The managers of health centres were informed about how to improve 
the allocation of available resources on the basis of the study results 
Radford et al. (2007) Yes. Participants of the study (representatives of CHCs) selected the 
measures to be included into a customised balanced scorecard for each 
center 
Yes. “Participants [of the study] indicated their scorecards would be shared 
with managers, department heads, boards of directors, finance committees, 
and clinical providers. They planned to use the information for board 
education, planning, benchmarking, quality improvement, and modifying 
operations,” (Radford et al., 2007: 28) 
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Table 2.6 Evidence of stakeholders’ involvement (continued) 
Paper's reference 
Evidence of stakeholders’ involvement at the measurement and/or 
analysis stages 
Evidence of stakeholders’ involvement at the action stage 
Ramírez-Valdivia et al. 
(2011) 
Yes. “The variables included in the DEA model are selected (…) by 
consensus with the Ministry of Health Primary Care Department experts.” 
(Ramírez-Valdivia et al., 2011: 1024) 
No 
Schinnar et al. (1990) Yes. Three expert panels (state officials and planners, partial care program 
directors, university researchers) were asked to develop specifications for 
each measure selected 
No 
Sebastian and Lemma 
(2010) 
No Yes. The study results were discussed with the Tigray Health Bureau in 
order to develop an improvement strategy 
Thanassoulis et al. (1995) Yes. "The resources used by DHAs [District Health Authorities] to provide 
perinatal care and ways of reflecting corresponding activity levels were 
carefully examined in consultation with specialists in the managerial and 
medical aspects of perinatal care provision." (Thanassoulis et al., 1995: 
590) 
No 
Varatharajan et al. (2004) No  Yes. Key informant interviews were held to identify the directions for 
performance improvement in primary care delivery in the province of 
Kerala, India, based on the study results 
Villiers et al. (2005) Yes. Focus group discussions with health care worker and patients were 
conducted during the study 
No 
Wang et al. (2014) Yes. “The expert review identified key modifications to the PCAT-C 
version [Primary Care Assessment Tool – Chinese version] to reflect the 
Tibetan context.” (Wang et al., 2014: 5) 
No 
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Overall, the findings of our review suggest that the involvement of stakeholders at 
different stages of organisational performance assessment has been rare. Therefore, it remains 
questionable whether the studies’ research findings possess face validity and whether these 
findings can be successfully used for the development of specific improvement strategies and 
plans. Furthermore, we found that the majority of studies that have reported an involvement 
of stakeholders were privileged with the involvement of managers and health care 
professionals. Notwithstanding the relevance of involving staff members, there are other 
stakeholders that should also be involved in the performance assessment process. In 
particular, the greater involvement of patients and citizens can contribute to highlight 
different perspectives, doing justice to the complexities related to performance assessment in 
health care provision.  
 
2.5 Conclusions 
The review undertaken fills a gap in the health care literature by analysing and 
systematising a very broad range of empirical studies dedicated to performance assessment in 
primary health care. By answering two relevant research questions, it extends and 
complements previous reviews in several important ways, offering valuable information for 
researchers, practitioners, and policymakers.  
In order to answer the research questions addressed in this study, we developed a 
conceptual framework for the performance assessment of primary care providers that was 
inspired by previous theoretical works. This framework served as a basis to analyse the 
selected empirical studies and also constitutes a valuable tool for researchers, policymakers, 
and health care managers to overview the process of performance measurement in the health 
care context. 
The first research question aimed to identify the main performance dimensions and 
measures that have been used in primary care assessments. We concluded that the past studies 
of performance in this context have focused on the four dimensions of performance included 
in the framework (accessibility, equity, efficiency, and effectiveness) and that a wide array of 
performance measures has been developed to assess these dimensions. We then systematised 
these measures in summary tables to assist the selection of an appropriate set of performance 
indicators for the evaluation of health care providers. We also concluded that the majority of 
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the studies have focused on the investigation of a single dimension. Given that trade-offs are 
likely to exist between the different performance dimensions, we believe that future research 
studies should make more effort to evaluate several performance dimensions and to discuss 
the evidence of trade-offs between them.  
The second research question of our review aimed to explore the extent of stakeholders’ 
involvement in the performance assessment process in primary health care. We concluded that 
only a minority of the reviewed studies have reported the involvement of targeted 
stakeholders during the three stages of performance assessment. This finding allowed us to 
infer about a weak connection between the reviewed empirical studies and health care policy 
and practice, which diminishes the potential impact of the studies’ research findings on 
performance improvement of primary care providers. Furthermore, the stakeholders involved 
in primary care assessments have mostly been health care staff members, policymakers, and 
managers, with only a small minority of studies reporting the involvement of other relevant 
stakeholders, such as patients and citizens. Therefore, it is advisable that future studies aim to 
involve the key stakeholders in the process of primary care assessment, including patients and 
citizens among others, to ensure that the models and results have face validity and also to 
strengthen the impact of empirical research on health care policy and practice.  
Despite the contributions discussed above, there are several limitations associated with 
this review. The first limitation relates to the fact that we only reviewed papers written in 
English. Indeed, there is a chance that including studies written in other languages would have 
identified additional performance measures or could have changed the proportion of studies 
that report having actively involved stakeholders in the assessment process. At the same time, 
by providing a review of the literature written in different languages we could expect the 
sample of papers to be more representative and better reflect the state of the art in this 
research area. It would therefore be valuable if future studies could cover articles written in 
other languages. The second limitation relates to the fact that data extraction involved 
judgements by the authors, mainly in respect to the classification of the measures used for 
performance assessment. Despite our great care in this process, this can be a potential source 
of bias. The third limitation relates to the absence of a quality assessment of the studies. We 
carefully selected criteria for exclusion and inclusion of the papers based on the common 
recommendations for systematic reviews in health care. However, to our knowledge, there is 
no established criterion for conducting quality appraisal of the empirical studies devoted to 
health care performance assessments. Therefore, this issue must be addressed in future 
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research. Notwithstanding these limitations, it is our conviction that this review adds to our 
understanding of performance assessment in primary health care and opens up new avenues 
for future research.  
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Chapter 3 
EXPLORING THE POTENTIAL OF DATA 
ENVELOPMENT ANALYSIS FOR ENHANCING P4P 
PROGRAMME DESIGN IN PRIMARY HEALTH 
CARE: AN APPLICATION TO THE PORTUGUESE 
CONTEXT 
 
3.1 Introduction 
For the last several decades, the implementation of pay-for-performance (P4P) 
programmes in health care has become a worldwide initiative that now involves nearly two-
thirds of the member countries of the Organisation for Economic Co-Operation and 
Development (OECD) (OECD, 2016). Such programmes aim to encourage quality 
improvements in the delivery of health care services by rewarding providers (primary care 
staff, specialists, or hospitals) for the achievement of desirable performance results (Cashin, 
Chi, Smith, Borowitz and Thomson, 2014). The idea behind P4P is that by making explicit 
the connection between the results of the work and respective bonus, one can motivate the 
staff to perform better in a problematic or highly important area of health care delivery 
(Eijkenaar, 2011). Considering that different areas of health care performance may require 
improvement, the objectives of P4P programmes significantly vary, from increasing uptake of 
IT services to lowering health care expenditure, reducing health disparities, or improving 
patient satisfaction. 
Although the present popularity of P4P programmes is not supported by conclusive 
evidence regarding their efficacy in practice (Cashin et al., 2014; Eijkenaar, Emmert, 
Scheppach and Schöffski, 2013; Scott Sivey, Ouakrim, Willenberg, Naccarella, Furler and 
Young, 2011; Van Herck, De Smedt, Annemans, Remmen, Rosenthal and Sermeus, 2010), 
there is no doubt that P4P programme design plays a central role on how well a programme 
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will accomplish its objectives (Eijkenaar, 2011). All P4P programmes share a core set of 
design elements, including performance domains and measures; target entity; basis for reward 
or penalty; nature, size, and frequency of the reward or penalty; data reporting and 
verification among others, and each of these elements is associated with a wide variety of 
choices (Cashin et al., 2014; Conrad, 2009). Several studies have provided overviews on the 
state of the art on P4P programme design and important determinants of a programme’s 
success have been highlighted, such as: (1) defining performance broadly, via a 
comprehensible set of process and outcome measures; (2) active monitoring of side-effects, 
such as “patient selection” and “treating to the test” among others; (3) applying sophisticated 
risk adjustment techniques; (4) involving key stakeholders in programme design; (5) 
favouring group incentives over individual incentives, especially for targets that require 
cooperation and coordination; (6) either rewarding or penalising the incentivised units, 
depending on the context; (7) targeting frequent and low-powered incentive payments; (8) 
favouring absolute targets over relative targets; (9) focusing on multiple targets rather than on 
single targets; and (10) P4P should be a permanent element of overall provider payment 
systems (Eijkenaar, 2011; Conrad, 2009). 
While recognising the importance of the suggested design choices, in this paper we aim 
to investigate a fundamental design element that has not attracted much attention in the P4P 
literature – the method for performance assessment. We can generally say that most P4P 
evaluations assume the assessment of a unit’s performance against a number of performance 
indicators (PIs) and these PIs are usually assessed separately from each other. Such 
evaluations neglect the existence of trade-offs between different PIs. They usually involve a 
simple ratio analysis, where the numerator represents the unit’s actual performance results on 
a particular PI and the denominator represents a defined benchmark: an absolute threshold, if 
an assessment of absolute performance takes place, or the top-ranked result on the PI among 
peer units, in case of relative performance assessment, or the unit’s previous results on the 
same measure, if the change in measure is being assessed. Afterwards, regardless the method 
chosen for the assessment of individual PIs, the results on multiple indicators are aggregated 
into a composite measure of performance, and for its calculation a fixed weighting system is 
commonly applied. These weighting systems aim to reflect value judgements regarding the 
relative importance of each PI. However, due to their inflexibility, these weighting systems 
frequently fail to account for possible variations in priorities held by different stakeholders. 
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As an alternative to the above described methodology for performance evaluation, in 
this paper we aim to explore the potential of Data Envelopment Analysis (DEA) for 
enhancing P4P programmes in health care. DEA is a non-parametric method, developed by 
Charnes et al. (1978) for measuring the relative performance of peer Decision Making Units 
(DMUs), for example, health care providers. According to the DEA methodology, a DMU’s 
relative performance score is defined as the weighted sum of outputs (i.e. goods or services 
produced from the inputs) to the weighted sum of inputs (i.e. resources), engaged in the 
production process. This means that, unlike a ratio analysis, DEA treats all inputs and outputs 
at once and considers the existence of trade-offs between different production factors. 
Furthermore, with an application of the standard DEA model, each DMU is free to select the 
weights that maximise its relative performance score, and this score ranges from 0 to 100%. 
As a result of DEA, DMUs with the maximum score (100%) are considered to be top 
performers and they form an empirical best practice frontier, while DMUs with a relative 
score less than 100% are seen as underperforming units that are “enveloped” by this frontier.  
To date, DEA has been used extensively in a wide range of industries. The majority of 
DEA applications can be found in banking, health care, agriculture, and transport systems 
(Liu, Lu, Lu and Lin, 2013). Within the health care systems, DEA has been commonly used 
for constructing composite performance measures for hospitals and less frequently for the 
performance assessment of primary care providers (Kalinichenko, Amado and Santos, 2013; 
Amado and Dyson, 2008; Hollingsworth, 2008). However, in the context of incentive 
regulation, DEA has received limited attention both within and outside the health care sector. 
The main contribution in this respect belongs to Bogetoft and colleagues (i.e. Bogetoft, 1994; 
Agrell et al., 2002) who have explored the use of DEA in minimising the expected payments 
to incentivised units. Following these studies, Felder and Schmitt (2004) developed a DEA-
based reimbursement scheme to incentivise German hospitals that have realised cost savings 
in comparison to the individual reference levels, identified by DEA. Later, Prior and Surroca 
(2007) proposed a common “reasonable frontier”, based on the concept of super-efficiency 
(see, for example, Andersen and Petersen, 1993), to set incentive-related targets for public 
hospitals in Spain. More recent studies include the paper by Perronnin, Pichetti and Sermet 
(2014) that ranked 693 French general practitioners according to their DEA scores and the 
study by Gök and Altındağ (2015) that performed a DEA-based assessment of the P4P 
programme’s effect on efficiency in Turkish public and private hospitals. Both studies used 
the standard DEA model for the calculation of composite quality measures, while the latter 
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study also examined the patterns of efficiency change over time by estimating the Malmquist 
Productivity Index. Likewise, Bastian, Kang, Griffin and Fulton (2016) measured the effect of 
the incentive programme on hospital efficiency and outcomes in the US military health 
system, using DEA. This study incorporated a DEA model with time windows and difference-
in-differences estimation analysis. Finally, the study by Shwartz et al. (2016) developed a 
DEA model for estimating composite quality measures in P4P health care programmes with 
an empirical application to the US nursing homes. The proposed DEA model includes the 
adjusted opportunity-based weights that reflect the actual results on the explored outcomes to 
the predicted probability of these outcomes in the US nursing homes. 
We believe that our study extends and complements the previous research in several 
important ways. Firstly, we step back from setting absolute weight restrictions derived from 
expert opinion, as in the study by Shwartz et al. (2016), or using unrestricted DEA models, as 
in the study by Perronin et al. (2014) and the study by Gök and Altındağ (2015). Instead of 
this, we develop a DEA model that has a greater degree of flexibility in choosing optimal 
virtual weights than any model with fixed numerical thresholds in weight assignment, but that 
still does not allow the assignment of close to zero weights to any of the inputs or outputs, as 
opposed to unrestricted DEA models. This is done through the imposition of ordinal and 
proportional virtual weight restrictions (Sarrico and Dyson, 2004; Wong and Beasley, 1990) 
and by introducing a parameter that regulates the level of dissimilarity between optimal 
virtuals (Ramón, Ruiz and Sirvent, 2010).  
Secondly, unlike previous research, in this study we explicitly account for the influence 
of environmental factors in the estimation of DEA scores related to P4P evaluations. We 
integrate our methodological approach with the composite index proposed by Camanho and 
Dyson (2006), to verify the relevance of the existing clustering of primary care providers in 
Portugal in relation to specific structural and populational characteristics. We also perform a 
cluster analysis to classify these providers according to their environmental characteristics, 
and then we adopt the procedure by Lӧber and Staat (2010) to compare each unit only with 
those peers that operate in the same or worse environmental conditions.  
Finally, this study also outlines how to operationalise the proposed DEA methodology 
in the context of P4P. The suggested DEA methodology opens up new possibilities for the 
elaboration of several bases for reward with an application of DEA, including rewards that are 
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linked to absolute and relative performance assessments, and also contributes to setting up 
learning networks among the providers. 
Therefore, the objectives of this study are twofold: 
1. To develop a DEA methodology for performance assessment of primary care 
providers in Portugal. This approach provides a fairer basis for providers’ 
comparison, as it allows each unit to be evaluated with a greater emphasis on the 
PIs on which the unit under assessment performs better, whilst accounting for 
the trade-offs between the different PIs and domains. In this respect, the 
proposed approach compares each unit with a group of other units that operate 
under similar conditions and with similar performance priorities, identifying 
those providers that are best performers and identifying targets for performance 
improvement for underperforming units. This is achieved by modifying the 
standard DEA method in order to account for the necessary relations between 
the weights attributed to each PI and each performance domain and in order to 
account for the effect of the relevant environmental variables.  
2. To propose an alternative methodology for P4P contracting based on the DEA 
assessment results. This methodology includes a combination of relative and 
absolute performance assessments in order to reinforce the effect of P4P on the 
Portuguese primary care providers with different performance levels, and each 
of these two assessments is proposed to be rewarded distinctly. Besides the P4P 
target setting, we propose how the DEA assessment results can be used in 
specific measures within the context of P4P in order to better stimulate the 
improvement of USFs’ performance.  
The remainder of the paper is organised as follows. Section 2 provides background to 
the P4P programme in the Portuguese primary care system and discusses the potential for 
improvement of P4P contracting in Portugal. Section 3 proposes an alternative DEA-based 
approach to assessing the performance of the Portuguese primary care providers and a new 
methodology for P4P contracting. Section 4 reports the results of the DEA assessment of 
USFs and compares the actual results, the contracted targets, and the suggested DEA targets 
for some USFs. Finally, section 5 draws the main conclusions from the paper, identifies the 
main limitations and suggestions for further research. 
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3.2 The P4P programme in the Portuguese primary care 
system 
3.2.1 Organisational structure of the primary care system in Portugal 
The primary care system is an entering point into the Portuguese National Health 
Service (NHS). It aims to provide health care services to patients with non-emergency health 
concerns, patients with chronic conditions, and also plays a central role in disease prevention 
and health promotion for local populations. The majority of primary care services in the 
Portuguese NHS are delivered by general practitioners (GPs)/family doctors who are assisted 
by nurses and other auxiliary health care staff. 
The organisational structure of the primary care system in Portugal has been undergoing 
a major reform, initiated by the Ministry of Health in 2005. Following this reform, Family 
Health Units (Unidades de Saúde Familiar, USFs) have been introduced into the Portuguese 
NHS as local providers of primary care services. At the moment, both newly established 
USFs and earlier established Primary Health Care Units (PHCUs) are operating in the health 
care system in Portugal, and there is a roughly equal split between the two models with 
regards to the population covered by each model (OECD, 2015). 
PHCUs and USFs have different organisational forms, level of autonomy, and payment 
mechanisms. PHCUs are clinic settings that comprise varying number of GPs, who are paid a 
fixed salary and equally service their patient lists or patients not registered with them. USFs, 
in turn, are voluntary organised multiprofessional teams that consist of two to twelve family 
doctors, the same number of family nurses, and a varying number of administrative staff 
members. Unlike PHCUs, USFs have functional and technical autonomy and a payment 
system that adopts P4P, and USFs can only provide services to patients from their registered 
patient lists. Also, there are two operational models of USFs – Model A and Model B. All 
USFs start as Model A, as it corresponds to the initial phase of USF’s development. Once 
greater organisational maturity has been achieved, USFs Model A can progress to Model B 
(OECD, 2015). By the end of 2015, there were 449 USFs, of which 241 USFs were classified 
as Model A and 208 USFs were classified as Model B (ACSS, 2015). 
One of the key distinctions between USFs Model A and USFs Model B is in their 
payment systems. In USFs Model A, the staff payment is mostly a fixed salary regulated by 
public administration legislation, but a financial incentive is also provided to the whole USF 
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for accomplishing specific incentive targets. In this model, there is no reward for individual 
staff members for performance on PIs. In USFs Model B, the staff payment consists of a 
small fixed component and a series of supplements that represent the largest part of the 
payment. These supplements include a capitation based payment with a defined maximum 
threshold, a fee-for-service payment for home visits and other contracted services, and a P4P 
component that is based on the attainment of individual staff members’ targets and practice 
targets (OECD, 2016).  
Another organisational change that was introduced by the primary care reform is the 
creation of Groups of Health Centres (Agrupamentos de Centros de Saúde, ACES). These 
centres work as local health authorities with administrative and financial autonomy and they 
aim to guarantee the provision of primary care services to the population in a determined 
geographic area. ACES encompass different units, including USFs, Personal Health Units 
(Unidades de Cuidados de Saúde Personalizados, UCSPs), Community Health Units 
(Unidades de Cuidados na Comunidade, UCCs), and Shared Assistance Resource Units 
(Unidades de Recursos Assistenciais Partilhados, URAPs) to provide services in the area of 
primary health care, social and public care, complementing the actions of each other (OECD, 
2015; ACSS, 2016). According to the official statistics, 55 ACES have been operating since 
2012 (ACSS, 2015).  
Finally, at the highest levels of the organisational hierarchy, there are five Regional 
Health Administrations (Administrações Regionais de Saúde, ARS) that are responsible for 
the provision of primary care services in five regions of Portugal: North, Lisbon and Tagus 
River, Centre, Alentejo, and Algarve. The work of the ARS, in turn, is coordinated by the 
Central Health System Administration (Administração Central do Sistema de Saúde, ACSS). 
The P4P programme that was introduced as a part of the primary care reform links three 
levels of organisational structure of the Portuguese primary care system through several types 
of contracting arrangements. In particular, there is an external contracting process that occurs 
between the ARS and the respective ACES and an internal contracting process that takes 
place between ACES and local primary care providers (ACSS, 2016). In this paper we will 
focus on the internal P4P contracts with the USFs. 
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3.2.2 Conceptual and methodological basis of P4P contracts with USFs 
The P4P contracts with USFs are designed to improve quality, accessibility, and 
efficiency of primary care services in the Portuguese NHS. In essence, they present annual 
arrangements between an ACES and a USF to be fulfilled by the respective USF in the 
prioritised areas of primary care delivery. 
The P4P contracts in 2013 covered four performance domains - accessibility, clinical 
performance, efficiency, and patient satisfaction – with a total of 32 PIs. These PIs are 
organised into two subsets – 15 PIs related to institutional incentives (hereinafter referred to 
as “institutional PIs”) (Table 3.1) and 17 PIs related to financial incentives (hereinafter 
referred to as “financial PIs”) (Table 3.2) (ACSS, 2012). 
 
Table 3.1 Description of the institutional PIs 
Domain Indicator(s) 
Accessibility 
 Proportion of consultations provided by a designated family doctor  
 Global utilisation rate of medical consultations  
 Rate of home visits by the doctor (per 1000 patients)  
 Rate of home visits by the nurse (per 1000 patients)  
Clinical performance  
 Percentage of patients with hypertension with at least one record of blood pressure in each 
semester 
 Percentage of women aged 25-64 who have had a colpocytology in the past 3 years  
 Percentage of diabetics with at least 2 HbA1C tests registered during the past 12 months and 
covering 2 semesters  
 Percentage of first consultations in the first 28 days of the newborn’s life 
 Percentage of fully immunised 2-year-old children in accordance with the National Vaccine 
Programme  
 Percentage of first consultations in the first trimester of pregnancy  
Patient satisfaction  Percentage of satisfied and very satisfied patients 
Efficiency  Average cost of medications prescribed per user 
 Average cost of complementary diagnostic and therapeutic means prescribed per user 
Accessibility/Clinical 
performance 
 2 PIs identified by the ARS 
 
Table 3.2 Description of the financial PIs 
Domain Indicator 
Clinical 
performance  
 Proportion of family planning consultations provided by the nurse 
 Percentage of women aged 25-49 who have had a colpocytology in the past 3 years 
 Percentage of pregnant women with 6 and more maternal health consultations provided by the 
nurse 
 Percentage of postpartum home visits by the nurse 
 Percentage of pregnant women who have received a postpartum examination 
 Percentage of neonatal heel pricks (Guthrie test) performed by the 7th day of the newborn’s life 
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Table 3.2 Description of the financial PIs (continued) 
Domain Indicator 
  Percentage of newborns who have received a home visit by the nurse by the 15th day of postnatal 
life 
 Percentage of babies with at least 6 infant health consultations provided between 0 and 11 months 
of the child’s life 
 Percentage of children with at least 3 infant health medical consultations during the second year of 
the child’s life 
 Percentage of 2-year-old children with at least one weight and height record in the past 12 months 
 Percentage of fully immunised 2-year old children in accordance with the National Vaccine 
Programme 
 Percentage of diabetics who have received a nurse consultation 
 Percentage of diabetics who have had at least one foot examination in the year 
 Percentage of diabetics with a record of therapeutic regime management (three items) in the past 
year 
 Percentage of patients with hypertension with at least one record of blood pressure in each 
semester 
 Percentage of patients with hypertension with a record of Body Mass Index in the past 12 months 
 Percentage of patients with hypertension aged 25 and more who have received a vaccination 
against tetanus 
 
The two subsets of PIs have several distinctions. In particular, the institutional 
incentives are designed to fulfill specific organisational objectives, such as infrastructure 
development or completion of specified training by staff, and both USFs Model A and Model 
B are eligible for this incentive payment. The financial incentives, in turn, are attributed to the 
nurse and administrative staff exclusively, and only USFs Model B can benefit from this type 
of incentive. Another distinction is that the financial PIs are uniform across all USFs and they 
explicitly focus on the assessment of clinical performance (Table 3.2). By contrast, the 
institutional PIs cover all four domains and they included a fixed subset of 13 nationwide PIs 
and a variable subset of two PIs that were defined by the respective ARS in 2013 (Table 3.1).  
The P4P contracts with USFs stipulate absolute targets on the institutional and financial 
PIs. These targets are revised annually through a negotiation process between the ACES and 
each USF. For the target setting purpose, the following information is considered: 
 the reference value on a PI from the local, regional, and national documents on 
operational and strategic planning in health care delivery; 
 the history of performance results on a PI of the respective USF, and also at 
regional and national levels; 
 the resources available in the respective USF and the influence of context 
variables on health care delivery; 
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 best practices in health care delivery, such as the improvement of accessibility, 
patient satisfaction, clinical performance, and efficiency (ACSS, 2016). 
In order to facilitate the process of target setting, the USFs’ past performance results are 
clustered in relation to three structural characteristics (the number of doctors, the number of 
years in operation (only for USFs Model A), and the model type) and three populational 
characteristics (the proportion of patients aged 65 and more, the population density of the 
respective municipality, and the proportion of diabetics in the patient list). As a result of this 
analysis, six different sets of cluster groups are formed to classify USFs against the above 
mentioned characteristics. Then, for each cluster group, the range of target values on PIs is 
derived to be used in further negotiation of the exact targets, established for every USF 
individually. 
When the contracting year is finished, the assessment of target attainment is executed 
separately for the institutional and financial PIs. For the financial incentives, the USF’s actual 
performance results on each PI are compared with three absolute thresholds. These thresholds 
are labeled as “achieved” (more than 90% of the target value is attained), “almost achieved” 
(from 80% to 90% of the target value is attained), and “not achieved” (less than 80% of the 
target value is attained). Then, a 2-point scoring system is applied for the calculation of a total 
achievement score against the financial PIs. In particular, 2 points are assigned for each 
financial PI that has been fully achieved, 1 point is assigned for each financial PI that has 
been partly achieved, 0 points are assigned if the target has not been achieved. A total of 30 to 
34 points makes a USF eligible to 100% of the financial incentive payment, while a total of 
25 to 29 points is sufficient in order to receive 50% of the payment. There is no financial 
incentive for USFs that score less than 25 points. 
For the institutional incentives, a composite measure of performance, known as Global 
Performance Index (Índice de Desempenho Global, IDG), is calculated. At the first stage of 
analysis, similarly to the financial incentives, the USF’s results on each institutional PI are 
compared with the contracted targets. Then, depending on a level of target attainment, the 
result on a PI is substituted with 110% (if more than 110% of the target value is achieved), or 
it remains the same (if 80% to 110% of the target value is achieved), or the adjusted result 
equals to 0 (if less than 80% of the target value is achieved). At the second stage of analysis, 
the adjusted results on PIs are assigned with fixed relative weights for the calculation of the 
IDG. Finally, the value of the IDG is calculated and it determines whether a USF will receive 
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the institutional incentive or not. In particular, an IDG lower than 75% does not allow a USF 
to receive the incentive, an IDG that is ranged from 75% to 100% multiplies the maximum 
bonus payment on its value, and an IDG of 100% makes a USF eligible to the maximum size 
of institutional incentive payment (ACSS, 2016). 
 
3.2.3 Potential for improvement of P4P contracting with USFs  
As described in the previous section, the P4P contracts with USFs implemented in the 
Portuguese NHS have the following characteristics: 
 they include absolute targets with several absolute thresholds for the evaluation 
of target achievement that do not reward any improvement “above the target”; 
 P4P targets are established exogenously, on the basis of a complex system of the 
reference values and through a negotiation process with the respective ACES; 
 the evaluation of target achievement is performed for each PI separately and a 
fixed weighting system is applied for the calculation of composite performance 
scores for the institutional and financial incentives. 
Each of these characteristics presents the potential for improvement that we discuss 
below in detail. 
Absolute performance assessment and its alternatives. The use of absolute targets 
for measuring and rewarding performance of health care providers may be considered to have 
advantages and disadvantages. On the one hand, absolute targets are generally more favoured 
in P4P programmes due to their transparency and less uncertainty, as they establish, in 
advance, a direct standard of expected results and set up clear goals to work toward 
(Cromwell et al., 2011; Eijkennar, 2011). On the other hand, absolute targets are frequently 
exposed to the effect of goal gradient, when little effort for improving performance can be 
expected if an established goal is unattainable or it has been already achieved (Mehrotra, 
Sorbero and Damberg, 2010). If we look again at the methodology for P4P evaluations of 
USFs, we can see that there is no additional reward for achieving more than 110% (or 90%) 
of the target value on an institutional (or financial) PI. For this reason, we might expect the 
existence of the effect of goal gradient at these levels of target attainment.  
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To avoid the effect of goal gradient, relative performance assessment may be 
implemented. Unlike the use of absolute targets, relative assessment of performance does not 
rely on a priori target values that are known in advance. By contrast, this type of assessment 
constructs a ranking of the incentivised units and rewards only top performers among those 
participating in a P4P programme. However, although relative rankings stimulate continual 
improvement, it has been argued that they may also encourage competition, reduce 
collaboration, and dissemination of best practices among the providers (Cromwell et al., 
2011; Eijkenaar, 2011). Furthermore, when a relative ranking is applied, there might be a 
situation when high levels of target achievement are not rewarded, if the distribution of 
performance scores is narrow among top performers, corresponding to a situation in which the 
difference in performance achievement of top providers is not statistically significant (Doran, 
Kontopantelis, Reeves, Sutton and Ryan, 2014). 
The third approach to measuring and rewarding performance involves the measurement 
of change in PIs over time. This is done by comparing actual performance results with past 
performance results on the same measures. Similarly to relative targets, this approach 
encourages continual improvement by avoiding the all-or-nothing property of absolute 
thresholds. This approach has the added advantage of eliminating the need for complex case-
mix adjustments. However, improvement measurement can also favour those providers that 
have the worst performance results at the beginning of a P4P programme, as they possess the 
largest scope for improvement (Cashin et al., 2014; Cromwell et al., 2011).  
As one can see, each of the approaches has its own advantages and limitations. In 
practice, as concluded by Cashin et al. (2014), 50% of the examined P4P programmes in 
OECD countries favour absolute targets, 17% of the studied programmes use relative 
rankings, and the remaining 33% of the studied programmes use a combination of several 
approaches.  
Despite the limited use of relative rankings in the present P4P programmes, the 
methodology for P4P evaluations proposed in this study assumes relative performance 
assessment. As opposed to a ratio analysis, our DEA-based methodology suggests the 
assessment of all PIs within a single optimization procedure and takes into account the best 
practice achievements of other providers with similar characteristics and similar strategic 
priorities. In this way, it guarantees a fairer and holistic comparison of health care providers. 
Moreover, the DEA approach does not encourage competition or reduce cooperation between 
67 
health care providers, since each unit with potential for improvement has its unique 
combination of performance targets determined by peer DMUs, by contrast to relative 
rankings that assume the assessment of performance against a valuation system that is 
common to all providers. Another advantage of our approach is that it does limit the number 
of top performers, whilst relative rankings based on a ratio analysis usually define a single 
best performing unit. In this way, we can ensure that all providers that have no potential for 
improvement are assigned with 100% performance scores, avoiding the problems associated 
with P4P in cases of a narrow distribution of top performance scores in relative rankings, 
mentioned by Doran et al. (2014). 
Target setting. The involvement of health care professionals in P4P target setting is 
recognised to bring certain benefits. In particular, this involvement helps to elicit necessary 
information about contextual factors that influence the attainability of the proposed targets 
and also enhances providers’ motivation for target achievement in P4P programmes. 
However, when key users are involved in such discussions, biased decisions can be made due 
to an existing conflict of interests. This is particularly true if there is no formalised and 
systematic process for the negotiation of P4P targets (Kirschner et al., 2012; Doran et al., 
2014). 
To mitigate the problem of potential bias, a system of target reference values was 
designed to support the negotiation of P4P targets between the ACES and the USFs. As a 
result of cluster analysis, there are different sets of cluster groups formed for each structural 
and populational characteristic, and each of these clusters has its own range of target values. 
We do not have access to information about the cluster method used or the way how these 
ranges of target values are derived. However, according to the ACSS methodology (ACSS, 
2016), there is no clear hierarchy that ranges the importance of the obtained clusters of USFs 
or the respective ranges of target reference values, which significantly limits the functionality 
of these clusters for the purpose of target setting. In order to overcome this problem, in this 
study we aim to derive a single set of target reference values that accounts for all relevant 
contextual factors.  
The current methodology used in the Portuguese NHS also suggests that USFs’ past 
performance results have direct influence on subsequent targets on PIs. In particular, the 
identification of target reference values in 2016 was based on the following principle: the 
potential for improvement in 2016 for each USF is greater if a low performance level was 
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achieved by the corresponding USF in 2015, and this potential is identified by cluster 
membership of the unit under assessment (ACSS, 2016). This principle has been developed in 
order to avoid situations characterised by USFs which are not willing to achieve the 
maximum possible level of performance in one year in order to have less demanding targets 
in the following year. However, the present methodology does not provide a quantitative 
method to verify if the targeted levels of performance are realistic and feasible for USFs. The 
feasibility of the proposed targets is determined through negotiation between ACES and 
USFs, and in such situations, the bargaining power of the incentivised units may become the 
principal factor for deciding on individual P4P targets. 
By contrast, our DEA-based approach suggests that P4P targets are derived 
endogenously, from the output levels of the identified benchmarks (if performance 
improvement is possible). The proposed targets present the maximum level of output 
production, considering current technology, available resources, and environmental factors. In 
this way, we can avoid the subjectivity of establishing targets through a negotiation process 
and confirm their feasibility based on the observed performance of benchmarks with similar 
characteristics. 
Composite measures of performance and related weighting systems. Composite 
measures are commonly used in P4P programmes to aggregate the results on multiple PIs into 
a single metric of performance. However, the design of meaningful and reliable composite 
measures is still challenging, as it requires careful consideration of a number of theoretical 
and methodological aspects (Nardo et al., 2008; Goddard and Jacobs, 2009). 
One of the aspects that considerably affects the resulting score on the composite 
measure is the weighting system used to combine the PIs into a single measure. At a broad 
view, we can distinguish two approaches for weightings: equal weighting and differential 
weighting. Equal weighting of PIs is an option that is easy to interpret, as it suggests that all 
PIs have equal importance in the composite. Differential weighting of PIs, in turn, aims to 
capture the underlying system of values associated with the measurement of different aspects 
of performance. Differential weighting of PIs is essential if greater organisational effort is 
needed in particular areas of performance, although in practice it may be difficult to reach a 
consensus regarding the relative importance of each PI (Jacobs, Smith and Goddard, 2004).  
Additionally, we can distinguish between fixed and flexible weighting systems. A fixed 
weighting system implies the assignment of weights that are uniform across all units under 
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assessment, while a flexible weighting system includes the possibility of modifying weights 
of PIs for each provider individually. 
The calculation of the IDG, as proposed by the ACSS methodology (ACSS, 2016), 
suggests the application of a differential fixed weighting system. Relative weights of the 
institutional PIs are defined by the ACSS in collaboration with health care experts, and these 
weights are fixed for all USFs. In particular, among the 10 institutional PIs on accessibility 
and clinical performance that are common for all USFs, and that will be further explored in 
this study, the greatest weight is assigned to the global utilisation rate of medical 
consultations (21.88% of the total weight assigned to the 10 PIs), followed by the weight 
assigned to the percentage of women aged 25-64 who have had a colpocytology in the past 3 
years (18.75% of the total weight assigned to the 10 PIs). The rates of home visits by the 
doctor and by the nurse are weighted equally, each assigned 12.5% of the total weight. 
Similarly, an equal weighting of 6.25% each was assigned to the following five PIs: the 
proportion of consultations provided by a designated family doctor; the percentage of 
diabetics with at least 2 HbA1C tests registered during the past 12 months and covering 2 
semesters; the percentage of fully immunised 2-year-old children in accordance with the 
National Vaccine Programme; percentage of first consultations in the first 28 days of the 
newborn’s life; and the percentage of first consultations in the first trimester of pregnancy. 
Finally, the least valued PI, receiving only 3.13% of the total weight attributted to the 10 PIs, 
is the percentage of patients with hypertension with at least one record of blood pressure in 
each semester. 
Although this fixed weighting system aims to reflect the varying complexity, associated 
priorities and benefits of the undertaken activities, it is likely to be inherently restrictive due 
to its inflexibility. The assignment of fixed weights to PIs does not respect the existing 
diversity in performance preferences held by policy makers, health care managers and 
providers, and the general public among other stakeholders (Smith, 2002).  
By contrast, the standard DEA model allows for flexibility in choosing weights assigned 
to each input and output of the DMU under assessment in such a way that it maximises the 
performance score of the respective DMU. The benefit-of-the-doubt approach to weighting, 
rooted in DEA, as discussed by Cherchye, Moesen, Rogge and Puyenbroeck (2007), suggests 
that more (or less) weight should be attributed to those PIs in which the unit performed better 
(or worse), assuming that better performance results were achieved on PIs that are more 
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important for the DMU under assessment. This means that the weights that are applied to the 
data are actually based on the observed performance data, or determined endogenously. 
However, an unrestricted benefit-of-the-doubt approach to weighting may be an undesirable 
feature of DEA, when a close to zero weight is assigned to some PIs or even to the majority of 
PIs. In this situation, all PIs with a close to zero weight will be almost ignored for the 
calculation of composite measures, and, therefore, the obtained results can be considered as 
unrealistic.  
There are different approaches to overcoming this problem. The most common solution 
described in the DEA literature involves the imposition of weight restrictions in DEA models, 
such as absolute multiplier restrictions (Roll, Cook and Golany, 1991), cone ratio restrictions 
(Charnes, Cooper, Huang and Sun, 1990), assurance regions (Thompson, Langemeier, Lee, 
Lee and Thrall, 1990; Thompson, Singleton, Thrall and Smith, 1986), and facet models 
(Green, Doyle and Cook, 1996; Portela and Thanassoulis, 2006), among other methods. In 
this study, we will use a DEA model that incorporates several types of weight restrictions, 
such as ordinal and proportional virtual weight restrictions (Sarrico and Dyson, 2004; Wong 
and Beasley, 1990) and introducing a parameter that regulates the level of dissimilarity 
between optimal virtual weights (Ramón et al., 2010), in order to best adopt the DEA 
methodology for the use in the context of P4P evaluations of USFs. A detailed description of 
the proposed approach is presented in the next section. 
 
3.3 Methods 
3.3.1 A DEA-based approach to assessing the performance of USFs  
DEA is a non-parametric method that derives a single relative performance score for 
each unit when compared with a set of homogeneous DMUs. DEA estimates the relative 
performance of a DMU by the extent to which the unit under assessment matches or falls 
short of the expected performance level identified by the production frontier.  
There are a number of the considerations involved in the development of a DEA model, 
including the most appropriate orientation towards the frontier and regarding the most 
appropraite returns to scale assumption (Jacobs et al., 2006b). With respect to the orientation 
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to the frontier, an input-oriented DEA model aims to minimise the quantity (or value) of the 
consumed inputs, while an output-oriented DEA model aims to maximise the quantity (or 
value) of the produced outputs. Regarding the returns to scale assumption, constant returns to 
scale assume that changes in the inputs result in proportional changes in the outputs, while 
variable returns to scale assume that an increase (or decrease) in the inputs does not 
necessarily lead to proportional changes. 
The mathematical formulation of the output-oriented DEA model, developed by 
Charnes et al. (1978), in its multiplier version and assuming constant returns to scale, is 
presented below: 
 
Eo = min ∑ 𝑣𝑖𝑥𝑖0
𝑚
𝑖=1       (1) 
s.t. ∑ µ𝑟𝑦𝑟0
𝑠
𝑟=1 =1, 
     ∑ 𝑣𝑖𝑥𝑖𝑗
𝑚
𝑖=1 − ∑ µ𝑟𝑦𝑟𝑗
𝑠
𝑟=1  ≥ 0,  j=1,…n, 
      vi,µr  ≥ Ɛ >0, i=1,…m, r=1,…s 
 
In this formulation, we assume that each DMUj consumes m inputs (xij, i=1,…,m) to 
produce s outputs (yrj, r=1,….,s), while 𝑣i and µr are the optimal pure weights attributed to the 
inputs and outputs respectively. Besides the optimal pure weights, we can also distinguish the 
optimal virtual weights that represent the product of the inputs (or outputs) by the respective 
optimal pure weights. The objective of the programme is to maximise the relative 
performance score of a given DMU0, calculated as 
1
𝐸𝑜
, by finding the positive optimal weights 
𝑣i and µr  for each input and output included into the model. 
The calculation of composite measures under the benefit-of-the-doubt approach 
suggests the use of a DEA model, which includes a dummy input (or output) equal to one and 
multiple outputs (or inputs) to represent individual PIs to be combined into the composite 
(Cherchye et al., 2007). To date, there have been a number of DEA applications in different 
fields that have used a benefit-of-the-doubt weighting approach to constructing composite 
measures. Examples of such applications are the estimation of urban quality of life (Morais 
and Camanho, 2001), the measurement of human development of countries (Despotis, 2005), 
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the measurement of the level of technological achievement and capabilities of countries 
(Filipetti and Peyrache, 2011; Cherchye, Moesen, Rogge, Van Puyenbroeck, Saisana, Saltelli, 
Liska and Tarantola, 2008), the measurement of countries’ environmental performance 
(Zanella, Camanho and Dias, 2013), and the measurement of the level of active ageing of 
countries (Amado, São José and Santos, 2016), among others. By adopting the benefit-of-the-
doubt approach, with a single dummy input, the formulation in (1) reduces to model (2): 
 
Eo = min 𝑣     (2) 
s.t. ∑ µ𝑟𝑦𝑟0
𝑠
𝑟=1 =1, 
     𝑣 − ∑ µ𝑟𝑦𝑟𝑗
𝑠
𝑟=1  ≥ 0,  j=1,…n, 
     v,µr  ≥ Ɛ >0, r=1,…s 
 
In this study, we will use a DEA model with a constant input equal to one and 10 
outputs that correspond to the fixed set of 10 institutional PIs on accessibility and clinical 
performance, as presented in Table 3.1. All outputs are formulated as “more is better” and are 
measured as a percentage. In this respect, only a minimal transformation of two variables was 
performed (converting the rate of home visits by the doctor and the rate of home visits by the 
nurse from percentiles into per cent terms). In consistency with previous works by Zanella et 
al. (2013) and Amado et al. (2016), the proposed model has an output orientation in order to 
estimate the maximum possible level of target attainment on all PIs, identified by the 
production frontier. 
In this model, we have imposed several types of weight restrictions to diminish the total 
flexibility in the assignment of relative output weights. Whilst aiming to achieve a fairer 
distribution of weights by allowing some level of flexibility, our weight restrictions aimed to 
respect existing value judgements used in the calculation of the IDG. 
The approach we have developed to restrict the weights involves imposing three types 
of weight restrictions aimed at: 1) restricting the dissimilarity in the weights assigned by 
different units; 2) respecting the order of weighting established in the current NHS system; 
and 3) balancing the distribution of weights between accessibility measures and clinical 
performance measures. To achieve the first objective, we adopted a multiplier bound 
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approach, proposed by Ramón et al. (2010), in order to deal with close to zero weights for the 
optimal multipliers. Previous DEA studies on constructing composite measures frequently 
relied on weight restrictions, derived from an exploratory analysis with a DEA model (e.g. 
Zanella et al., 2013). However, the presence of alternative optimal weight solutions, as 
previously discussed by Cooper, Ruiz and Sirvent (2007), makes it difficult to justify any 
specific weighting scheme obtained in such a way. 
The approach by Ramón et al. (2010) noticeably differs from more traditional weight 
restriction approaches and facet models, mentioned earlier, as it does not require any external 
information or related value judgements for the definition of weight boundaries or the 
existence of full dimensional efficient facets on the frontier. Moreover, the developed model 
does not lead to infeasibility problems or problems in choosing between the alternative 
optimal solutions. Finally, as argued by Ramón et al. (2010), it not only avoids the problem of 
close to zero weights, but also avoids extreme dissimilarity in the optimal weighting schemes 
to the maximum possible extent. Considering these desirable properties, we believe that the 
approach developed by Ramón et al. (2010) is the most suitable to achieve our purpose to 
restrict the total flexibility in weight assignment in the context of P4P evaluation of USFs. 
For an application of the approach by Ramón et al. (2010), it is important to identify the 
extreme efficient units (i.e. units, for which there is at least one optimal solution where none 
of the variables was assigned a weight approximately equal to zero) by running the standard 
CCR model. After that, at the first step of analysis, we maximise the minimum of the ratios 
between virtuals of the extreme efficient units, so that we look for the least dissimilar optimal 
virtual weights that allow the extreme efficient units (i.e. DMUs in E) to remain as such. At 
this stage, the following problem has to be solved: 
 
max φjo=
𝑧
ℎ
    (3) 
s.t. 𝑣=1, 
     ∑ µ𝑟𝑦𝑟0
𝑠
𝑟=1 =1, 
     𝑣 − ∑ µ𝑟𝑦𝑟𝑗
𝑠
𝑟=1  ≥ 0,  jϵE  
     z ≤ µryr0 ≤ h, r =1,...,s 
     µr, z, h ≥ Ɛ >0, r =1,...,s  
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In this formulation, the level of dissimilarity between the virtuals of the extreme 
efficient units is measured by a parameter φjo. If φjo=1, then all virtuals have the same value, 
which is equivalent to a system of equal weighting. If φjo=0, this means that the virtuals are 
free to be assigned with any value and most probably, close to zero weights will be attributed 
to some of the variables. However, in case of the extreme efficient units, there is at least one 
solution with non-zero optimal weights, so there is no possibility to get φjo=0 by solving 
model (3).  
At the second stage of analysis, we apply φ*, which is the minimum across all φj, jϵE, to 
underperforming DMUs (all those that are not extreme efficient) by solving the following 
problem: 
 
Eo = min 𝑣        (4) 
s.t. ∑ µ𝑟𝑦𝑟0
𝑠
𝑟=1 =1, 
    𝑣 − ∑ µ𝑟𝑦𝑟𝑗
𝑠
𝑟=1  ≥ 0, j=1,…n, 
     z ≤ µryr0 ≤ h, r =1,...,s 
     
𝑧
ℎ
≥ φ* 
     v,µr,z, h ≥ Ɛ >0, r =1,...,s 
 
By identifying φ*, we preserve the original distribution between underperforming and 
extreme efficient units, identified by the standard CCR model and we also regulate the 
dissimilarity between the optimal virtual weights of all DMUs. It is important to note that 
although the φ* value is fixed for a given set of DMUs, each DMU is free to select the 
optimal virtual weights on the condition that the minimum ratio between them is not lower 
than φ*. This is a clear advantage of this approach, as we step back from imposing absolute 
boundaries, between which the virtuals are forced to lie, and only set weighting limits in form 
of φ*, which is derived endogenously, from the dataset explored. 
To achieve our second objective for the weighting system, we developed a set of 
restrictions to account for the existing value judgements regarding the relative importance of 
the 10 institutional PIs. Although the current ACSS methodology (ACSS, 2016) provides the 
exact weighting of each PI in the calculation of the IDG, it also clearly sets out that “we 
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cannot say that an indicator weighted with “4” is twice as complex or requires two times more 
work than an indicator weighted with “2”. We can only say that the indicator weighted with 
“4” is probably more complex or the activity, which it reflects, requires more resources or it is 
more effective in producing health gains than the one weighted with “2” [translated from 
Portuguese]” (ACSS, 2016: 47). In this respect, in order to capture an ordering of importance 
of the included PIs, rather than to refer to the exact values of the weights, we formulated 
ordinal virtual weight restrictions, or virtual assurance regions of type I (virtual ARI 
restrictions), as proposed by Sarrico and Dyson (2004). Particularly, we ordered the outputs 
from the most valued to the least valued PI, as suggested by the weights proposed in the 
ACSS methodology. In this way, we were able to identify five groups of virtuals with 
differing degrees of relative importance, given that PIs with equal weighting were assigned to 
the same group. The formulation of the set of restrictions that was applied when evaluating 
DMU0 is presented below: 
 
µ2𝑦2𝑜 ≥ µ6𝑦6𝑜 ≥ µ3𝑦3𝑜,µ4𝑦4𝑜 ≥ µ1𝑦1𝑜, µ7𝑦7𝑜,   µ8𝑦8𝑜, µ9𝑦9𝑜,   µ10𝑦10𝑜 ≥ µ5𝑦5𝑜      (5) 
 
As one can see, the formulated ordinal virtual weight restrictions have only been 
applied to the DMU under assessment to obtain a reasonable weighting system specific for 
each USF. Sarrico and Dyson (2004) recognised such approach to be a better alternative to 
applying restrictions to all DMUs, as it helps to avoid the infeasibility problem. However, one 
needs to be aware of the limitations of imposing virtual restrictions only to the DMU under 
assessment – each DMU will be assessed with a different set of restrictions, which means that 
rankings cannot be elaborated based on the results.  
In order to achieve our third objective for the weighting system, we developed another 
virtual weight restriction. Considering that the explored PIs belong to different dimensions – 
accessibility and clinical performance – we aimed to regulate the magnitude of relative 
contribution of each of the performance domains to the resulting score. We believe that target 
achievement on both accessibility and clinical performance is equally important, as we could 
not find scientific evidence that would support the opposite view. For this reason, we imposed 
proportional virtual weight restrictions, as proposed by Wong and Beasley (1990), to ensure 
that the sum of the virtual weights attributed to the four PIs on accessibility equals the sum of 
the virtual weights assigned to the six PIs on clinical performance. In fact, if we look at the 
distribution of relative weights between the 10 PIs defined by the ACSS methodology, we can 
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see that the sum of the weights in both domains is approximately equal (53.13% of the total 
weight is attributed to the PIs on accessibility and 46.87% of the total weight is attributed to 
the PIs on clinical performance). The formulation of the restriction applied when evaluating 
DMU0 is presented below: 
 
∑ µ𝑟𝑦𝑟0
4
𝑟=1 = ∑ µ𝑟𝑦𝑟0
10
𝑟=5     (6) 
 
Following the approach used in the previous case, this restriction was only applied to 
the DMU under assessment. 
 
3.3.2 Accounting for the influence of environmental factors 
In performance assessment it is important to consider the effect of environmental 
factors, given that the attainment of performance targets is more difficult for the units that 
operate in adverse environmental conditions. However, as pointed out by Jacobs, Smith and 
Goddard (2004), “there is no generally accepted method for taking into account 
environmental variables at the level of the composite scores, or for testing whether an 
environmental variable has a significant influence on the production process and the resultant 
performance of the unit”( Jacobs et al., 2004: 59).  
In order to test the influence of the earlier mentioned structural and populational 
characteristics of USFs on DEA scores, we applied the approach proposed by Camanho and 
Dyson (2006). This approach suggests the computation of a Malmquist index that comprises 
two components: first component allows assessing performance differences between groups 
of DMUs, and second component measures the gap between the frontiers identified for these 
groups. In this way, it is possible to verify if different groups of DMUs have similar 
performance levels, measured to their group frontiers, and also to test whether these groups of 
DMUs share the same frontier or not. This means that the effect of environmental variables 
can be identified by a significant gap between the frontiers of different groups. 
Assume that we have NA DMUs belonging to Group A that consume inputs X
A to 
produce outputs YA , and NB DMUs belonging to Group B that consume inputs X
B to produce 
outputs YB. Each DMUj from Group A can be then represented by its input-output vector (𝑋𝑗
𝐴, 
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𝑌𝑗
𝐴) that in case of the benefit-of-the-doubt model transforms into (1, 𝑌𝑗
𝐴). A similar notation 
(1, 𝑌𝑗
𝐵) can be used for DMUs in Group B. In this case, 
1
𝐸𝐴
 (1, 𝑌𝑗
𝐵) represents the measure of 
relative performance for a DMU belonging to Group B with regards to the frontier of Group 
A. The Malmquist Index (MI) can be formulated as the following: 
 
𝑀𝐼𝐴𝐵 =
[∏  
1
𝐸𝐴
 (1, 𝑌𝑗
𝐴) 𝑁
𝐴
𝑗=1 ]
1
𝑁𝐴
[∏  
1
𝐸𝐵
(1, 𝑌𝑗
𝐵) 𝑁
𝐵
𝑗=1 ]
1
𝑁𝐵
 × [
(∏  
1
𝐸𝐵
(1,𝑌𝑗
𝐴) 𝑁
𝐴
𝑗=1 )
1
𝑁𝐴
(∏  
1
𝐸𝐴
 (1,𝑌𝑗
𝐴) 𝑁
𝐴
𝑗=1 )
1
𝑁𝐴
×
(∏  
1
𝐸𝐵
 (1,𝑌𝑗
𝐵) 𝑁
𝐵
𝑗=1 )
1
𝑁𝐵
(∏  
1
𝐸𝐴
 (1,𝑌𝑗
𝐵) 𝑁
𝐵
𝑗=1 )
1
𝑁𝐵
]
1
2
      (7) 
 
          Within-group performance spread (IEAB)      Productivity gap between frontiers (IFAB) 
 
It is important to note that in our formulation we use Farrell’s measure of performance 
(Farrell, 1957) that is the reciprocal to the input-oriented distance measure, developed by Färe 
and Lovell (1978) originally included into the index by Camanho and Dyson (2006). Also, the 
index can be applied to any number of groups of DMUs, as discussed by Camanho and Dyson 
(2006). In our study, we tested the difference between two, three, and four groups of USFs in 
compliance with the groupings suggested by the ACSS methodology (ACSS, 2016).  
In this formulation of the index, the first ratio reflects the within-group performance 
spread by comparing the geometric means of the performance estimates of DMUs, identified 
by their group frontiers. If this ratio is more than one, then greater consistency in performance 
levels is observed among DMUs of Group A compared to DMUs of Group B, while the 
opposite is true if the ratio is less than one. 
The second component of the index estimates the productivity gap between the frontier 
of Group A and the frontier of Group B. It includes four possible combinations of estimating 
the performance of DMUs of each group to both of the group frontiers. A resulting score on 
this component of more than one indicates a higher performance level of the frontier of Group 
A in comparison to the one of Group B, while the opposite is true if the ratio is less than one. 
In addition, if first (or the second) component of the index equals to one, than we can say that 
there is no difference in the distances to the respective frontiers (or between the performance 
frontiers) of the two groups.  
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In this study, the values obtained for the frontier gaps between different groups was 
used to identify the factors that appear to have a negative impact on the level of productivity 
(identified by an IF smaller than one). Afterwards, these factors were included in a cluster 
analysis aimed at forming clusters that are subject to similar conditions.  
In the process of verification of the existing clustering of USFs for the purpose of DEA-
based assessment, we have identified two important issues that may impede effective target 
setting for future periods. Firstly, as we have mentioned earlier, USFs’ past performance 
results are directly accounted for in the present clustering of USFs, so that USFs with sub-
optimal performance results can be potentially assigned to groups with less demanding targets 
for the following years. Secondly, each of the six environmental characteristics has been 
treated separately in the performed cluster analysis, resulting in six different sets of clusters 
without a clear hierarchical system that relates these clusters for the purpose of target setting. 
In this respect, in order to achieve an effective target setting, we decided to run a cluster 
analysis that will not consider USFs’ past performance results for assigning cluster 
membership to USFs and will also produce a unique set of clusters by considering all relevant 
environmental factors simultaneously.  
Cluster analysis can be performed using various methodologies. In this study, we have 
tested different methods of cluster analysis, such as two-step clustering, k-means clustering, 
and several methods of hierarchical clustering (centroid method, Ward’s method, and the 
average linkage within groups). For all methods, where it was relevant, we have opted to 
choose the squared Euclidean distance as a measure of distance between cases. In addition, 
we performed validation of the obtained results via two internal indices of cluster evaluation – 
the Davies-Bouldin index (DB index) (Davies and Bouldin, 1979) and the Calinski-Harabasz 
index (CH index) (Calinski and Harabasz, 1974). In particular, by minimising DB index, we 
obtain clusters that are the most distinct from each other, while by maximising CH index, we 
achieve the maximum separation of the clusters calculated via the average between- and 
within-cluster sum of squares (Liu, Li, Xiong, Gao and Wu, 2010).  
Considering the way the clustering variables were defined, we were able to define an 
hierarchy of clusters based on how favourable is the environment with regards to performance 
achievement. In this way, in order to evaluate USFs with the consideration of the differences 
in their environments, we applied the methodology by Banker and Morey (1986) for 
incorporating categorical variables in DEA models, using a simplified algorithm of analysis, 
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suggested by Lӧber and Staat (2010). The categories used are the clusters that resulted from 
the cluster analysis. As argued by Lӧber and Staat (2010), instead of introducing categorical 
variables, we can run separate DEA models for the following datasets: one run based on 
observations from a category with the most adverse environmental conditions, followed by 
another run for obtaining results for DMUs of a category with the second most adverse 
environmental conditions by including observations from this and previous categories, 
followed by another run for obtaining results for DMUs of a category with the third most 
adverse environmental conditions by including observations from the three described 
categories, and so forth. In this way, we will compare each DMU only with those DMUs that 
operate in the same or worse environmental conditions. 
 
3.3.3 P4P contracting with USFs based on the DEA assessment results 
As we have mentioned earlier, there are three different approaches to incentivising 
health care providers, which are based on the measurement of absolute performance, relative 
performance, or improved performance respectively (OECD, 2016; Cromwell et al., 2011). 
These three approaches tend to reward and stimulate different types of performers. For 
example, the measurement of absolute performance mostly rewards existing top performers, 
regardless of the fact of whether they have exceeded the contracted targets or not. Relative 
targets, in turn, provide the greatest incentive to improve for those providers who are ranked 
close to the top performers, whilst top and poor performers are motivated to a lesser extent to 
enhance their performance results. Finally, if improved performance is rewarded, any type of 
performers can be entitled to a bonus payment, on the condition that these providers have 
improved their performance compared to the previous results, although low-performing 
providers may find it easier to earn a reward in a long term perspective, as they possess the 
largest scope for improvement (OECD, 2016; Cromwell et al., 2011).  
Besides the use of a single approach to rewarding providers’ performance, it is possible 
to create various combinations of these approaches to reinforce their effect on different types 
of performers. Furthermore, instead of using a single performance benchmark, many of the 
existing P4P programmes adopt a system of tiered benchmarks in order to evaluate a unit’s 
performance against a broader performance spectrum. One of such systems is actually used in 
the present P4P contracts with USFs, as USFs’ target attainment on institutional and financial 
PIs is assessed against three absolute thresholds. At the same time, these contracts rely 
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exclusively on absolute performance assessment for assigning bonus payments to USFs. As a 
result, such incentive system may not encourage performance improvement among USFs due 
to the effect of goal gradient and may disguise the maximum performance level of each USF. 
As an alternative to the existing approach to rewarding USFs, we suggest adopting the 
earlier described DEA-based methodology in order to effectively combine absolute 
measurement with relative measurement in the elaboration of several bases for reward. We 
believe that a distinct system of graduated bonus payments should be linked to each of the 
two approaches to performance measurement along with several supplementary rewards for 
the accomplishment of certain conditions that are detailed below. In particular, it is our 
conviction that the following methodology can be applied for P4P contracting with USFs: 
1. The evaluation of USFs under the suggested DEA-based methodology to 
determine the best performing units and underperforming units and also to 
provide bonus payments for a particular year, associated with relative 
performance assessment, to those USFs that received high DEA scores. In 
particular, we recommend implementing a system of graduated rewards with a 
differentiation in the size of a bonus payment according to the achieved 
performance levels. For example, it is possible to introduce a reward system that 
provides the full bonus to the best performing USFs, a smaller incentive (for 
instance, 80% of the maximum bonus) to USFs that scored 80% and more (but 
not 100%), and no incentive to USFs that scored below 80%. 
2. For the underperforming USFs, absolute targets for the following year will be 
derived from the respective benchmarks, identified by the DEA model results. 
For the best performing USFs, we suggest the creation of a benchmarking 
programme that will contribute to transferring knowledge from the best practices 
to the units that did not score 100%. This programme may include trainings and 
workshops led by the best performing USFs as a form of establishing learning 
networks between providers with similar strategic priorities and environmental 
characteristics. For the development of these trainings and workshops, the best 
performing USFs should receive an additional reward.  
3. The evaluation of USFs’ performance results in the following year should 
include two components. The first component would involve measuring absolute 
target attainment of the USFs that were previously classified as 
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underperforming. In particular, it would be possible to adopt the system of tiered 
thresholds and the 2-point scoring systems that are currently used for 
performance assessment against financial PIs and described earlier in this study. 
In particular, for each PI, the attainment of more than 90% of a DEA target 
could be scored with 2 points, the attainment from 80% to 90% of a DEA target 
could be scored with 1 point, and no points would be assigned for the attainment 
of less than 80% of a DEA target. In this case, considering that there are 10 PIs, 
a total of 20-18 points, 17-15 points, and 14 points and less entitle a USF to 
100%, 50%, and 0% of the bonus payment, associated with absolute 
performance measurement. Furthermore, we can link the performance results 
demonstrated by underperforming units in the following year with a 
supplementary bonus attributed to the respective best performing USFs that 
acted as benchmarks and developed the targeted benchmarking events, if all 
absolute targets established for the underperforming units have been achieved. 
The second component of this evaluation repeats the first step of the algorithm 
(i.e. the evaluation of USFs with an application of the DEA model, definition of 
the best performing and underperforming USFs, attribution of the bonus 
payment associated with relative performance assessment to the entitled USFs) 
and, therefore, makes the whole process recurrent. 
The suggested approach to P4P target setting and performance evaluation of USFs has 
several valuable advantages. In particular, it provides clear and direct standards of the 
expected performance determined for each underperforming USF individually in the context 
of absolute performance measurement, so that there is less uncertainty regarding the 
attainability of the respective reward compared to a reward system that adopts relative 
rankings. These absolute targets are derived endogenously, on the basis of DEA, and their 
feasibility is confirmed by the performance levels of the respective best performing USFs. In 
addition, by implementing relative performance assessment through DEA, USFs are 
encouraged to show their best possible performance results instead of focusing on the 
achievement of absolute targets (for USFs classified as underperforming in the previous 
period) or in the light of the threat of being overtaken (for USFs classified as best performing 
in the previous period). This means that if the production technology of primary health care 
adopted by USFs improves over time, the respective benchmarks will automatically increase. 
Finally, the suggested approach contributes to an effective dissemination of best practices 
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through the implementation of learning networks between the best performing USFs and 
underperforming USFs. This is a clear advantage of the approach in the context of P4P, as we 
would ultimately aim for an overall improvement of USFs’ performance rather than merely 
rewarding current high performers. Furthermore, by providing a reward to the benchmarks 
related with the performance improvement of their respective underperforming units, we 
cultivate a culture of collaboration rather than a culture of competition.  
 
3.4 Results 
3.4.1 Summary statistics of the data 
The data used for this study are the values obtained in each of the PI used for the 
contracting year of 2013. We have selected 356 USFs that complied with the following 
criteria: 
1. The USFs under selection started their operation before 1 January 2013; 
2. The USFs under selection did not cease their activities before 1 January 2014; 
3. The USFs’ performance data are available with respect to the 10 specified 
institutional PIs for the contracting year of 2013. 
The first two criteria allowed us to choose only those USFs that were functioning 12 
months in the year of assessment. According to the ACSS methodology (ACSS, 2016), all 
USFs that operate more than six months in the year of assessment are eligible to participate in 
the P4P programme and, therefore, they can be potentially included into the DEA assessment. 
However, for USFs operating less than one year performance targets are reduced 
proportionally to a period in operation, and direct comparison of performance results of these 
units with the remaining USFs would be unfair.  
The third criterion was formulated to refine the initial set of PIs for analysis and to deal 
with missing data. Of the 15 institutional PIs that were identified for the contracting year of 
2013, we have selected a set of 10 PIs, as presented in Table 3.3. In particular, we have 
chosen those PIs that were common for all USFs, eliminating in this way two PIs identified 
by the ARS for each USF individually for the contracting year of 2013. In addition, we have 
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excluded the three PIs from the initial set, for which no data were available – one PI on 
patient satisfaction and two PIs on efficiency, described in Table 3.1.  
 
Table 3.3 Descriptive statistics on the 10 institutional PIs 
Domain 
 
Indicator 
Ref. 
value1 
Mean SD Min  Max 
A
cc
es
si
b
il
it
y
 
 Proportion of consultations provided by a 
designated family doctor (y1) 
85.00% 85.68% 5.54% 62.53% 96.16% 
 Global utilisation rate of medical consultations 
(y2) 
75.00% 71.60% 5.61% 47.39% 83.35% 
 Rate of home visits by the doctor (per 100 
patients) (y3) 
3.00% 2.72% 1.01% 0.26% 5.99% 
 Rate of home visits by the nurse (per 100 
patients) (y4) 
14.50% 13.37% 4.14% 1.15% 28.76% 
C
li
n
ic
al
 p
er
fo
rm
an
ce
 
 Percentage of patients with hypertension with 
at least one record of blood pressure in each 
semester (y5) 
95.00% 81.77% 14.05% 19.37% 98.24% 
 Percentage of women aged 25-64 who have 
had a colpocytology in the past 3 years (y6) 
60.00% 81.45% 14.51% 18.70% 97.73% 
 Percentage of diabetics with at least 2 HbA1C 
tests registered during the past 12 months and 
covering 2 semesters (y7) 
85.00% 59.94% 11.84% 20.48% 85.81% 
 Percentage of first consultations in the first 28 
days of the newborn’s life (y8) 
75.00% 96.14% 3.16% 84.98% 100.00% 
 Percentage of fully immunised 2-year-old 
children in accordance with the National 
Vaccine Programme (y9) 
98.00% 89.59% 8.82% 57.49% 100.00% 
 Percentage of first consultations in the first 
trimester of pregnancy (y10) 
80.00% 88.38% 6.99% 60.62% 100.00% 
SD – Standard deviation; Min – Minimum; Max - Maximum 
 
According to official statistics (ACSS, 2015), there were 357 USFs operating by the end 
of 2012, so we assume that only one USF is missing from our sample to present a complete 
list of USFs that comply with all three criteria. No other missing data entries were identified. 
Additionally, prior to running DEA, the dataset was verified for the presence of extreme 
values with an application of the outlier labeling rule, or Tukey's method (Hoaglin, Iglewicz 
and Tukey, 1986; Tukey, 1977). This method is based on multiplying the interquartile range 
(i.e. the difference between the third and first quartile of the distribution) by a factor of 2.2 
and subtracting the resulting value from the first quartile value (or adding it to the third 
                                                 
 
1 Reference values used for target setting in 2012 (ACSS, 2012). 
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quartile value) in order to establish a lower (or upper) boundary, below (or beyond) which any 
value is considered to be extreme. The detected extreme values were then replaced with the 
lower bounding value, if the extreme values were located below the lower boundary, or with 
the upper bounding value, if they the extreme values were located beyond the upper 
boundary. 
Descriptive statistics on target attainment against the 10 institutional PIs for the 
contracting year of 2013 are presented in Table 3.3. Along with standard summary statistics, 
such as the means, standard deviations, minimum and maximum values of the indicators, 
Table 3.3 also includes reference values used for target setting in 20122, as we have no access 
to data on the exact targets established for USFs for the year of 2013.  
As one can see from Table 3.3, a substantial amount of variation is observed across the 
indicators. For instance, there is an evident variability with regards to the average 
performance results, since some indicators present low average values (such as the rate of 
home visits by the doctor - 2.72%), while the average for others is close to 100% (such as 
percentage of first consultations in the first 28 days of the newborn’s life - 96.14%). It should 
be noted, however, that not all accessibility indicators are feasible and desirable at 100% 
level, such as the case of the rate of home visits by the doctor and the rate of home visits by 
the nurse, as the relevant reference values were 3% and 14% accordingly in 2012. And the 
same time, we recognise that, except for these two cases, the majority of institutional PIs, 
presented in Table 3.3, are designed in a way to cover as many eligible patients as possible. In 
fact, there was no reference target value for the remaining 8 PIs that was lower than 60% for 
the year of 2012. 
 
3.4.2 Identifying factors for classifying USFs into clusters with similar 
environmental conditions 
In order to support the process of P4P target setting and evaluation, the present ACSS 
methodology (ACSS, 2016) assumes the clustering of USFs in accordance with the following 
characteristics: 
                                                 
 
2 These reference values were used for setting exact targets for USFs for the contracting year of 2012; in 2013, 
they were substituted by other reference values, obtained after a cluster analysis. The targets used in 2013 were 
not published for all USFs. 
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1. Structural characteristics: 
1a. Number of family doctors working in USF:  
 Group A - [0; 5[ doctors; 
 Group B - [5; 9[ doctors; 
 Group C - [9; +∞] doctors; 
 1b. Number of years in operation as USF (only for Model A): 
 Group D - [0; 2[ years; 
 Group E - [2; +∞] years; 
1c. Model type: 
 Group F- USF Model A; 
 Group G - USF Model B; 
2. Populational characteristics3: 
2a. Percentage of patients aged 65 and more in the patient list: 
 Group H - [0; 3.87[ % of patients aged 65 and more; 
 Group I - [3.87; 4.62[ % of patients aged 65 and more 
 Group G - [4.62; 6.78[ % of patients aged 65 and more; 
 Group K - [6.78; +∞] % of patients aged 65 and more; 
2b. Population density in the municipality, where USF operates: 
 Group L - [0; 209[ people per km2; 
 Group M - [209; 651[ people per km2; 
 Group N - [651; 1696[ people per km2; 
 Group O - [1696; +∞] people per km2; 
2c. Percentage of diabetics in the patient list: 
 Group P - [0; 15.41[ % of diabetics; 
 Group Q - [15.41; 17.82[ % of diabetics; 
 Group R - [17.82; 20.97[ % of diabetics; 
 Group S - [20.97; +∞ ] % of diabetics. 
The selection of each of these variables for clustering has its own reasoning and might 
be relevant for DEA assessment of USFs’ performance results. In particular, more 
experienced USFs and USFs Model B may have better performance results due to greater 
                                                 
 
3 We re-calculated the ranges of quartiles for each populational characteristic, given that we use data for 2013 
and we only consider USFs operating all 12 months in the contracting year 
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organisational maturity, while greater number of doctors may result in better organisational 
accessibility of the provider. Patients aged over 65 usually require more health care services, 
and this non-discretionary variable is frequently accounted for risk adjustment of the DEA 
scores in primary health care assessments (e.g. Pelone et al., 2012; Ramírez-Valdivia et al., 
2011; Milliken et al., 2011; Luoma, 1996). Similarly, the demand for primary health care 
services might be greater in the areas with high population density, which was also considered 
in previous studies devoted to the DEA-based performance assessments of primary care 
providers (e g., Cordero-Ferrera et al., 2011; Ramírez-Valdivia et al., 2011). Lastly, the 
percentage of diabetics in patient lists serves as a proxy for the level of morbidity of the 
population covered. As concluded by Starfield, Weiner, Mumford and Steinwachs (1991), 
patients with several disorders tend to require more consultations per year, which results in 
less time available for other patients and activities. Therefore, we expect that USFs with lower 
percentage of diabetics should perform better. 
To verify the relevance of the proposed clusters for DEA analysis, we calculated the 
index suggested by Camanho and Dyson (2006) for each of the six characteristics. For the 
calculation of the performance scores, we applied model (4) with restrictions (5) and (6) and 
the value φ* calculated for the whole dataset for each of the components of the index (7), that 
was also modified for the case of three and four groups. The resulting scores on the index and 
its components are recorded in Table 3.4. 
Table 3.4 Results on the Malmquist indices  
 Number of doctors Number 
of years  
Model 
type 
% of patients aged 65 and more 
Group comparison A to B B to C A to C D to E F to G H to I I to G H to G H to K I to K G to K 
Within-group 
performance spread 
(IE) 
0.9539 1.0066 0.9602 0.9655 0.8506 1.0376 1.0160 1.0542 1.1512 1.1095 1.0920 
Productivity gap 
between frontiers (IF) 
0.9536  1.0211 0.9738 0.9215 0.9970 0.9932 0.9851 0.9785 0.9826 0.9893 0.9811 
Malmquist Index (MI) 0.9096 1.0279 0.9350 0.8896 0.8480 1.0305 1.0009 1.0315 1.1311 1.0976 1.0714 
 
Table 3.4 Results on the Malmquist indices (continued) 
 Population density % of diabetics 
Group 
comparison 
L to M M to N L to N L to O M to O N to O P to Q Q to R P to R P  to S Q to S R to S 
Within-group 
performance 
spread (IE) 
0.9285 1.0188 0.9459 1.0054 1.0829 1.0629 1.0414 1.0183 1.0604 1.1374 1.0922 1.0726 
Productivity 
gap between 
frontiers (IF) 
1.0199 1.0002 1.0201 1.0077 0.9880 0.9789 0.9661 0.9969 0.9631 0.9748 1.0090 0.9882 
Malmquist 
Index (MI) 
0.9470 1.0191 0.9650 1.0131 1.0699 1.0405 1.0060 1.0151 1.0213 1.1087 1.1021 1.0599 
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In general, the observed results confirm our assumptions and a common understanding 
regarding the influence of the specified environmental factors on the best practice frontier. In 
particular, we can say that the number of years in operation has the most significant effect on 
the frontier, as the biggest productivity gap was observed between two groups of USFs Model 
A operating less than and more than 2 years (IFDE=0.9215). Furthermore, a negative effect on 
the level of USFs’ productivity results from a higher percentage of patients with diabetes 
(IFPR=0.9631, IFRS=0.9882) and from a higher percentage of patients aged 65 and more 
(IFHG=0.9785, IFGK=0.9811). The Malmquist results have also confirmed the expected effect 
of population density: it has a positive impact on productivity up to a certain density level 
(around 1696 patients per km2, considering that IFLN=1.0201), but after reaching this limit, the 
effect of higher population density is negative (IFNO=0.9789). This can be explained by the 
fact that very high population density is usually associated with deprivation and lower socio-
economic background of the population covered, which is known to be an adverse factor for 
performance in primary health care (Amado and Dyson, 2009). Based on the Malmquist 
results, we can also say that USFs Model A and Model B have almost identical frontiers 
(IFFG=0.9970), which means that USF model type does not have a significant effect on 
productivity level. As for the number of doctors, better productivity levels were observed 
among USFs with more than five doctors (IFAB=0.9536, IFAC=0.9738).  
To complement the analysis of the indices, we have also calculated the Pearson 
correlation coefficients to see the relationship between target achievement on the 10 
institutional PIs (y1,….,y10), the DEA scores derived from model (4) with restrictions (5) and 
(6) and the value φ* calculated for the whole dataset, and the specified non-discretionary 
factors (with exception of model type, since it is a categorical variable). We have added two 
more variables– number of nurses and number of administrative staff members - to include all 
staff categories into analysis. The resulting coefficients are recorded in Table 3.5. 
As we can see from Table 3.5, only four variables confirmed their influence on P4P 
target attainment by USFs. In particular, more experienced USFs, USFs that operate in 
municipalities with low population density, USFs that have a low percentage of patients aged 
65 and more and/or a low percentage of diabetics are likely to achieve better performance 
results in terms of the explored DEA scores and PIs on clinical performance. Additionally, a 
low population density, a low percentage of diabetics, and more years in operation as USF 
have a positive effect on accessibility. 
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Table 3.5 Pearson correlation coefficients 
Domain  
Number 
of 
doctors 
Number of 
nurses 
Number of 
administrative 
staff members 
Number of 
years in 
operation4 
% of 
patients 
aged 65 and 
more 
Population 
density 
% of 
diabetics 
 y1 0,009 -0,022 -0,047 0,013 -0,043 -0,008 -0,102 
 y2 -0,091 -0,075 -0,020 0,180** -0,083 -0,368** -0,010 
Accessibility y3 0,080 0,066 0,057 0,290** 0,041 -0,020 -0,079 
 y4 -0,053 0,015 -0,024 0,031 -0,017 -0,029 -0,215** 
 y5 0,028 0,028 0,027 0,278** -0,375** -0,091 -0,348** 
 y6 0,071 0,059 0,047 0,349** -0,446** -0,111* -0,285** 
Clinical y7 0,094 0,091 0,094 0,382** -0,262** -0,144** -0,279** 
Performance y8 -0,105* -0,051 -0,004 0,118* -0,166** -0,300** -0,227** 
 y9 -0,021 0,059 0,030 0,283** -0,302** -0,263** -0,300** 
 y10 0,033 0,076 0,052 0,201** -0,281** -0,192** -0,238** 
DEA score  0,028 0,040 0,020 0,310** -0.239** -0,151** -0.249** 
* significant at p<0.05 
**significant at p<0.01 
 
As we can see from Table 3.5, only four variables confirmed their influence on P4P 
target attainment by USFs. In particular, more experienced USFs, USFs that operate in 
municipalities with low population density, USFs that have a low percentage of patients aged 
65 and more and/or a low percentage of diabetics are likely to achieve better performance 
results in terms of the explored DEA scores and PIs on clinical performance. Additionally, a 
low population density, a low percentage of diabetics, and more years in operation as USF 
have a positive effect on accessibility. 
As a result of the analysis of the Malmquist indices based on the methodology proposed 
by Camanho and Dyson (2006) and the Pearson correlation coefficients, we chose four 
variables – number of years in operation, percentage of patients aged 65 and more, population 
density, and percentage of diabetics - as the clustering criteria for USFs. We have not chosen 
model type for identifying clusters for several reasons. Firstly, model type is highly correlated 
with the number of years in operation, as more mature USFs are likely to be Model B. 
Secondly, by calculating the index by Camanho and Dyson (2006), we confirm that there is 
almost no gap between the frontiers of USFs Model A and USFs Model B, suggesting that 
USFs of both model types can be evaluated within a single group.  
                                                 
 
4 Calculated for both USFs Model A and USFs Model B 
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We have also decided to leave the number of doctors out of the clustering analysis of 
USFs. There is a fixed number of patients that can be registered per family doctor, established 
by the public administration legislation, and no USF is obliged to accept patients beyond this 
limit. Since all PIs are formulated as ratios, where denominator represents/accounts for the 
number of registered/eligible patients, we cannot say that a greater number of family doctors 
or other staff members will lead to better performance on the explored PIs. As a proof of this 
assumption, the Pearson correlation coefficients generally do not confirm the influence of 
USFs’ staff composition (number of doctors/nurses/administrative staff members) on the 10 
institutional PIs and the DEA scores. 
 
3.4.3 Cluster analysis results 
As we have described earlier, we identified four clustering criteria for classifying USFs, 
including the number of years in operation, the percentage of patients aged 65 and more, 
population density, and the percentage of diabetics. After choosing the clustering criteria for 
USFs, we have tested five different methods of cluster analysis (average linkage within 
groups, centroid method, k-means clustering, two-step clustering, and Ward’s method) to find 
the best solution for our case. In making this decision, we have considered the following 
parameters: 
 the value of DB indices and CH indices for deciding on the most appropriate 
number of clusters; 
 the size of the clusters by looking for the most balanced distribution of USFs 
among the proposed clusters, as the number of DMUs in the group materially 
affects the DEA results; in this respect, it is desirable to form clusters of a 
relatively similar size, or, at least, to avoid forming clusters with a very small 
number of units included in them; 
 the relative contribution of each of the clustering criteria to separation of the 
clusters by exploring F-ratios of a one-way ANOVA test. 
Furthermore, since we chose the squared Euclidean distance as a measure of distance 
between cases in cluster analysis, graphical representation also helps to find the best way in 
which clusters can be formed. 
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Table 3.6 presents the results for the DB indices and the CH indices calculated for 2-5 
clusters for each of the tested cluster methods. 
 
Table 3.6 Internal indices for cluster validation 
 Average linkage 
within groups 
Centroid method K-means 
clustering 
Two-step 
clustering 
Ward’s method 
DB 
Index 
CH 
Index 
DB 
Index 
CH 
Index 
DB 
Index 
CH 
Index 
DB 
Index 
CH 
Index 
DB 
Index 
CH 
Index 
2 clusters 2.46 31.64 1.67 5.65 4.13 20.69 2.37 6.79 2.00 85.18 
3 clusters 2.27 110.12 1.25 664.73 6.46 674.38 3.02 653.72 18.51 604.89 
4 clusters 7.67 342.81 3.55 445.38 6.82 463.12 18.44 439.35 29.72 403.21 
5 clusters 7.94 257.69 3.36 333.14 9.58 336.79 20.87 331.30 8.21 324.69 
 
The optimal number of clusters for each method corresponds to the maximum CH index 
and the minimum DB index, as discussed earlier, and these values are highlighted in bold in 
Table 3.6. As suggested by the analysis of the indices, two or three clusters are the best 
options for classifying USFs. 
Table 3.7 and Table 3.8 present the number of USFs included into each cluster for the 
case of three clusters and the case of two clusters respectively.  
 
Table 3.7 Distribution of USFs for the case of three clusters 
 Average linkage 
within groups 
Centroid method K-means clustering Two-step clustering Ward’s method 
Large cluster 226 USFs 301 USFs 228 USFs 294 USFs 234 USFs 
Medium cluster 111 USFs 44 USFs 86 USFs 41 USFs 83 USFs 
Small cluster 19 USFs 11 USFs 42 USFs 21 USFs 39 USFs 
 
Table 3.8 Distribution of USFs for the case of two clusters 
 Average linkage 
within groups 
Centroid method K-means 
clustering 
Two-step clustering Ward’s method 
Large cluster 245 USFs 345 USFs 240 USFs 336 USFs 234 USFs 
Small cluster 111 USFs 11 USFs 116 USFs 20 USFs 122 USFs 
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Additionally, Figure B1 and Figure B2 in Appendix B present scatter plots for the 
distributions of USFs between three and two clusters in relation to three of the four clustering 
criteria – population density, number of years in operation, and percentage of diabetics.  
Finally, Table 3.9 and Table 3.10 record F-ratios derived from a one-way ANOVA test 
of the clustering criteria. As we mentioned before, the magnitude of the F-ratios can give us 
an idea about the relative importance of each of the criteria to assining cluster membership of 
USFs. In particular, a high value of F-ratio with a low significance value implies that the 
explored variable significantly varies across clusters and it contributes to the separation of the 
clusters.  
Table 3.9 F-ratios for the clustering criteria for the case of two clusters 
 Average linkage 
within groups 
Centroid 
method 
K-means 
clustering 
Two-step 
clustering 
Ward’s 
method 
Number of years in operation 282.44** 7.37** 2.41 2.48 305.22** 
Percentage of diabetics 35.06** 121.79** 478.99** 196.34** 6.55* 
Percentage of patients aged 65 
and more 
11.28** 50.14** 270.99** 76.91** 2.83 
Population density 31.04** 5.65* 20.69** 6.79** 85.18** 
* significant at p<0.05 
** significant at p<0.01 
 
Table 3.10 F-ratios for the clustering criteria for the case of three clusters 
 Average linkage 
within groups 
Centroid method K-means 
clustering 
Two-step 
clustering 
Ward’s 
method 
Number of years in 
operation 
306.00** 6.75** 3.15* 4.98** 180.37** 
Percentage of diabetics 17.49** 60.73** 298.02** 103.87** 3.62* 
Percentage of patients aged 
65 and more 
10.10** 43.51** 128.01** 66.20** 13.15** 
Population density 110.12** 664.74** 674.39** 653.72** 604.89** 
* significant at p<0.05 
** significant at p<0.01 
 
We can clearly see from the values of F-ratios (Table 3.9 and Table 3.10) that three of 
the five methods – centroid method, k-means clustering, and two-step clustering – suggest 
assigning the least relative importance to the number of years in operation as a clustering 
criterion (or even do not consider it at all, as suggested by the observed significance levels) in 
case of three clusters and in case of two clusters. This means that USFs with different levels 
of experience may belong to the same clusters formed by these three metthods, which is 
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confirmed by the respective scatter plots in Figure B1 and Figure B2. However, accoring to 
our previous analysis, the number of years in operation as USF is the most impornant 
predictor of USFs’ performance results among the four clustering criteria, as it has the highest 
positive correlation with the DEA scores and also positively affects target attainment on eight 
of the 10 institutional PIs (Table 3.5). For this reason, we believe that the relative contribution 
of this criterion should be high enough to classify USFs in accordance to their experience. 
Although in the case of three clusters this requirement is fulfilled in the solution provided by 
the average linkage within groups (Table 3.9 and Figure B1), this method suggests the 
creation of a very small group consisting of 19 USFs (Table 3.7), which contradicts our initial 
requirement regarding the size of the clusters. 
In the case of two clusters, both the average linkage within groups and Ward’s method 
provide similar solutions: they consider the number of years in operation as a principal 
clustering criterion (Table 3.9) and split USFs into two groups, respecting approximately the 
same proportion (about 2:1). At the same time, in our view, Ward’s method provides a better 
clustering of USFs in comparison to the average linkage within groups for several reasons. 
Firstly, Ward’s method classifies USFs into two clusters with a smaller difference in size than 
between the clusters suggested by the average linkage within groups (Table 3.8). Secondly, 
Ward’s method has the lowest DB index for the case of two clusters, while none of the cluster 
validation indices confirmed the case of two clusters to be the best solution for the average 
linkage within groups (Table 3.6). Finally, Ward’s method explicitly distinguishes population 
density as a clustering criterion with a significant relative importance in the cluster separation, 
while the average linkage within groups more equally weighs the remaining three criteria 
(Table 3.9). In this way, the solution by Ward’s method can be more easily interpreted in 
terms of environmental effects, as one cluster gathers 122 USFs with less experience and/or 
with a higher population density (adverse environmental conditions), while the other consists 
of 234 more experienced USFs that operate in municipalities with a relatively lower 
population density (positive environmental conditions) (Figure B2). As a result, we have 
selected the solution provided by Ward’s method for the case of two clusters among all the 
tested solutions.  
3.4.4 The DEA assessment results and alternative P4P targets for USFs 
By identifying two clusters of USFs that perform in different environmental conditions, 
we ensure the homogeneity of USFs that belong to the same cluster. Following the procedure 
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by Lӧber and Staat (2010), we run distinct DEA models for these two clusters: for USFs of 
Cluster 1 (122 USFs) we calculate the performance scores by including observations from this 
cluster exclusively, and for obtaining results for USFs of Cluster 2 (234 USFs), we consider 
data from both clusters. In this way, we will compare each USF only with those USFs that 
operate in the same or worse environmental conditions. 
In order to proceed to the performance evaluation of the USFs, we have to specify the 
value of φ* that represents the limit for the minimum difference in virtual weights in the DEA-
based assessment of USFs. 
For this purpose, we have implemented the two-step procedure proposed by Ramón et 
al. (2010). Firstly, we have run the benefit-of-the-doubt model (2) with the weight restrictions 
(5) and (6) to identify extreme efficient units for Cluster 1 and for Cluster 2. In this model, we 
used a constant input that is equal to one and 10 outputs corresponding to the 10 institutional 
PIs described in Table 3.3. 
As a result, we identified three extreme efficient USFs for Cluster 1 and six extreme 
efficient USFs for Cluster 2. The information about the optimal virtual weights of these USFs 
is recorded in Table 3.11 and Table 3.12. 
 
Table 3.11 Optimal virtual weights for the extreme efficient USFs for Cluster 1 
 µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF Ramalde 12.31% 12.99% 12.31% 12.39% 6.17% 12.99% 6.17% 6.19% 12.31% 6.17% 
USF Porta do Sol 6.97% 19.36% 11.68% 11.99% 6.97% 13.57% 6.97% 6.97% 6.97% 8.53% 
USF Barcel Saúde 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
 
Table 3.12 Optimal virtual weights for the extreme efficient USFs for Cluster 2 
 µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF Vale do Vez 2.22% 26.37% 12.59% 8.82% 0.35% 26.37% 8.82% 8.58% 5.26% 2.22% 
USF Portus Alacer 5.88% 26.82% 5.88% 11.42% 5.88% 20.60% 5.88% 5.88% 5.88% 5.88% 
USF Nós e Vós Saúde 2.43% 37.83% 7.30% 2.43% 2.43% 37.83% 2.43% 2.43% 2.43% 2.43% 
USF Nova Via 2.73% 31.92% 8.18% 7.17% 2.73% 31.92% 2.73% 7.17% 2.73% 2.73% 
USF Porta do Sol 0.00% 35.25% 7.17% 7.59% 0.00% 31.78% 5.57% 0.00% 6.54% 0.00% 
USF Mais Saúde 6.51% 28.02% 8.96% 6.51% 6.34% 18.31% 6.34% 6.34% 6.34% 6.51% 
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The extreme efficient units specified by the benefit-of-the-doubt model (2) with the 
weight restrictions (5) and (6) will remain as such even after adding the φ* related restriction 
to the model specification, as argued by Ramón et al. (2010). Therefore, we can conclude that 
eight of the 356 USFs are considered best performers under the proposed DEA-based 
methodology for performance assessment of USFs. 
If we look at performance profiles of best performing USFs, we can see that most of 
them have top-quartile or best results on the contracted PIs. For example, USF Portus Alacer 
has the best result on the global utilisation rate among all USFs (83.35%), which is the most 
valued PI, according to the ACSS methodology, and it also has the best result on the rate of 
home visits by the nurse (per 100 patients) (28.76%), which is the third most valued PI. 
Likewise, USF Nós e Vós Saúde has the highest results on the percentage of women aged 25-
49 who have had a colpocytology in the past 3 years (85.81%) among all USFs, which is the 
second most important PI. USF Vale do Vez, in turn, has top quartile results on the following 
five PIs among all USFs: the global utilisation rate of medical consultations (81.90%), the rate 
of home visits by the doctor (per 100 patients) (5.76%), the rate of home visits by the nurse 
(per 100 patients) (19.17%), the percentage of diabetics with at least 2 HbA1C tests registered 
during the past 12 months and covering 2 semesters (93.59%), and the percentage of first 
consultations in the first trimester of pregnancy (95.12%). Additionally, USF Vale do Vez has 
100% of first consultations in the first trimester of pregnancy and all 2-year-old children fully 
immunized in accordance with the National Vaccine Programme.  
In Cluster 1, USF Ramalde has top quartile results on all PIs, except for the proportion 
of consultations provided by a designated family doctor. Similarly, USF Barcel Saúde has the 
best results in Cluster 1 with regards to the percentage of women aged 25-49 who have had a 
colpocytology in the past 3 years (80.16%), the percentage of patients with hypertension with 
at least one record of blood pressure in each semester (97.73%), and the percentage of 
diabetics with at least 2 HbA1C tests registered during the past 12 months and covering 2 
semesters (97.06%). However, both USF Ramalde and USF Barcel Saúde are outperformed 
by best performing USFs from Cluster 2. By contrast, USF Porta do Sol acts as a best 
performer in both clusters, which means that even if compared to USFs with better 
environmental conditions, USF Porta do Sol still achieves top-ranked performance results.  
Following the procedure by Ramón et al. (2010), we then maximised the ratios between 
the minimum and the maximum virtual weights of the extreme efficient USFs by solving 
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model (3) with weight restrictions (5) and (6). By maximising φ, we ensure that these units 
cannot unbalance the distribution of the virtual weight any further in order to be treated as 
fully efficient in the evaluation of each cluster, and, therefore, we avoid the problem of 
alternative optimal solutions. The results on the optimal values of φ along with the 
corresponding optimal virtuals are recorded in Table 3.13 and Table 3.14. 
 
Table 3.13 The maximised φ of the extreme efficient USFs for Cluster 1 
 φ µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF Ramalde 54.52% 11.58% 13.42% 11.58% 13.42% 7.32% 13.42% 7.32% 7.32% 7.32% 7.32% 
USF Porta do Sol 53.44% 11.38% 13.62% 13.62% 11.38% 7.28% 13.62% 7.28% 7.28% 7.28% 7.28% 
USF Barcel Saúde 6.57% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
 
Table 3.14 The maximised φ of the extreme efficient USFs for Cluster 2 
 φ µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF Vale do Vez 40.06% 6.39% 15.94% 15.94% 11.73% 6.39% 15.94% 6.39% 6.39% 8.51% 6.39% 
USF Portus Alacer 40.84% 8.56% 16.44% 8.56% 16.44% 6.71% 16.44% 6.71% 6.71% 6.71% 6.71% 
USF Nós e Vós Saúde 11.51% 4.28% 37.17% 4.28% 4.28% 4.28% 28.62% 4.28% 4.28% 4.28% 4.28% 
USF Nova Via 10.31% 3.84% 30.86% 8.67% 6.63% 3.18% 30.86% 3.18% 6.41% 3.18% 3.18% 
USF Porta do Sol 13.65% 5.66% 29.72% 7.16% 7.46% 4.06% 29.72% 4.06% 4.06% 4.06% 4.06% 
USF Mais Saúde 52.43% 11.19% 13.81% 13.81% 11.19% 7.24% 13.81% 7.24% 7.24% 7.24% 7.24% 
 
As we can see from Table 3.13 and Table 3.14, the minimum of the optimal φ is 6.57% 
for Cluster 1 and it equals 10.31% for Cluster 2. We used these values in model (4) (with 
restrictions (5) and (6)) as the bound φ* to establish the minimum level of dissimilarity 
between the optimal virtual weights of the underperforming USFs. The results on 
performance evaluation of all USFs (DEA scores and optimal virtual weights) are presented 
in Table C1 in Appendix C.  
In order to provide further insight regarding the influence of the value φ* on the 
resulting scores, we undertook a sensitivity analysis of the DEA results to the specification of 
this value. In particular, we have repeated the evaluation of 122 USFs from Cluster 1 under 
eleven different scenarios, going from φ*=0 to φ*=0.5 by 0.05. Figure 3.1 presents the box-
plots for the undertaken sensitivity analysis for a sample of 37 USFs of ARS Lisbon and 
Tagus River (all USFs belong to Cluster 1). The maximum resulting scores for each USF 
correspond to the scenario with φ*=0. In this case, the model allows for a total flexibility in 
the level of dissimilarity between the optimal virtuals, being the least restrictive scenario 
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among all. By contrast, if φ*=0.5, the model restricts the affordable level of dissimilarity 
between the optimal virtuals by 50%, which means that the minimum optimal weight cannot 
be lower than 50% of the maximum optimal weight. In this scenario, the resulting scores are 
either equal or worse when compared to the results from the other runs with lower values of 
φ*.  
As we can see from the box-plots in Figure 3.1, the level of variability of the DEA 
scores among 23 USFs that scored more than 70% as the minimum score (e.g. USF 303, USF 
294, USF 93) is relatively low (less than 5%). By contrast, the level of variability of the DEA 
scores among 4 USFs that scored less than 30% as the minimum score (USF 353, USF 351, 
USF 349, USF 347) is very high (more than 20%). There is also an intermediate group of 10 
USF that have the minimum score of 30-70% (e.g. USF 340, USF 333, USF 321) with a 
varying degree of robustness of the DEA scores under the explored scenarios. In this way, we 
can verify that the value φ* (in combination with weight restrictions (5) and (6)) affects the 
resulting scores of severely underperforming USFs to a much greater extent than it affects the 
assessment results of top performing USFs. At the same time, we suggest that only those 
USFs that scored 80% and more under the proposed DEA methodology are rewarded with a 
bonus associated with relative performance assessment, and in this group of USFs the 
methodology is very robust. 
A comparative analysis of the scores under the ACSS methodology and the DEA 
methodology can also provide interesting insights. For example, USF 170 and USF 93 from 
ARS Lisbon and Tagus River achieved a 100% score under the ACSS methodology, while 
they are not considered to be the best performers under the suggested DEA methodology: 
USF 170 scored 88.48%, while USF 93 scored 92.32%.  
97 
Figure 3.1 Sensitivity analysis of DEA scores to the specification of the value φ* for a sample of 37 USFs of ARS Lisbon and Tagus River
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This means that both USFs had relatively undemanding targets on some of the 
explored PIs for the contracting year of 2013, when compared to the DEA targets 
established by our approach. Table 3.15 and Table 3.16 present the actual results and 
the contracted targets for USF 170 and USF 93 respectively along with the DEA targets, 
suggested by our model.  
Besides the actual DEA targets that are labeled as “100%”, Table 3.15 and Table 
3.16 also present a 90% value of the DEA targets and an 80% value of the DEA targets 
to show the respective thresholds, associated with the measurement of the absolute 
target attainment for the following year, according to the suggested methodology for 
P4P contracting with USFs. 
 
Table 3.15 Performance results and targets of USF 170  
 Actual 
results 
Contracted 
targets  
DEA targets 
100%  90% 80% 
 Proportion of consultations provided by a designated 
family doctor (y1) 
89.06% 88.30% 86.51% 77.86% 69.21% 
 Global utilisation rate of medical consultations (y2) 
73.16% 73.00% 76.66% 68.99% 61.33% 
 Rate of home visits by the doctor (per 100 patients) 
(y3) 
3.54% 2.90% 3.58% 3.22% 2.86% 
 Rate of home visits by the nurse (per 100 patients) 
(y4) 
11.22% 10.80% 21.89% 19.70% 17.51% 
 Percentage of patients with hypertension with at 
least one record of blood pressure in each semester 
(y5) 
87.51% 83.00% 92.46% 83.21% 73.97% 
 Percentage of women aged 25-64 who have had a 
colpocytology in the past 3 years (y6) 
56.45% 55.00% 76.13% 68.52% 60.90% 
 Percentage of diabetics with at least 2 HbA1C tests 
registered during the past 12 months and covering 2 
semesters (y7) 
85.23% 75.00% 90.56% 81.50% 72.45% 
 Percentage of first consultations in the first 28 days 
of the newborn’s life (y8) 
96.97% 90.00% 93.81% 84.43% 75.05% 
 Percentage of fully immunised 2-year-old children 
in accordance with the National Vaccine Programme 
(y9) 
93.81% 96.00% 98.11% 88.30% 78.49% 
 Percentage of first consultations in the first trimester 
of pregnancy (y10) 
95.40% 86.00% 91.78% 82.53% 73.36% 
 
As discussed earlier, the DEA targets were drawn from the performance profiles 
of the relevant benchmarks that belong to the production frontier. In particular, USF 
Ramalde from ARS Norte acts as a single benchmark to USF 170, while USF Porta do 
Sol from ARS Norte serves as a single benchmark to USF 93. From Table 3.15 and 
Table 3.16, we can clearly see the difference in the actual targets and the targets 
identified by the benchmarks for both USFs. 
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Table 3.16 Performance results and targets of USF 93 
 Actual 
results 
Contracted 
targets  
DEA targets 
100%  90% 80% 
 Proportion of consultations provided by a designated 
family doctor (y1) 
79.73% 80.00% 84.34% 75.91% 67.47% 
 Global utilisation rate of medical consultations (y2) 
73.91% 73.00% 77.46% 69.71% 61.97% 
 Rate of home visits by the doctor (per 100 patients) 
(y3) 
4.45% 3.00% 3.76% 3.38% 3.01% 
 Rate of home visits by the nurse (per 100 patients) 
(y4) 
15.23% 14.00% 18.53% 16.68% 14.82% 
 Percentage of patients with hypertension with at 
least one record of blood pressure in each semester 
(y5) 
90.81% 92.00% 95.74% 86.17% 76.59% 
 Percentage of women aged 25-64 who have had a 
colpocytology in the past 3 years (y6) 
59.06% 60.00% 78.10% 70.29% 62.48% 
 Percentage of diabetics with at least 2 HbA1C tests 
registered during the past 12 months and covering 2 
semesters (y7) 
86.88% 92.00% 94.92% 85.43% 75.94% 
 Percentage of first consultations in the first 28 days 
of the newborn’s life (y8) 
85.45% 85.00% 96.55% 86.90% 77.24% 
 Percentage of fully immunised 2-year-old children 
in accordance with the National Vaccine Programme 
(y9) 
89.37% 97.00% 98.74% 88.87% 78.99% 
 Percentage of first consultations in the first trimester 
of pregnancy (y10) 
93.96% 85.00% 96.90% 87.21% 77.52% 
 
For example, the actual target for the most valued PI - global utilisation rate of 
medical consultations – was 73% for both USFs, while our approach suggests setting 
different targets on this PI: 76.66% for USF 170 and 77.46% for USF 93. It is 
interesting to note that both USFs achieved results on this PI that are very close to the 
contracted targets – 73.16% (USF 170) and 73.91% (USF 93). We can also track a 
similar situation with regards to the proportion of consultations provided by a 
designated family doctor (USF 170 – 89.06% achieved vs. 88.30% targeted, USF 93 – 
79.73% achieved vs. 80.00% targeted), the rate of home visits by the nurse (per 100 
patients) (USF 170 – 11.22% achieved vs. 10.80% targeted, USF 93 – 15.23% achieved 
vs. 14.00% targeted), and percentage of women aged 25-64 who have had a 
colpocytology in the past 3 years (USF 170 – 56.45% achieved vs. 55.00% targeted, 
USF 93 – 59.06% achieved vs. 60.00% targeted). In this situation, we might expect that 
the effect of goal gradient comes into effect. This means that rather than exhibiting the 
maximum possible performance level on these PIs, as suggested by more demanding 
targets of the identified benchmarks (for example, the targets of 76.13% and 78.10% are 
suggested for the percentage of women aged 25-64 who have had a colpocytology in the 
past 3 years for USF 170 and USF 93 respectively), these USFs aimed to achieve the 
results that are as close to the contracted targets as possible.  
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From Table 3.15 we can also see that, for example, the DEA target on the 
proportion of consultations provided by a designated family doctor (86.51%) is lower 
than the actual result (89.06%) and the contracted target (88.30%) of USF 170. As 
pointed out by Allen et al. (1997), a DEA model with weight restrictions may produce 
the targets for underperforming DMUs that involve deterioration to the current level of 
some of the outputs in order to enable performance improvement with regard to the 
other outputs. This means that in order to score better under the DEA methodology, 
USF 170 should reconsider its current mix of outputs and relocate a part of the 
resources used for the provision of consultations by a designated family doctor to the 
provision of other health care services that have greater importance in the context of this 
assessment. A similar situation can be observed in relation to the other DEA targets 
suggested to USF 170, including the DEA targets for the percentage of first 
consultations in the first 28 days of the newborn’s life and percentage of first 
consultations in the first trimester of pregnancy. 
There are also some USFs that scored higher under the DEA approach compared 
to the actual scores on the P4P programme. For example, while USF 309 scored 55% on 
the ACSS assessment, it has a higher score of 73.87% according to our approach. 
Unlike the previous examples, this USF has two benchmarks – USF Ramalde and USF 
Porta do Sol. This means that the targets for USF 309 can be obtained by a convex 
combination of the achieved performance results of these two best performers, 
considering the relevant intensity coefficients λ. The information about the actual 
results, the contracted targets, and the DEA targets along with the two absolute 
thresholds (labeled as “90%” and “80%”) in the DEA target attainment is recorded in 
Table 3.17. 
Similarly to the previous cases, all targets suggested by our approach to USF 309 
are higher than the contracted targets. However, by avoiding the all-or-nothing property 
of absolute thresholds, we allow this USF to score better than it has actually scored 
according to the ACSS methodology. 
In other words, while the ACSS methodology disregards any result that is lower 
than 80% of the targeted values for the calculation of a total achievement score (in case 
of USF 309, these are the rate of home visits by the doctor (per 100 patients) (79.56% 
achievement rate of the contracted target) and percentage of diabetics with at least 2  
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Table 3.17 Performance results and targets of USF 309 
 Actual 
results 
Contracted 
targets  
USF 
Ramalde 
(λ=0.01) 
USF 
Porta do 
Sol 
(λ=0.99) 
DEA targets 
100%  90% 80% 
 Proportion of consultations 
provided by a designated family 
doctor (y1) 
92.20% 85.00% 86.51% 84.34% 85.46% 76.91% 68.37% 
 Global utilisation rate of medical 
consultations (y2) 
68.47% 70.00% 76.66% 77.46% 77.05% 69.35% 61.64% 
 Rate of home visits by the doctor 
(per 100 patients) (y3) 
1.91% 2.40% 3.58% 3.76% 3.67% 3.30% 2.94% 
 Rate of home visits by the nurse 
(per 100 patients) (y4) 
11.40% 13.00% 21.89% 18.53% 20.26% 18.23% 16.21% 
 Percentage of patients with 
hypertension with at least one 
record of blood pressure in each 
semester (y5) 
69.02% 80.00% 92.46% 95.74% 94.05% 84.65% 75.24% 
 Percentage of women aged 25-64 
who have had a colpocytology in 
the past 3 years (y6) 
48.90% 55.00% 76.13% 78.10% 77.08% 69.37% 61.66% 
 Percentage of diabetics with at 
least 2 HbA1C tests registered 
during the past 12 months and 
covering 2 semesters (y7) 
53.71% 80.00% 90.56% 94.92% 92.67% 83.40% 74.14% 
 Percentage of first consultations in 
the first 28 days of the newborn’s 
life (y8) 
75.61% 80.00% 93.81% 96.55% 95.14% 85.63% 76.11% 
 Percentage of fully immunised 2-
year-old children in accordance 
with the National Vaccine 
Programme (y9) 
91.89% 95.00% 98.11% 98.74% 98.42% 88.58% 78.74% 
 Percentage of first consultations in 
the first trimester of pregnancy 
(y10) 
78.17% 85.00% 91.78% 96.90% 94.26% 84.83% 75.41% 
 
HbA1C tests registered during the past 12 months and covering 2 semesters (67.14% 
achievement rate of the contracted target)), the DEA assessment takes into account all 
results on PIs proportionally to the established best practice frontier for calculating the 
resulting score. 
This is particularly illustrative on the example of the rate of home visits by the 
doctor (per 100 patients), as by failing to provide at least two more doctor home visits 
(or to improve the result on this PI by 0.02%), target attainment on this PI is fully 
disregarded for the estimation of the resulting score of USF 309, as suggested by the 
ACSS methodology. 
Another example is USF 353 that scored relatively low on both methodologies 
(ACSS score – 20.00%, DEA score – 41.33%), showing significant potential for 
performance improvement. The information about the actual results, the contracted 
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targets, and the DEA targets along with the two absolute thresholds (labeled as “90%” 
and “80%”) in the DEA target attainment is recorded in Table 3.18.  
 
Table 3.18 Performance results and targets of USF 353 
 
 
Actual 
results 
Contracted 
targets  
DEA targets 
100%  90% 80% 
Proportion of consultations provided by a designated 
family doctor (y1) 
87.88% 85.00% 84.34% 75.91% 67.47% 
Global utilisation rate of medical consultations (y2) 
47.39% 65.00% 77.46% 69.71% 61.97% 
Rate of home visits by the doctor (per 100 patients) 
(y3) 
0.26% 1.20% 3.76% 3.38% 3.01% 
Rate of home visits by the nurse (per 100 patients) (y4) 
2.60% 14.50% 18.53% 16.68% 14.82% 
Percentage of patients with hypertension with at least 
one record of blood pressure in each semester (y5) 
62.43% 80.00% 95.74% 86.17% 76.59% 
Percentage of women aged 25-64 who have had a 
colpocytology in the past 3 years (y6) 
30.84% 45.00% 78.10% 70.29% 62.48% 
Percentage of diabetics with at least 2 HbA1C tests 
registered during the past 12 months and covering 2 
semesters (y7) 
49.15% 70.00% 94.92% 85.43% 75.94% 
Percentage of first consultations in the first 28 days of 
the newborn’s life (y8) 
66.67% 80.00% 96.55% 86.90% 77.24% 
Percentage of fully immunised 2-year-old children in 
accordance with the National Vaccine Programme (y9) 
95.89% 98.00% 98.74% 88.87% 78.99% 
Percentage of first consultations in the first trimester of 
pregnancy (y10) 
72.73% 85.00% 96.90% 87.21% 77.52% 
 
USF Porta do Sol from ARS Norte is a single benchmark to USF 353 and it 
managed to achieve top performance results, despite working under similar 
environmental conditions. In this way, we believe that the establishment of a training 
programme between these two USFs would contribute to transferring the necessary 
knowledge from USF Porta do Sol to USF 353 on how to improve the USF’s 
performance. 
 
3.5 Conclusions 
In this study we aim to contribute to enhancing P4P programme design in health 
care, both conceptually and in practice, using the example of the P4P contracts 
concluded with USFs, the Portuguese primary care providers, in relation to the method 
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used for performance assessment and target setting. To achieve this aim, we propose a 
DEA-based methodological approach under the benefit-the-doubt model that within a 
single optimization procedure evaluates the USF’s performance against the 10 
institutional PIs and also derives realistic targets in case further improvement is 
possible. The developed DEA model includes a unique combination of weight 
restrictions - a parameter that regulates the level of dissimilarity between optimal 
virtuals (Ramón et al., 2010) along with ordinal and proportional virtual weight 
restrictions (Sarrico and Dyson, 2004; Wong and Beasley, 1990) – that, in our view, 
provides an optimal balance between the exogenously derived preferences regarding the 
relative importance of each individual PI and domain and the endogenously defined 
affordable level of dissimilarity in virtual weight assignment for each provider. The 
established restrictions still allow for a great degree of flexibility in weight assignment, 
as opposed to any fixed weighting system, preserving in this way one of the main 
advantages of DEA. A particularly valuable feature of the proposed DEA model is that 
even considering the incorporated weight restrictions, it does not assume any externally 
defined numerical thresholds in weight assignment that are usually difficult to justify 
and in certain situations may lead to infeasibility problems, as pointed out by Sarrico 
and Dyson (2004). At the same time, the model guarantees the assignment of non-zero 
weights for the 10 institutional PIs, so that all individual PIs are considered in the 
calculation of composite scores of performance. Another valuable advantage of the 
proposed DEA methodology is that it appears to be robust to the specification of the 
value φ* in the group of top performing USFs, so that there is a clearly defined group of 
the USFs that are eligible to receive a bonus payment based on the DEA assessment 
results. Furthermore, the model can be easily adapted for the use of a different set of PIs 
or a different number of performance domains, making possible to develop further 
applications of the proposed model within and outside P4P context. 
Another advantage of the proposed DEA methodology is that it explicitly 
accounts for the influence of environmental factors on P4P target attainment by USFs. 
We identified four relevant environmental factors - number of years in operation as 
USF, population density, percentage of patients aged 65 and more, and percentage of 
diabetics – via analysis of the Malmquist indices by Camanho and Dyson (2006) and 
the Pearson correlation coefficients. Following this identification, we performed a 
cluster analysis to provide a single classification of USFs in relation to their 
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environmental conditions, by contrast to the existing ACSS methodology. As a result of 
this cluster analysis, we were able to form a small cluster of 122 USFs that operate in 
less favourable conditions and a large cluster of 234 USFS that operate in more 
favourble conditions. In order to guarantee a fair comparison of USFs, we performed a 
DEA assessment of each USF by comparing its results only with those peers that 
operate in the same or worse environments, as suggested by Lӧber and Staat (2010). As 
a result of the DEA assessment, we identified 8 best performing USFs and 348 
underperforming USFs. 
On the basis of the DEA assessment results, we propose an alternative 
methodology for P4P contracting with USFs. This methodology suggests that a distinct 
system of graduated bonus payments should be linked to absolute performance 
assessment of the USFs that were classified as underperforming in the previous year and 
have their absolute targets derived from the respective benchmarks, and a similar bonus 
system should also be linked to relative performance assessment of all USFs in order to 
reward those units that scored relatively high in the undertaken DEA assessment. This 
combination aims to reinforce the effect of P4P on providers’ performance, as while 
absolute targets set clear goals to work towards and offer greater control to the 
providers with regards to the attainability of a reward, relative assessment encourages 
continual improvement and stimulates the achievement of best possible performance 
results. It is also suggested that a benchmarking programme is developed in order to 
contribute to transferring knowledge from the best practices to the units that did not 
score 100%. Our suggestion is that this benchmarking programme can be linked with 
several supplementary rewards for the best performing USFs. 
Whilst this study improves our understanding regarding the implementation of 
P4P in primary care, we recognise that it has some limitations. Firstly, for the estimation 
of relative performance scores of USFs, we have only considered those PIs that are 
currently included into the P4P contracts with USFs, subject to data availability. The 
majority of the studied indicators represent the volume of health care services provided 
by a USF to its registered patients, and these, in many cases, can only provide a partial 
view on performance of primary care providers (Amado and Dyson, 2008). Therefore, 
to enable a more comprehensive and in-depth analysis of USFs’ performance, it would 
be highly desirable that future studies also include outcome measures of USFs’ 
performance as well measures related to the cost of health care delivery by USFs. 
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Secondly, in future studies it is also important to take into account a wider range of 
environmental factors that can potentially affect USFs’ performance. These are, for 
example, the socio-economic characteristics of the population, considering that, 
according to previous research, these characteristics are confirmed to have a significant 
effect on outcomes achievement in primary care delivery (e.g. Amado and Dyson, 
2009). Since our model does not include any outcome measures, it is expected that the 
socio-economic characteristics of the population would not significantly affect the 
possibility of achieving better/worse performance results against the explored PIs, 
although this assumption should be carefully verified in future research. Finally, in this 
study we have adopted the benefit-of-the-doubt approach, in which all inputs are 
substituted with a single input equal to one and outputs represent the 10 institutional 
PIs, in order to perform a P4P assessment and produce the targets for USFs, being in 
line with the ACSS methodology. However, the use of an assessment model that is 
based on volume measures may provide a fairer comparison of USFs, as it accounts for 
potential differences in resources. In our view, the development of such model should 
also be addressed in future studies. 
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Chapter 4 
CONCLUSIONS 
 
4.1 General discussion of the results 
The purpose of this thesis was to explore the methodological issues related to 
performance assessment and incentive regulation in the context of primary health care 
and to propose specific ways for improvement of performance measurement in this 
research area.  
In the first article included in this thesis, we developed a conceptual framework 
that incorporates three stages of performance assessment (measurement, analysis, and 
action) and captures four performance dimensions (accessibility, equity, efficiency, and 
effectiveness), following previous theoretical works in this research field. In the 
developed conceptual framework, we have also linked each dimension with the relevant 
sub-dimensions to provide a better understanding of the performance aspects measured 
by each dimension. Furthermore, after undertaking a systematic review of the empirical 
literature on primary care assessments, we were able to propose a functional 
classification of PIs for each of the performance dimensions. In this respect, we believe 
that the developed framework and classification fully describe the main conceptual 
elements that are needed for a comprehensive assessment of primary care providers and 
also help to reveal the relationships between these elements. It is also our conviction 
that the use of these theoretical developments in future studies on primary care 
assessments can facilitate the design of balanced measurement systems and can 
contribute to choosing appropriate performance dimensions, sub-dimensions, and PIs 
according to the specified objectives of such assessments. 
In the development of the framework, we have also emphasised the need to 
involve the targeted stakeholders at the measurement, analysis, and action stages of 
performance assessment. However, the undertaken literature review revealed that the 
involvement of stakeholders at different stages of organisational performance 
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assessment has been rare, limiting in this way the impact of the reviewed research for 
the targeted performance improvement in health care policy and practice. Furthermore, 
we have also concluded that the involvement of managers and health care professionals 
into primary care assessments is more frequent than the involvement of other relevant 
stakeholders. In this situation, we might expect that the differences in stakeholders’ 
perspectives regarding important conceptual and practical aspects in the performance 
assessment of primary care providers are not fully accounted for, which can adversely 
affect face validity of the studies’ research findings. 
The second article aimed to explore the potential of DEA, a non-parametric 
frontier technique proposed by Charnes et al. (1978), for enhancing P4P programme 
design in primary health care. In particular, we aimed to propose a DEA methodology 
for performance assessment of USFs, primary care providers in Portugal, and a new 
methodology for P4P contracting based on the DEA assessment results.  
In the development of a DEA methodology for performance assessment of USFs, 
we modified the standard DEA model by adopting the benefit-of-the-doubt approach 
and introducing a unique combination of weight restrictions - a parameter that regulates 
the level of dissimilarity between optimal virtual weights, proposed by Ramón et al. 
(2010), combined with ordinal and proportional virtual weight restrictions (Sarrico and 
Dyson, 2004; Wong and Beasley, 1990). In our view, such combination of the weight 
restrictions provides an optimal balance between the exogenously derived preferences 
regarding the relative importance of each PI and the endogenously defined affordable 
level of dissimilarity in virtual weight assignment for each provider. The established 
restrictions still allow for a great degree of flexibility in weight assignment, as opposed 
to any fixed weighting system, preserving in this way one of the main advantages of 
DEA.  
The proposed DEA-based approach also explicitly accounts for the influence of 
environmental factors on P4P target attainment. In particular, having analysed the 
Malmquist indices by Camanho and Dyson (2006) and the Pearson correlation 
coefficients, we identified four relevant environmental factors – the number of years in 
operation, population density, the percentage of patients aged 65 and more, and the 
percentage of diabetics – and performed a cluster analysis to classify the providers in 
relation to their environmental conditions. As a result of this cluster analysis, we obtain 
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a small group of 122 USFs that operate in less favorable conditions and a large group of 
234 USFs that operate in more favorable conditions. 
We applied the proposed DEA methodology for the assessment of 356 USFs in 
relation to their results against the 10 institutional PIs in the contracting year of 2013. 
As suggested by Lӧber and Staat (2010), each USF was compared only with those peers 
that operate in the same or worse environments in accordance to the cluster membership 
of the USFs. As a result of the DEA assessment, we have identified 8 best performing 
USFs and 348 underperforming USFs. 
We suggested a new methodology for P4P contracting with USFs based on the 
DEA assessment results. This methodology includes a combination of absolute and 
relative performance assessments that reinforces the effect of P4P on USFs with 
different performance levels. In particular, we proposed rewarding absolute target 
attainment of the USFs that were classified as underperforming in the previous year and 
have their absolute targets derived from the respective benchmarks and rewarding 
relative target attainment of the USFs that scored relatively high on the undertaken DEA 
assessment. Each of these two assessments is proposed to be linked to a distinct system 
of graduated rewards. We also suggested that a benchmarking programme should be 
created in order contribute to disseminating of best practices between the USFs with 
similar characteristics and similar performance priorities. The development of this 
benchmarking programme would be rewarded by several supplementary bonus 
payments for the best performing USFs. 
In general, we believe that there are a number of valuable features of the proposed 
DEA methodology for performance evaluation and subsequent target setting in the 
context of P4P. In particular, our approach assumes a holistic performance assessment 
that recognizes the existence of multiple trade-offs between individual PIs and respects 
the relative strengths and weaknesses as well as different priorities in P4P target 
attainment of USFs. The proposed approach also considers the effect of the relevant 
environmental factors in the assessment of USFs, so that it effectively disentangles the 
variation in USFs’ performance results that are attributable to environmental conditions 
from factors that are under direct control of health care managers and staff. In this way, 
we guarantee that the absolute targets established for underperforming USFs for 
subsequent periods are realistic and feasible, since these targets are based on adjusted 
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estimates of performance. Furthermore, if the proposed DEA methodology was adopted 
for P4P evaluations of USFs, it would encourage the providers to show their best 
possible results, given that DEA is based on a relative assessment of performance. 
From a joint analysis of the research findings of the two articles, we can also draw 
several conclusions. In particular, we believe that performance assessment of USFs in 
the context of P4P can be significantly improved, if the proposed conceptual framework 
for primary care assessments is adopted. The present P4P contracts suggest assessing 
and rewarding USFs’ performance against a small range of PIs and a limited number of 
sub-dimensions, leaving out important sub-dimensions included into the framework. For 
example, these contracts suggest the assessment of PIs on realised accessibility, 
however, it would be desirable to clarify beforehand whether all USFs have the same 
level of potential accessibility. This is an important piece of knowledge, since the 
differences in terms of economic accessibility, organisational accessibility, geographic 
accessibility, and service availability across USFs may ultimately result in a better or 
worse level of realised access to USFs among their registered patients and, therefore, 
may represent one of the areas for further improvement. 
There is also no assessment of the effect of the Portuguese P4P programme on 
equity of access, equity of treatment, or equity of health care outcomes. However, it is 
recognised that the implementation of P4P programmes may exacerbate health care 
disparities in relation to specific patient groups by selecting those patients for whom it 
is easier to achieve good performance results (Conrad, 2009).  
Furthermore, the P4P contracts include two measures on cost-efficiency - the 
average cost of medications prescribed per user and the average cost of complementary 
diagnostic and therapeutic means prescribed per user – with only a limited adjustment 
for the patient case-mix, such as accounting for differences in the percentage of patients 
aged 65 and more and accounting for differences in the percentage of diabetics. In our 
view, it would be desirable to compare the costs of health care delivery in each of the 
medical conditions separately, such as, for example, the average health care costs for 
patients with asthma, for patients with diabetes, for patients with hypertensions and so 
forth, considering the comorbidity status of the patients. Furthermore, comparing health 
care costs with the outputs and outcomes of health care delivery under a DEA 
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assessment can provide further insight regarding the cost and allocative efficiencies of 
USFs. 
Regarding the assessment of effectiveness, there are some differences between the 
P4P contracts concluded in 2013 and 2016. In particular, the P4P contracts in 2016 
suggested measuring the proportion of patients with hypertension aged less than 65 
years and with arterial pressure less than 150/90 and the proportion of diabetics with the 
last HgbA1c ≤ 8.0% to assess USFs’ outcomes achievement. These outcome measures 
were absent in the P4P contracts in 2013. Moreover, the assessment of clinical 
effectiveness in the latest P4P contracts included a larger range of activities associated 
with the management of maternal health, family planning, and child health in the first 
year of life. The measurement of patient satisfaction was also preserved in the P4P 
contracts in 2016. At the same time, we recommend to assess the effectiveness of 
interpersonal care within the context of P4P as one of the important predictors of 
outcomes achievement. 
 
4.2 Suggestions for future studies 
In this section we aim to outline the main suggestions for future research, based 
on the analysis of the two research articles included in this thesis. 
1. Given that the undertaken systematic literature review showed that the four 
performance dimensions have mostly been explored separately, it is important that 
future studies investigate the relationships between different dimensions by 
exploring several or all dimensions simultaneously. Similarly, it is recommended to 
further explore the relationships between different sub-dimensions within a single 
dimension, such as, for example, the relationship between potential and realised 
accessibilities. 
2. Considering an insufficient involvement of targeted stakeholders at different stages 
of performance assessment, we suggest that future studies should make more effort 
to involve these stakeholders into primary care assessments. Moreover, it is 
recommended that a greater emphasis is given to the involvement of patients and 
citizens among other stakeholders. 
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3. We also recommend exploring the possibility of conducting quality appraisal of the 
empirical studies devoted to health care performance assessments. 
4. Another suggestion is to enlarge a set of sub-dimensions and the respective PIs 
included in the performance assessment of USFs by adopting the conceptual 
framework for primary care assessments developed in this thesis. 
5. It is also recommended that future studies take into account a wider range of 
environmental factors that can potentially affect USFs’ performance, such as the 
socio-economic characteristics of the population among other factors. 
6. Finally, we recommend undertaking a DEA assessment based on volume measures, 
as it allows a fairer assessment of USFs by accounting for potential differences in 
resources between the providers. 
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Appendix A: Summary of the reviewed studies 
 
Table A1 Summary of the reviewed studies 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Aakvik and Holmås (2006) To examine the relationship between the availability of 
physicians and health outcomes in Norwegian 
municipalities 
General practitioners  Norway General practice 
 
Yes No No No 
Abrams et al. (1995) To investigate the administrative and policy 
implications of managed care for community health 
centres and to assess the cost and utilisation 
performance of community health centres in managed 
care networks 
7 community health 
centres 
USA General practice No No Yes* No 
Akazili et al. (2008) To determine the degree of efficiency of health centres 
in Ghana and recommend performance targets for the 
inefficient facilities 
89 public health centres Ghana General practice No No Yes No 
Al-Taiar et al. (2010) 
 
To investigate the relationship between different 
measures of physical access, including straight-line 
distances, road distances and travel time and the impact 
of these measures on the vaccination of children in 
Yemen 
Primary care centres Yemen Preventive care Yes No No No 
A – accessibility, B – equity, C – efficiency, D – effectiveness 
*Efficiency has been analysed through partial ratio-based measures (the first category of efficiency studies) 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Amado and Dyson (2009) 
 
To examine the role of DEA in helping decision 
makers to understand and improve the performance of 
primary care practices 
14 general practitioner 
practices 
 
UK Chronic disease 
management  
 
No Yes Yes Yes 
Amado and Santos (2009) 
 
To contribute to the discussion regarding appropriate 
ways to compare the performance of primary care 
providers 
351 health care centres Portugal General practice No Yes Yes Yes 
Andes et al. (2002) To develop a model which helps to determine best 
practices of efficient physician offices while allowing 
for choices between inputs 
115 primary care 
physician practices 
USA General practice 
 
No No Yes No 
Arakawa et al. (2011) To evaluate patient accessibility to tuberculosis 
treatment in different referral services in Ribeirão 
Preto, an interior city in Sao Paulo state 
4 referral services of 
primary health units, 
district health units and 
referral centres 
Brazil Acute and non-
acute infectious 
disease 
management 
Yes No No No 
Aysola et al. (2013) To determine if patient-centred medical homes 
(PCMHs) are associated with improved quality and 
equity in paediatric primary care 
PCMHs USA Maternal and 
child care 
Yes Yes No Yes 
Baker (1992) To explain variations in the level of development 
among general practices in three counties of south west 
England 
287 general practices UK General practice 
 
Yes No Yes* No 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Barbaro et al. (2014) 
 
To evaluate prenatal care for adolescents in health 
units, in accordance with the attributes of Primary 
Health Care guidelines 
1 Basic Health District 
Unit, 1 School-Based 
Health Centre, 6 Basic 
Health Units, 4 Family 
Health Units 
Brazil Maternal and 
child care 
 
Yes No No Yes 
Bates et al. (1996) To illustrate the nature of the problems arising when 
attempting to assess the efficiency with which the 
prescribing of drugs is achieved by general 
practitioners in UK National Health Service 
106 general practices UK General practice 
 
No No Yes No 
Bell et al. (2013) To examine potential (geographical) access to primary 
health care in the city of Mississauga, Ontario, Canada 
677 general practices Canada General practice Yes No No No 
Bissonnette et al. (2012) 
 
To examine neighbourhood access to primary health 
care in the city of Mississauga, Ontario, Canada 
677 general practices Canada General practice Yes No No No 
Breyer (1977) To determine the degree to which original goals of a 
national health centre policy were met and to suggest 
areas for future improvement 
9 health centres USA General practice Yes No Yes* Yes 
Bryce et al. (2000) To describe the efficiency of HMOs and to test the 
robustness of these findings across alternative models 
of efficiency 
585 HMOs USA General practice No No Yes No 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Buck (2000) To assess the efficiency with which health authorities’ 
Community Dental Services provide dental care in 
England 
100 Community Dental 
Services 
UK Dental care No No Yes No 
Buja et al. (2014) To compare the performance of primary health care 
services in managing diabetes, congestive heart failure 
and coronary heart disease, by age group 
Local Health Units Italy Chronic disease 
management  
No Yes No No 
Campbell et al. (2007) To assess the quality of primary care in England with 
the introduction of pay-for-performance 
42 primary care practices UK Chronic disease 
management 
No No No Yes 
Carrier et al. (2011) To test for associations between quality of care and the 
composition of a physician’s patient panel 
Non-federal US 
physicians  
USA General practice 
 
No Yes No No 
Chilingerian and Sherman 
(1996) 
To explore the use of DEA to locate best practice 
physicians and the potential savings if inefficient 
physicians adopt these best practice patterns 
326 primary care 
physicians working in 
HMOs 
USA 
 
General practice 
 
No No Yes No 
Chilingerian and Sherman 
(1997) 
To present a detailed real application that demonstrates 
how to improve physician profiles with enhanced DEA 
models 
326 primary care 
physicians working in 
HMOs 
USA 
 
General practice 
 
No No Yes No 
Collier et al. (2006) 
 
To benchmark relative performance assessment for 
primary care physicians who work in a university clinic 
16 primary care 
physicians 
USA 
 
General practice 
 
No No Yes Yes 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Cordero-Ferrera et al. (2011) To extend the existing literature about efficiency 
measurement in primary health care with the 
application of a recently developed method to deal with 
exogenous variables 
97 primary care centres Spain 
 
General practice 
 
No No Yes No 
Cordero-Ferrera et al. (2014) 
 
To extend the literature on measuring efficiency in 
primary health care by considering the influence of 
quality indicators and environmental variables 
conjointly in a case study 
94 primary care centres Spain 
 
General practice 
 
No No Yes No 
Coughlin et al. (2008) 
 
To explore the relationships between race/ethnicity and 
area factors affecting access to health care in the 
United States 
US primary care 
physicians 
USA Preventive care 
 
No Yes No No 
Dahrouge et al. (2010)  
 
To evaluate whether gender differences in the primary 
care experience in each model of primary care exist 
and whether the extent of gender differences between 
models differs 
137 primary care practices Canada 
 
General practice 
 
No Yes No No 
Dahrouge et al. (2013) 
 
To evaluate the delivery of primary health services for 
different socio-economic groups and assessed the 
performance of different organisational models in 
terms of equality of health care delivery in Ontario, 
Canada 
137 primary care practices Canada 
 
General practice 
 
No Yes No No 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Defelice and Bradford (1997) To define whether solo or group practice physicians are 
relatively more inefficient 
924 primary care 
physicians  
USA General practice 
 
No No Yes No 
Deidda et al. (2014) To analyse the efficiency of primary care centres 
adopting Information and Communication Technology 
devices, using a new database on primary care centres 
in the Basque Region in Spain 
130 primary care centres Spain 
 
General practice No No Yes No 
Draper et al. (2000) To examine the efficiency of HMOs 249 HMOs USA General practice No No Yes No 
Edward et al. (2011) 
 
To illustrate the performance trends in delivering the 
basic primary health services the first five-year period 
following elections in 2004 and to reflect on the 
potential and limitations of the scorecard as a 
performance management tool to measure and improve 
health service delivery in similar health care contexts 
3 district hospitals,7 
comprehensive health 
centres, 15 basic health 
centres 
Afghanistan General practice Yes No No Yes 
Ferreira et al. (2013) 
 
To contribute to a better understanding of the 
performance of Primary Health Care by measuring it in 
a Portuguese region (Lisbon and Tagus Valley) and 
identifying best practices 
22 health care centres Portugal 
 
General practice No Yes Yes Yes 
Friedberg et al. (2007) To examine whether larger physician group size and 
affiliation with networks of multiple groups are 
associated with higher quality of care 
132 physician groups USA 
 
General practice 
 
No No No Yes 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Furtado et al. (2013) 
 
To analyse the presence and extent of Primary Health 
Care attributes and the strength of affiliation of 
children under one year old in a Family Health Unit 
2 School Health centres, 7 
Basic Health Units, 5 
Family Health Units 
Brazil 
 
Maternal and 
child care 
Yes No No Yes 
García et al. (1999)  To analyse the efficiency of primary care centres in the 
province of Zaragoza in Spain 
54 primary care centres Spain General practice No No Yes No 
Geboers et al. (2002) To examine the possibility of performing a 
comprehensive assessment of the quality of care 
provided in primary care practices 
39 primary care practices Holland General practice Yes No No Yes 
Gesler et al. (2006) 
 
To examine whether or not there is poorer geographic 
access to health care in more rural counties and to 
explore whether rural populations are adequately 
served in terms of national standards 
284 primary care 
physicians 
USA General practice 
 
No Yes No No 
Gilson et al. (1995) 
 
To provide the quantitative analysis of structural 
quality, giving details of the nature of the quality 
weaknesses 
58 primary health 
organisations 
Tanzania 
 
General practice 
 
Yes No No No 
Giuffrida and Gravelle (2001)  
 
To compare different methods of measuring the 
performance of English FHSAs in providing primary 
care 
90 FHSAs  UK 
 
General practice 
 
Yes No Yes Yes 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Giuffrida (1999) 
 
To explore the productivity change in the provision of 
primary health care in England between the financial 
years 1990/91 and 1994/95 using routine 
administrative data from Family Health Services 
Authorities (FHSAs) and to decompose it into pure 
efficiency, technical and scale changes 
90 FHSAs UK 
 
General practice 
 
Yes No Yes Yes 
Gray et al. (2007) 
 
To assess the quality of diabetes care and intermediate 
clinical outcomes within a multiethnic population after 
a sustained period of investment in quality 
improvement 
32 primary care practices UK Chronic disease 
management  
 
No Yes No No 
Guagliardo et al. (2004) 
 
To propose a method for measuring and analysing 
spatial accessibility to physicians that is easily 
understood by health policy makers and is particularly 
useful for congested urban areas 
Primary care physicians  USA 
 
Maternal and 
child care 
Yes No No No 
Gusmano et al. (2013) 
 
To compare access to primary and specialty care in 
three metropolitan regions of France and to identify the 
factors that contribute to disparities in access to care 
within and among these regions 
Primary and specialty care 
providers 
France 
 
General practice No Yes No No 
Habib et al. (2011) 
 
To analyse the pattern of antenatal care consultations at 
the health centres and the characteristics of the 
physicians and the women and to determine the 
predictors of good antenatal care performance 
7 primary health care 
centres 
Saudi Arabia 
 
Maternal and 
child care 
 
No No No Yes 
139 
Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
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Medical 
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studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Haggerty et al. (2007) 
 
To investigate variations in accessibility, continuity of 
care, and coordination of services as experienced by 
patients in Quebec on the eve of major reforms, and to 
provide baseline information against which reforms 
could be measured 
100 primary health care 
clinics 
Canada 
 
General practice Yes No No Yes 
Haggerty et al. (2008) 
 
To identify attributes of clinic organisation and 
physician practice that predict accessibility, continuity, 
and coordination of care as experienced by patients 
100 primary health care 
clinics 
Canada 
 
General practice Yes No No Yes 
Hall et al. (2008) To expand the definition of access to physician 
services, using a survey of primary care providers in 
the Florida Medicaid program  
3222 primary care 
providers 
USA 
 
General practice Yes No No No 
Halsteinli et al. (2010) To assess productivity growth in Norwegian outpatient 
child and adolescent mental health service units  
From 48 to 60 outpatient 
child and adolescent 
mental health service units 
Norway Mental care 
 
No No Yes No 
Heard et al. (2013) To evaluate a large, ongoing effort to improve urban 
primary health care in Bangladesh through expansion 
of publicly funded urban health facilities and 
contracting with partner non-governmental 
organisations  
Urban primary health care 
centres in non-
governmental 
organisations 
Bangladesh General practice Yes No Yes* Yes 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Hedeen et al. (2002) To compare quality of care provided to veterans at 
Community-Based Outpatient Clinics and at traditional 
hospital-based VA Medical Centre clinics 
20 Community-Based 
Outpatient Clinics, 20 VA 
Medical Centre clinics 
USA General practice No No No Yes 
Huang and McLaughlin (1989) To apply DEA to the evaluation of rural primary health 
care programs 
77 primary care clinics USA General practice No No Yes No 
Huerta Munoz and Källestål 
(2012) 
To measure geographical accessibility, model spatial 
coverage of the existing primary health facility 
network, estimate the number of primary health 
facilities working under capacity and the population 
underserved in the Western Province of Rwanda 
113 primary health care 
facilities 
Rwanda General practice Yes No No No 
Idzerda et al. (2011) To assess whether the Roma, as a vulnerable 
population, are able to effectively access primary care 
services, and if not, what barriers prevent them from 
doing so 
Primary health care 
services  
Serbia Maternal and 
child care 
No Yes No No 
Jaakkimainen et al. (2011) To evaluate differences in performance between 
Family Health Network and Family Health Group and 
to compare performance before and after physicians 
joined these new primary care groups 
3466 Family Health 
Network and 474 Family 
Health Group physicians 
USA General practice No No No Yes 
Jacobs et al. (2006a) To examine the degree to which variations in the 
performance of health care organisations are explained 
by a range of factors that are subject to differing 
degrees of managerial control 
304 Primary Care Trusts  UK General practice Yes No No Yes 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Jahangoshai Rezaee et al. 
(2012) 
To introduce a new integrated approach to measure 
unified efficiency of the healthcare systems 
54 health centres USA General practice No No Yes No 
Jaiveer et al. (2006) 
 
To assess the performance of 12 local practices using 
the Alphabet Strategy with respect to the diabetes 
quality indicators before and after the implementation 
of GMS2 
13 (2004) and 12(2005) 
general practices 
UK Chronic disease 
management  
No No No Yes 
Kelaher et al. (2006) 
 
 To examine the effects of socioeconomic disadvantage 
on access to after hours care and episodes of not 
seeking after hours care when needed among users and 
non-users of after hours care 
General practitioners and 
emergency departments  
Australia General practice No Yes No No 
Keller et al. (2014) To assess the quality of primary care for people living 
with HIV (PLWH) and to explore factors associated 
with meeting Health Resources and Services 
Administration-identified HIV performance measures 
Primary HIV medical care  USA Acute and non-
acute infectious 
disease 
management 
No No No Yes 
Kern et al. (2014) To compare quality of care provided by physicians in 
PCMHs with that provided by physicians using paper 
medical re-cords and, separately, with that provided by 
physicians using electronic health records without the 
PCMH (to determine whether effects were driven by 
electronic health records) 
675 primary care 
physicians 
USA General practice No No o Yes 
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Country of 
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Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Kirigia et al. (2001) 
 
To investigate the technical inefficiencies among 155 
primary health care clinics in Kwazulu-Natal Province 
of South Africa and to draw policy implications 
155 primary health care 
clinics 
South Africa General practice No No Yes No 
Kirigia et al. (2004) 
 
To determine the degree of technical efficiency of 
individual primary health care facilities in Kenya; to 
recommend the performance targets for inefficient 
facilities; to estimate the magnitudes of excess inputs; 
and to recommend what should be done with those 
excess inputs 
32 public health centres Kenya General practice No No Yes No 
Kirigia et al. (2008) 
 
To measure the technical and scale efficiency of health 
centres; to evaluate changes in productivity; and to 
highlight possible policy implications of the results for 
policy makers 
17 public health centres Seychelles 
 
General practice No No Yes No 
Kirigia et al. (2011) 
 
To estimate the technical efficiency of community 
health centres (CHCs), community health posts (CHPs) 
and maternal and child health posts (MCHPs) in 
Kailahun and Kenema districts of Sierra Leone, 
estimate the output increases needed to make 
inefficient MCHPs, CHCs and CHPs efficient, and 
explore strategies for increasing technical efficiency of 
these institutions 
22 community health 
centres, 21 community 
health posts,36 maternal 
and child health posts  
Sierra Leone 
 
General practice No No Yes No 
Klemenc-Ketis et al. (2014) To validate a tool for patient evaluation of nurse 
practitioners 
7 family medicine 
practices  
Slovenia General practice No No No Yes 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Kontodimopoulos et al. (2006) To investigate the efficiency of a set of small-scaled 
Greek hospitals known as hospital-health centres  
17 hospital-health centres  Greece General practice No No Yes No 
Kontodimopoulos et al. (2007) To compare technical and scale efficiency of primary 
care centres from the two largest Greek providers, the 
National Health System (NHS) and the Social Security 
Foundation (IKA) and to determine if, and how, 
efficiency is affected by various exogenous factors 
such as catchment population and location 
194 primary care centres 
(103 NHS and 91 IKA) 
Greece General practice No No Yes No 
Lamarche et al. (2010) 
 
To assess the care experience of primary health care 
users, to determine whether assessments vary 
according to the geographical context in which services 
are obtained and to determine whether the observed 
variations are consistent across all components of the 
care experience 
100 primary health care 
clinics 
Canada General practice No Yes No No 
Lebrun et al. (2013) To asses racial/ethnic disparities in clinical quality 
among US health centres 
1131 health centres USA General practice No Yes No No 
Lee et al. (2009) To develop a tool for assessing the performance of 
primary care services in South Korea from the patient’s 
perspective and to test the validity of the tool under the 
conceptual framework of the recently developed 
definition of primary care in Korea 
16 primary care providers South Korea General practice Yes No No Yes 
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Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Lemos et al. (2014) To assess the performance of health services for 
indigenous and non-indigenous populations with 
regard to tuberculosis control 
Primary care providers 
and specialists  
Brazil Acute and non-
acute infectious 
disease 
management 
No Yes No No 
Lewis and Holcomb (2012)  To evaluate a novel method of primary care delivery in 
a military family practice setting. 
14 practice physicians, 
family nurse practitioners, 
and physician assistants 
USA General practice Yes No Yes* Yes 
Linna et al. (2003) To measure the productive efficiency of public dental 
health provision across Finland and to investigate 
various factors explaining the technical and cost 
efficiency of public dental care 
228 public dental health 
centres 
Finland Dental care No No Yes No 
Llanwarne et al. (2013) 
 
To examine the relationship between clinical quality 
and patient experience using data from 2 established 
measures of quality in primary care in England 
7759 general practices UK General practice Yes No No Yes 
Luo and Qi (2009) 
 
To present an enhancement of the two-step floating 
catchment area (2SFCA) method for measuring spatial 
accessibility and to measure the spatial access to 
primary care physicians in northern Illinois 
Primary care physicians  USA General practice Yes No No No 
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Medical 
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studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Luo and Wang (2003) 
 
To synthesize two GIS-based accessibility measures 
into one framework and to apply the methods to 
examining spatial accessibility to primary health care 
in the Chicago ten-county region 
Primary care physicians  USA General practice Yes No No No 
Luo et al. (2004) 
 
To examine temporal changes of access to primary 
health care in Illinois between 1990 and 2000 in a GIS 
environment 
Primary care physicians  USA General practice Yes No No No 
Luoma (1996) 
 
To examine the productive efficiency of Finnish health 
centres by applying DEA and econometric methods 
202 health centres Finland General practice No No Yes No 
Macinko et al. (2007) To presents methodology for the rapid assessment of 
the organisation and performance of primary care 
services at district level 
40 primary care clinics Brazil General practice Yes No No Yes 
Manzoli et al. (2014) To compare the performance of local providers, such 
as Italian local health authorities (LHAs) and health 
districts, using prevention quality indicators 
44 local health units and 
11 health districts 
Italy General practice Yes No No No 
Marathe et al. (2007) To examine factors affecting the variation in technical 
and cost efficiency of community health centres  
493 community health 
centres 
USA General practice No No Yes No 
Marschall and Flessa (2011)  To determine the relative efficiency of primary care 
facilities in Nouna, a rural health district in Burkina 
Faso 
20 health centres Burkina Faso General practice No No Yes No 
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Performance dimensions 
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Masiye et al. (2006) To estimate the degree of technical, allocative and cost 
efficiency in individual public and private health 
centres in Zambia; and to identify the relative 
inefficiencies in the use of various inputs among 
individual health centres 
40 health centres Zambia General practice No No Yes No 
McGrail and Humphreys 
(2009) 
 
To critically appraise the two-step floating catchment 
area (2SFCA) method, a recent solution for measuring 
primary care service accessibility across rural areas of 
Victoria, Australia 
Primary care physicians  Australia General practice Yes No No No 
McGrail (2012) 
 
To assess measure recent improvements of the measure 
the two step floating catchment area (2SFCA) method 
and to measure spatial accessibility of primary health 
care providers in the state of Victoria, Australia 
Primary care physicians  Australia General practice Yes No No No 
Millett et al. (2008) 
 
To examine ethnic disparities in the management of 
hypertension among patients with and without 
cardiovascular comorbidities after the implementation 
of a major pay-for-performance incentive scheme in 
UK primary care 
16 family practices UK Chronic disease 
management  
No Yes No No 
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Millett et al. (2009a) 
 
To examine disparities in coronary heart disease 
management and intermediate clinical outcomes within 
a multiethnic population before and after the 
introduction of a major pay for performance initiative 
in April 2004 
36 family practices  UK Chronic disease 
management  
No Yes No No 
Millett et al. (2009b) 
 
To examine the impact of a major pay for performance 
incentive on trends in the quality of diabetes care in 
white, black, and South Asian ethnic groups in an 
urban setting in the U.K. 
16 family practices UK Chronic disease 
management  
No Yes No No 
Milliken et al. (2011) 
 
To compare the relative productive efficiencies of 4 
models of primary care service delivery using the DEA 
method on 130 primary care practices in Ontario, 
Canada 
130 primary care practices  Canada General practice No No Yes No 
Mills et al. (2004) To examine the performance of different models of PC 
provision, in order to identify their strengths and 
weaknesses from the perspective of a government 
wishing to develop an overall strategy for improving 
PC provision 
21 primary care sites South Africa General practice Yes No No Yes 
Montgomery et al. (2004) To examine changes in the quality of primary care 
experienced and reported by Medicare beneficiaries 
from 1998 to 2000 
Primary care providers  USA General practice Yes No No Yes 
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Morris and Landes (2006) To assess the equity of access to primary care 
orthodontic treatment in relation to deprivation in the 
County Durham and Tees Valley Strategic Health 
Authority area 
General dental 
practitioners 
UK Dental care 
 
No Yes No No 
Morris et al. (2005) To investigate inequality and inequity in the use of 
general practitioner consultations, outpatient visits, day 
cases and inpatient stays in England 
Primary care practices UK 
 
General practice 
 
No Yes No No 
Mosquera et al. (2013) To evaluate the performance of the essential 
dimensions of the PHC strategy in six localities 
geographically distributed throughout Bogotá city 
Private and public primary 
health care clinics in 
Bogota, Colombia 
Colombia General practice Yes No No Yes 
Murillo-Zamorano and 
Petraglia (2011) 
To assess the incidence of quality on the measurement 
of technical efficiency in the primary health care sector 
85 primary care centres Spain General practice No No Yes No 
Newton et al. (2008) 
 
To assess inequalities in the availability of NHS dental 
services between Health Boards in Scotland 
2134 general dental 
practitioners 
UK Dental care No Yes No No 
Nuti et al. (2011) 
 
To measure technical efficiency of Tuscan Local 
Health Authorities and its relationship with quality and 
appropriateness of care 
12 Local Health 
Authorities 
Italy General practice No No Yes No 
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Osei et al. (2005) 
 
To estimate the relative technical efficiency and scale 
efficiency of a sample of public hospitals and health 
centres in Ghana; and to demonstrate policy 
implications for health sector policy-makers 
17 district hospitals, 17 
health centres 
Ghana General practice No No Yes No 
Ozcan (1998) 
 
To analyse physician practice behaviour and develops 
measures of physician practice efficiency as a basis for 
improving productivity and reducing costs in otitis 
media treatment 
160 physicians  USA Acute and non-
acute infectious 
disease 
management 
No No Yes No 
Ozcan et al. (2000) 
 
To compare resource utilisation between primary care 
physicians and specialists in the treatment of Medicaid 
sinusitis patients in Virginia 
176 physicians (152 
generalists and 24 
otolaryngologists) 
USA Acute and non-
acute infectious 
disease 
management 
No No Yes No 
Pai et al. (2000) To examine the physician efficiency and resulting cost 
patterns by region 
178 physicians USA Acute and non-
acute infectious 
disease 
management 
No No Yes No 
Parchman and Culler (1994) To examine the relationship between the availability of 
primary care physicians and access to health care as 
measured by the avoidable hospital condition rates 
26 health service areas USA General practice Yes No No No 
  
150 
Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
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Pelletier et al. (2014) 
 
To develop a hierarchical, freighted composite model 
to reliably compare primary care physicians across 
domains of care 
199 primary care 
physicians 
USA General practice No No No Yes 
Pelone et al. (2012) To compare technical efficiency of general practice 
delivered by the twenty Regions of Italy’s 
decentralized healthcare system and to determine if it 
was affected by contextual factors 
General practices in 20 
regions 
Italy 
 
General practice 
 
Yes No Yes No 
Perry and Gesler (2000) To assess physical access to primary health care in a 
remote and impoverished region of Andean Bolivia 
Primary health care 
providers 
Bolivia General practice Yes No No No 
Pietilä et al. (1998) To investigate the costs of orthodontic care provided 
for children and adolescents up to the age of 18 by 
municipal health centres in Finland, and to study the 
productivity of these services 
217 municipal health 
centres 
Finland Dental care No No Yes No 
Pina & Torres (1992) To examine the alternative approach to the analysis of 
the efficiency of the health care organisations 
10 health centres Spain General practice No No Yes No 
Puig-Junoy & Ortún (2004) To improve knowledge of cost efficiency in primary 
care contracting in the Catalan health system  
180 primary care teams Spain General practice Yes No Yes No 
Rabetti & Freitas (2011) To evaluate the efficiency of the Family Health 
Strategy in actions related to hypertension 
66 municipalities Brazil Chronic disease 
management  
No No Yes No 
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Radford et al. (2007) To develop a scorecard that CHCs could use to 
evaluate organisational performance, to test the 
scorecard by providing CHCs with timely information 
about their own performance and comparative 
information about the performance of their peers, to 
assess the perceived usefulness of the scorecard, and to 
determine the interest in and feasibility of continuing 
the scorecard 
14 community health 
centres  
USA 
 
General practice Yes No Yes* No 
Rahman & Capitman (2012) To explore the factors that may have contributed to 
productive efficiency gains of 67 primary health care 
centres 
67 primary health care 
centres 
USA General practice No No Yes No 
Ramírez-Valdivia et al. (2011) To empirically determine which factors affect more the 
technical efficiency of the PHCs managed by each 
municipality using a multiple step analysis 
259 municipalities  Chile General practice No No Yes No 
Renner et al. (2005) To measure the technical efficiency and scale 
efficiency of a sample of public peripheral health units 
in Sierra Leone 
37 peripheral health units Sierra Leone General practice No No Yes No 
Ricketts et al. (2001) To test the concept of ambulatory care sensitive 
condition rates as markers in a combined rural and 
urban context and explore their use as health program 
outcome measure 
120 primary care service 
areas in North Carolina 
USA General practice Yes No No No 
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Ridde et al. (2013) To evaluate the effects on healthcare access inequities 
of an intervention exempting children under 5 years 
from user fees in Burkina Faso 
18 primary health care 
centres 
Burkina Faso Maternal and 
child care 
No Yes No No 
Roeger et al. (2010) To examine the equity of access to GPs in an Australia 
capital city (Adelaide), utilising specialised geographic 
information systems 
General practitioners Australia General practice No Yes No No 
Rollins et al. (2001) To analyse HMO efficiency longitudinally, using a 
DEA model, and to compare the various types of 
HMOs and their efficiency using DEA 
36 HMOs USA General practice No No Yes No 
Rosenman and Friesner (2004) To compare the efficiency of single specialty and 
multispecialty group medical practices 
156 primary care 
practices, 346 speciality 
care practices 
USA General practice No No Yes No 
Rosenman et al. (1997) To measure the relative technical efficiencies of 28 
HMOs licensed to practice in the State of Florida in the 
autumn of 1994 
28 HMOs USA General practice No No Yes No 
Ryvicker et al. (2012) To identify environmental and socio-demographic 
factors associated with primary care visits among older 
adults in New York City 
49 Primary Care Service 
Areas 
USA General practice No Yes No No 
Safran et al. (1998) To evaluate the relationship between seven defining 
elements of primary care and three outcomes 
Primary care physicians USA General practice Yes No No Yes 
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Safran et al. (2002) To compare the primary care received by seniors in 
Medicare HMOs with that of seniors in the traditional 
FFS Medicare program, and among HMOs, and to 
examine performance differences associated with 
HMO model-type and profit status 
121 HMOs USA General practice Yes No No Yes 
Salinas-Jiménez and Smith 
(1996) 
To explore the role of quality indicators in primary 
care, and to examine the extent to which DEA gives 
useful insights into FHSA performance in terms of 
quality 
85 FHSA USA General practice Yes No Yes Yes 
Saronga et al. (2014) To assess the actual dimension and distribution of the 
costs of providing antenatal care and childbirth 
services in selected rural primary health care facilities 
in Tanzania 
11 health centres and 
dispensaries 
Tanzania Maternal and 
child care 
No No Yes* No 
Schinnar et al. (1990) To formulate measures of efficiency and effectiveness; 
examine the possible relationship between the two; and 
explore organisational, fiscal, and client variables that 
may account for the variance in these performance 
measures 
54 mental health partial 
care programs 
USA Mental care No No Yes Yes 
Schmacker (2008) To examine factors affecting the productive efficiency 
of primary care clinics 
from 85 to 91 primary 
care clinics (per year), 442 
observations 
USA General practice No No Yes No 
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Sebastian and Lemma (2010) 
 
To estimate the technical efficiency of a sample of 
health posts in rural Tigray, to identify those factors 
which might be explaining the efficiency results. 
60 health posts Ethiopia General practice No No Yes No 
Seid and Stevens (2005) To examine whether and how different kinds of 
access to care (financial, potential, and realised) 
predict parent-report child primary care 
experiences in an urban community sample 
Primary care providers USA Maternal and 
child care 
Yes No No No 
Sequist et al. (2008) To evaluate the association between clinical 
performance and patient experiences in a 
statewide sample of physician practice sites and a 
sample of physicians within a large physician 
group 
373 practice sites and 
119 individual primary 
care physicians  
USA General 
practice 
Yes No No Yes 
Sequist et al. (2011) To analyse trends in ambulatory quality of care 
and physician reports of barriers to quality 
improvement within the Indian Health Service  
740 federally employed 
physicians 
USA General 
practice 
No Yes No No 
Shah et al. (2003) To evaluate primary care accessibility and quality 
for Ontario's aboriginal population 
Primary care providers Canada General 
practice 
No Yes No No 
Shahidzadeh-Mahani et al. 
(2008) 
To determine factors affecting quality of family 
planning services 
25 urban Primary 
Health Care clinics 
Iran Maternal and 
child care 
No No No Yes 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Shi et al. (2003) 
 
To compare the primary health care quality of 
community health centres and health maintenance 
organisations in South California in order to elucidate 
the quality of CHC performance relative to mainstream 
settings such as the HMO 
Community health centres 
and health maintenance 
organisations  
USA General practice Yes No No Yes 
Shi et al. (2012) To describe current clinical quality among the nation’s 
community health centres and to examine health centre 
characteristics associated with performance excellence 
1039 community health 
centres 
USA 
 
General practice No No No Yes 
Shi et al. (2013) To examine the quality of the primary care experienced 
by health centre patients and to investigate whether 
race/ethnicity and insurance coverage are significantly 
associated with patients’ experiences 
Federally funded health 
centres 
USA General practice No Yes No No 
Siddharthan et al. (2000) To measure the relative technical efficiencies of 164 
HMOs licensed to practice in the United States 
164 HMOs USA General practice No No Yes No 
Staat (2003) To analyse the differences regarding the efficiency of 
service provision by Austrian general practitioners 
591 physicians Austria General practice No No Yes No 
Stevens and Shi (2002) 
 
To compared the quality of primary care experienced 
specifically by children of different racial and ethnic 
groups 
Primary care physicians USA Maternal and 
child care 
No Yes No No 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Stevens et al. (2014) 
 
To evaluate whether patient-reported indicators of care 
that are consistent with the medical-home model are 
associated with patient-reported receipt of 
recommended preventive diabetes services for adults 
considered vulnerable 
Primary care physicians USA Chronic disease 
management  
Yes No No Yes 
Szczepura et al. (1993) To describe the exploratory use of a statistical 
technique called DEA 
52 general practices UK General practice No No Yes No 
Teach et al. (2006) To test the hypotheses that higher spacial accessibility 
to primary care paediatric services among a population 
of urban and largely disadvantaged children would be 
associated with (1) more scheduled primary care visits 
for asthma, (2) better longitudinal asthma management, 
and (3) fewer unscheduled visits for asthma care 
Paediatric primary care 
providers 
USA Maternal and 
child care 
Yes No No Yes 
Testi et al. (2013) To evaluate the performance of primary care practices 
in the treatment of their diabetic patients 
96 family physicians Italy Chronic disease 
management  
No No Yes Yes 
Thanassoulis et al. (1995) To explore the use of DEA for the assessment of units 
providing perinatal care in England and estimate 
performance targets for them 
83 District Health 
Authorities 
UK Maternal and 
child care 
No No Yes Yes 
Tilley and Chalkley (2005) To assess the extent of access to the publicly funded 
General Dental Service by adults in Scotland 
General dental services UK Dental care Yes No No No 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Toda et al. (2012) To assess whether poorer areas have poorer health 
services by investigating associations between public 
facility characteristics and the poverty level of the area 
in which the facility is located 
248 public health centres 
and dispensaries  
Kenya General practice No Yes No No 
Tourigny et al. (2010) To evaluate how a primary care reform, which aimed 
to promote interprofessional and interorganisational 
collaborative practices, affected patients’ experiences 
of the core dimensions of primary care 
5 family medicine groups Canada General practice Yes No No Yes 
Tsai et al. (2010) To examine the relationship between physician 
specialty and the quality of primary medical care 
experiences 
Primary care physicians 
and specialists 
Taiwan General practice Yes No No Yes 
Tyler et al. (1995) To assess whether Community Mental Health centres 
operate at different levels of technical efficiency in the 
production of case management services 
39 community mental 
health centres 
USA Mental care No No Yes No 
Ulmer et al. (2000) To discuss results of medical records reviews assessing 
quality of care at CHCs for acute otitis media, diabetes, 
asthma, and hypertension 
20 community health 
centres 
USA General practice No No No Yes 
Utriainen and Widström 
(1990) 
To assess the effectiveness, output and costs of dental 
care at different health centres and to analyse the 
relationships between these factors 
34 health centres Finland Dental care Yes No Yes* Yes 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Varatharajan et al. (2004) To provide an approach to assess primary health care 
performance under decentralized government 
10 primary health centres  India General practice Yes No Yes* Yes 
Varela et al. (2010) To measure the variations in performance of small 
municipalities in the State of São Paulo, Brazil, 
regarding the technical efficiency in the use of public 
funds in public primary health care actions concerning 
the funding profile, in a scenario of fiscal federalism 
359 municipalities Brazil General practice No No Yes No 
Venning et al. (2000) To compare the cost effectiveness of general 
practitioners and nurse practitioners 
20 general practices UK General practice No No Yes* Yes 
Villiers et al. (2005) To contribute to the nutritional well-being of young 
children living in Duncan Village by investigating 
factors that influence clinic attendance of mothers and 
to formulate recommendations for optimisation of 
accessibility of primary health care clinics in the area 
Primary health care clinics South Africa Maternal and 
child care 
Yes No No Yes 
Wagner and Shimshak (2000) To evaluate the efficiency of primary care physicians 
from a managed care organisation 
21 primary care 
physicians 
USA General practice No No Yes No 
Wagner et al. (2003) To examine physician practices within the 
organisation using DEA 
21 primary care 
physicians 
USA General 
practice 
No No Yes No 
Wang and Luo (2005) To explore both spatial and non-spatial factors in 
examining accessibility to primary healthcare in 
Illinois 
Primary care physicians USA General practice No Yes No No 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Wang (2011) To analyse the spatial accessibility of a number of 
immigrant groups to linguistically diverse primary care 
(family) physicians in the Toronto Census 
Metropolitan Area  
Primary care physicians Canada 
 
General practice 
 
No Yes No No 
Wang et al. (2014a) To assess performance on quality measures among 
small primary care practices that recently adopted an 
electronic health record (EHR), and how performance 
differs between practices that have achieved patient- 
centred medical home (PCMH) recognition and those 
that have not 
150 primary care practices USA 
 
General practice 
 
No No No Yes 
Wang et al. (2014b) To develop a primary care assessment tool in Tibetan 
area and assess the primary care quality among 
different healthcare settings 
Primary care providers 
(township health centres, 
county hospitals, 
prefecture hospitals) 
China 
 
General practice 
 
Yes No No Yes 
Weiss et al. (2001) To determine primary care accessibility for low-
income patients 
179 ambulatory care 
facilities 
USA General practice Yes No No No 
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Table A1 Summary of the reviewed studies (continued) 
Paper's reference Study aims Units of analysis 
Country of 
application 
Medical 
condition 
studied 
Performance dimensions 
explored in primary care 
delivery 
A B C D 
Wensing et al. (2008) To determine whether patient evaluations of the 
accessibility to general practice and co-ordination with 
other care providers were associated with 
characteristics of general practice organisation 
284 general practices Austria, 
Belgium, 
England, France, 
Germany, Israel, 
The Netherlands, 
Slovenia, 
Switzerland, and 
Wales 
General practice Yes No No Yes 
Wong et al. (2010) To compare the primary care experiences of GOPC 
users and the users of care provided by private general 
practitioners in Hong Kong via a territory-wide 
telephone survey 
General outpatient clinics, 
private general practice 
clinics 
China General practice Yes No No Yes 
Zallman et al. (2010) To assess the quality of outpatient care delivered by 
resident and staff physicians 
Resident and staff 
physicians 
USA General practice No No No Yes 
Zavras et al. (2002) 
 
To critically evaluate the relative efficiency of primary 
health care centres of the principal Greek public 
insurance provider, the Social Security Institute 
133 primary care centres Greece 
 
General practice 
 
No No Yes No 
Total     59 33 75 57 
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Appendix B: Scatter plots for the distribution of USFs 
between clusters 
 
Figure B1 Scatter plots for the distribution of USFs between three clusters (orange dots-
large cluster, green dots – medium cluster, blue dots – small cluster) 
 
Average linkage within groups 
  
K-means clustering 
 
Ward’s method 
 
Centroid method 
 
Two-step clustering 
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Figure B2 Scatter plots for the distribution of USFs between two clusters (orange dots-
large cluster, green dots – small cluster) 
  
Average linkage within groups 
 
K-means clustering 
 
Ward’s method 
 
Centroid method 
 
Two-step clustering 
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Appendix C: The DEA assessment results of USFs 
 
Table C1 The DEA scores and optimal virtual weights of USFs 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 1 100.00% 2.67% 25.89% 12.61% 8.84% 2.67% 25.89% 4.29% 8.84% 4.52% 3.80% 
USF 2 100.00% 6.03% 26.58% 6.03% 11.37% 6.03% 19.86% 6.03% 6.03% 6.03% 6.03% 
USF 3 100.00% 3.83% 37.15% 5.19% 3.83% 3.83% 30.85% 3.83% 3.83% 3.83% 3.83% 
USF 4 100.00% 6.97% 20.73% 8.16% 14.14% 6.97% 15.14% 6.97% 6.97% 6.97% 6.97% 
USF 5 100.00% 6.97% 19.36% 11.68% 11.99% 6.97% 13.57% 6.97% 6.97% 6.97% 8.53% 
USF 6 100.00% 5.88% 30.13% 8.10% 5.88% 5.88% 20.58% 5.88% 5.88% 5.88% 5.88% 
USF 7 100.00% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 8 100.00% 3.84% 30.86% 8.67% 6.63% 3.18% 30.86% 3.18% 6.41% 3.18% 3.18% 
USF 9 99.84% 2.73% 41.60% 2.84% 2.84% 2.73% 36.13% 2.73% 2.84% 2.73% 2.84% 
USF 10 99.79% 11.43% 13.57% 11.43% 13.57% 4.52% 13.57% 4.52% 4.52% 11.43% 11.43% 
USF 11 99.22% 5.97% 27.54% 9.04% 7.45% 2.94% 27.54% 2.94% 2.94% 6.18% 7.45% 
USF 12 98.73% 3.42% 30.49% 9.73% 6.36% 3.42% 30.30% 3.42% 6.02% 3.42% 3.42% 
USF 13 98.73% 4.69% 35.08% 5.55% 4.69% 4.69% 26.57% 4.69% 4.69% 4.69% 4.69% 
USF 14 98.29% 8.17% 25.50% 8.17% 8.17% 8.17% 9.17% 8.17% 8.17% 8.17% 8.17% 
USF 15 98.01% 3.42% 33.17% 6.15% 7.27% 3.42% 30.17% 3.42% 3.42% 3.42% 6.15% 
USF 16 97.95% 6.25% 18.75% 18.75% 6.25% 6.25% 18.75% 6.25% 6.25% 6.25% 6.25% 
USF 17 97.88% 2.67% 40.71% 2.67% 3.95% 2.67% 36.63% 2.67% 2.67% 2.67% 2.67% 
USF 18 97.80% 3.72% 31.42% 11.15% 3.72% 3.72% 31.42% 3.72% 3.72% 3.72% 3.72% 
USF 19 97.72% 3.69% 35.78% 5.48% 5.05% 3.69% 26.13% 5.05% 5.05% 5.05% 5.05% 
USF 20 97.70% 3.72% 36.07% 5.32% 4.89% 3.72% 26.73% 4.89% 4.89% 4.89% 4.89% 
USF 21 97.59% 7.20% 26.99% 8.61% 7.20% 2.78% 26.99% 3.04% 2.78% 7.20% 7.20% 
USF 22 97.54% 4.30% 37.09% 4.30% 4.30% 4.30% 28.48% 4.30% 4.30% 4.30% 4.30% 
USF 23 97.42% 3.23% 31.33% 10.78% 4.66% 3.23% 28.11% 4.66% 4.66% 4.66% 4.66% 
USF 24 97.37% 1.17% 17.84% 15.49% 15.49% 1.17% 15.49% 15.49% 1.17% 15.49% 1.17% 
USF 25 97.12% 5.50% 30.84% 7.22% 6.44% 3.18% 30.84% 3.18% 3.18% 6.44% 3.18% 
USF 26 97.08% 3.80% 36.83% 5.20% 4.17% 3.80% 29.89% 4.17% 4.17% 4.17% 3.80% 
USF 27 96.97% 2.72% 41.37% 2.95% 2.95% 2.72% 35.47% 2.95% 2.95% 2.95% 2.95% 
USF 28 96.84% 8.13% 24.38% 9.36% 8.13% 8.13% 9.36% 8.13% 8.13% 8.13% 8.13% 
USF 29 96.75% 1.22% 18.56% 18.56% 11.67% 1.22% 18.56% 5.67% 11.67% 11.67% 1.22% 
USF 30 96.71% 2.69% 40.90% 3.21% 3.21% 2.69% 35.00% 2.69% 3.21% 3.21% 3.21% 
USF 31 96.57% 5.23% 34.16% 5.23% 5.39% 5.23% 23.87% 5.23% 5.23% 5.23% 5.23% 
USF 32 96.54% 5.63% 31.60% 5.63% 7.15% 3.26% 24.55% 5.63% 5.63% 5.32% 5.63% 
USF 33 96.51% 4.42% 35.39% 5.77% 4.42% 4.42% 27.90% 4.42% 4.42% 4.42% 4.42% 
USF 34 96.49% 6.03% 28.00% 9.95% 6.03% 2.89% 23.00% 6.03% 6.03% 6.03% 6.03% 
USF 35 96.44% 1.18% 17.98% 17.98% 12.86% 1.18% 17.98% 3.94% 12.86% 12.86% 1.18% 
USF 36 96.41% 5.11% 32.77% 7.00% 5.11% 5.11% 24.44% 5.11% 5.11% 5.11% 5.11% 
USF 37 96.33% 4.85% 33.52% 4.85% 6.77% 4.85% 25.74% 4.85% 4.85% 4.85% 4.85% 
USF 38 96.29% 4.61% 36.17% 4.61% 4.61% 4.61% 26.95% 4.61% 4.61% 4.61% 4.61% 
USF 39 96.17% 4.33% 35.49% 4.33% 5.85% 4.33% 28.36% 4.33% 4.33% 4.33% 4.33% 
USF 40 96.15% 4.68% 35.97% 4.68% 4.68% 4.68% 26.61% 4.68% 4.68% 4.68% 4.68% 
USF 41 95.95% 4.51% 36.46% 4.51% 4.51% 4.51% 27.43% 4.51% 4.51% 4.51% 4.51% 
USF 42 95.83% 4.16% 29.22% 12.47% 4.16% 4.16% 29.22% 4.16% 4.16% 4.16% 4.16% 
USF 43 95.72% 4.94% 35.19% 4.94% 4.94% 4.94% 25.32% 4.94% 4.94% 4.94% 4.94% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 44 95.68% 4.93% 33.76% 6.38% 4.93% 4.93% 25.36% 4.93% 4.93% 4.93% 4.93% 
USF 45 95.62% 6.51% 29.71% 7.28% 6.51% 3.06% 27.79% 3.06% 6.51% 6.51% 3.06% 
USF 46 95.46% 4.57% 36.30% 4.57% 4.57% 4.57% 27.17% 4.57% 4.57% 4.57% 4.57% 
USF 47 95.45% 5.66% 31.26% 7.43% 5.66% 3.22% 31.26% 3.41% 5.66% 3.22% 3.22% 
USF 48 95.43% 3.21% 40.36% 3.21% 3.21% 3.21% 33.93% 3.21% 3.21% 3.21% 3.21% 
USF 49 95.37% 3.85% 30.76% 3.85% 11.54% 3.85% 30.76% 3.85% 3.85% 3.85% 3.85% 
USF 50 95.35% 4.80% 35.57% 4.80% 4.83% 4.80% 25.98% 4.80% 4.80% 4.80% 4.80% 
USF 51 95.29% 4.49% 35.36% 5.67% 4.49% 4.49% 27.57% 4.49% 4.49% 4.49% 4.49% 
USF 52 95.19% 2.66% 40.53% 2.66% 4.15% 2.66% 36.69% 2.66% 2.66% 2.66% 2.66% 
USF 53 95.16% 2.99% 41.03% 2.99% 2.99% 2.99% 35.05% 2.99% 2.99% 2.99% 2.99% 
USF 54 95.10% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 55 94.97% 7.23% 27.49% 8.04% 7.23% 2.83% 27.49% 2.83% 2.83% 7.23% 6.77% 
USF 56 94.82% 12.50% 12.50% 12.50% 12.50% 0.82% 12.50% 12.50% 0.82% 12.50% 10.86% 
USF 57 94.68% 7.17% 27.27% 7.17% 8.38% 2.81% 27.27% 2.81% 2.81% 7.12% 7.17% 
USF 58 94.58% 5.51% 31.39% 6.17% 6.93% 3.24% 25.01% 6.17% 3.24% 6.17% 6.17% 
USF 59 94.56% 8.15% 25.56% 8.15% 8.15% 8.15% 9.27% 8.15% 8.15% 8.15% 8.15% 
USF 60 94.44% 6.85% 28.73% 7.57% 6.85% 2.96% 23.53% 6.85% 2.96% 6.85% 6.85% 
USF 61 94.32% 7.15% 28.56% 7.15% 7.15% 3.12% 28.56% 3.12% 7.15% 4.94% 3.12% 
USF 62 94.28% 4.61% 36.17% 4.61% 4.61% 4.61% 26.95% 4.61% 4.61% 4.61% 4.61% 
USF 63 94.23% 2.64% 40.16% 3.60% 3.60% 2.64% 35.85% 2.64% 2.64% 3.60% 2.64% 
USF 64 94.19% 5.62% 32.16% 5.62% 6.59% 4.19% 26.18% 5.62% 4.19% 4.19% 5.62% 
USF 65 94.16% 3.06% 40.83% 3.06% 3.06% 3.06% 34.72% 3.06% 3.06% 3.06% 3.06% 
USF 66 94.13% 5.11% 33.37% 6.41% 5.11% 5.11% 24.43% 5.11% 5.11% 5.11% 5.11% 
USF 67 94.00% 4.52% 34.14% 6.81% 4.52% 4.52% 27.38% 4.52% 4.52% 4.52% 4.52% 
USF 68 93.92% 4.27% 36.21% 4.27% 5.26% 4.27% 28.67% 4.27% 4.27% 4.27% 4.27% 
USF 69 93.92% 5.61% 32.85% 5.61% 5.93% 5.61% 21.95% 5.61% 5.61% 5.61% 5.61% 
USF 70 93.91% 4.59% 32.99% 7.83% 4.59% 3.40% 32.99% 3.40% 3.40% 3.40% 3.40% 
USF 71 93.86% 10.04% 14.96% 10.04% 14.96% 2.46% 14.96% 2.46% 10.04% 10.04% 10.04% 
USF 72 93.81% 3.84% 25.00% 10.58% 10.58% 3.84% 10.58% 10.58% 10.58% 10.58% 3.84% 
USF 73 93.81% 4.84% 34.31% 6.01% 4.84% 4.84% 25.80% 4.84% 4.84% 4.84% 4.84% 
USF 74 93.75% 4.95% 35.15% 4.95% 4.95% 4.95% 25.25% 4.95% 4.95% 4.95% 4.95% 
USF 75 93.64% 4.82% 35.55% 4.82% 4.82% 4.82% 25.91% 4.82% 4.82% 4.82% 4.82% 
USF 76 93.64% 3.01% 40.97% 3.01% 3.01% 3.01% 34.96% 3.01% 3.01% 3.01% 3.01% 
USF 77 93.33% 4.85% 35.14% 4.85% 5.16% 4.85% 25.76% 4.85% 4.85% 4.85% 4.85% 
USF 78 93.33% 5.90% 31.79% 5.90% 6.40% 3.28% 28.36% 3.28% 5.90% 5.90% 3.28% 
USF 79 93.24% 5.19% 32.37% 5.19% 7.26% 3.34% 25.91% 5.19% 5.19% 5.19% 5.19% 
USF 80 93.24% 4.89% 34.51% 5.71% 4.89% 4.89% 25.54% 4.89% 4.89% 4.89% 4.89% 
USF 81 92.89% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 82 92.87% 4.72% 35.85% 4.72% 4.72% 4.72% 26.42% 4.72% 4.72% 4.72% 4.72% 
USF 83 92.81% 12.50% 12.50% 12.50% 12.50% 0.82% 12.50% 10.86% 12.50% 12.50% 0.82% 
USF 84 92.81% 8.20% 25.41% 8.20% 8.20% 8.20% 9.02% 8.20% 8.20% 8.20% 8.20% 
USF 85 92.75% 5.51% 32.78% 5.51% 6.20% 5.51% 22.46% 5.51% 5.51% 5.51% 5.51% 
USF 86 92.75% 6.14% 30.36% 6.14% 7.37% 3.13% 25.66% 6.14% 3.13% 5.81% 6.14% 
USF 87 92.73% 5.31% 32.23% 5.31% 7.15% 5.31% 23.45% 5.31% 5.31% 5.31% 5.31% 
USF 88 92.69% 3.68% 35.65% 3.68% 7.00% 3.68% 31.62% 3.68% 3.68% 3.68% 3.68% 
USF 89 92.67% 5.34% 33.68% 5.64% 5.34% 5.34% 23.29% 5.34% 5.34% 5.34% 5.34% 
USF 90 92.58% 8.69% 15.18% 10.94% 15.18% 1.00% 15.18% 10.94% 10.94% 10.94% 1.00% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 91 92.57% 6.46% 29.19% 7.89% 6.46% 3.01% 24.61% 6.46% 3.01% 6.46% 6.46% 
USF 92 92.35% 3.02% 40.93% 3.02% 3.02% 3.02% 34.88% 3.02% 3.02% 3.02% 3.02% 
USF 93 92.32% 8.13% 24.39% 9.35% 8.13% 8.13% 9.35% 8.13% 8.13% 8.13% 8.13% 
USF 94 92.23% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 12.04% 12.04% 12.04% 0.91% 
USF 95 92.21% 5.49% 33.14% 5.87% 5.49% 5.49% 22.54% 5.49% 5.49% 5.49% 5.49% 
USF 96 92.21% 4.85% 33.56% 6.73% 4.85% 4.85% 25.73% 4.85% 4.85% 4.85% 4.85% 
USF 97 92.12% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 98 92.03% 5.57% 30.19% 5.57% 8.68% 5.57% 22.16% 5.57% 5.57% 5.57% 5.57% 
USF 99 92.02% 5.31% 18.94% 18.94% 6.81% 5.31% 18.94% 6.81% 6.81% 6.81% 5.31% 
USF 100 92.01% 5.26% 33.91% 5.56% 5.26% 5.26% 23.68% 5.26% 5.26% 5.26% 5.26% 
USF 101 91.95% 3.17% 40.48% 3.17% 3.17% 3.17% 34.13% 3.17% 3.17% 3.17% 3.17% 
USF 102 91.93% 4.74% 34.69% 5.82% 4.74% 4.74% 26.28% 4.74% 4.74% 4.74% 4.74% 
USF 103 91.90% 5.57% 26.43% 8.49% 9.52% 2.72% 24.85% 2.72% 2.72% 8.49% 8.49% 
USF 104 91.88% 4.85% 34.29% 4.85% 6.00% 4.85% 25.73% 4.85% 4.85% 4.85% 4.85% 
USF 105 91.79% 6.23% 30.54% 7.01% 6.23% 3.15% 28.10% 6.23% 3.15% 6.23% 3.15% 
USF 106 91.76% 5.23% 33.22% 6.31% 5.23% 5.23% 23.83% 5.23% 5.23% 5.23% 5.23% 
USF 107 91.73% 1.23% 18.75% 15.01% 15.01% 1.23% 15.01% 15.01% 2.51% 15.01% 1.23% 
USF 108 91.72% 5.16% 34.51% 5.16% 5.16% 5.16% 24.18% 5.16% 5.16% 5.16% 5.16% 
USF 109 91.68% 4.39% 36.83% 4.39% 4.39% 4.39% 28.05% 4.39% 4.39% 4.39% 4.39% 
USF 110 91.65% 4.47% 35.24% 4.47% 5.81% 4.47% 27.63% 4.47% 4.47% 4.47% 4.47% 
USF 111 91.63% 4.29% 34.95% 6.48% 4.29% 4.29% 28.57% 4.29% 4.29% 4.29% 4.29% 
USF 112 91.61% 5.96% 26.43% 8.81% 8.81% 5.96% 8.81% 8.81% 8.81% 8.81% 8.81% 
USF 113 91.58% 5.29% 32.67% 5.92% 6.13% 3.37% 28.06% 5.92% 3.37% 5.92% 3.37% 
USF 114 91.55% 5.25% 34.24% 5.25% 5.25% 5.25% 23.74% 5.25% 5.25% 5.25% 5.25% 
USF 115 91.51% 4.72% 35.83% 4.72% 4.72% 4.72% 26.39% 4.72% 4.72% 4.72% 4.72% 
USF 116 91.50% 1.64% 25.03% 11.66% 11.66% 1.64% 11.66% 11.66% 11.66% 11.66% 1.71% 
USF 117 91.47% 5.14% 34.50% 5.14% 5.22% 5.14% 24.29% 5.14% 5.14% 5.14% 5.14% 
USF 118 91.46% 5.05% 32.50% 5.05% 7.39% 5.05% 24.74% 5.05% 5.05% 5.05% 5.05% 
USF 119 91.41% 4.77% 35.25% 4.77% 5.22% 4.77% 26.17% 4.77% 4.77% 4.77% 4.77% 
USF 120 91.40% 4.34% 35.27% 6.05% 4.34% 4.34% 28.32% 4.34% 4.34% 4.34% 4.34% 
USF 121 91.35% 1.13% 17.13% 14.88% 16.87% 1.13% 16.87% 1.13% 1.13% 14.88% 14.88% 
USF 122 91.28% 4.92% 34.74% 5.42% 4.92% 4.92% 25.40% 4.92% 4.92% 4.92% 4.92% 
USF 123 91.23% 4.27% 37.20% 4.27% 4.27% 4.27% 28.66% 4.27% 4.27% 4.27% 4.27% 
USF 124 91.22% 5.49% 32.20% 6.12% 6.18% 3.32% 27.79% 6.12% 3.32% 6.12% 3.32% 
USF 125 91.17% 3.14% 30.48% 11.70% 4.68% 3.14% 28.15% 4.68% 4.68% 4.68% 4.68% 
USF 126 91.12% 8.16% 24.49% 9.18% 8.16% 8.16% 9.18% 8.16% 8.16% 8.16% 8.16% 
USF 127 91.10% 4.80% 34.44% 5.96% 4.80% 4.80% 26.00% 4.80% 4.80% 4.80% 4.80% 
USF 128 90.94% 4.52% 36.43% 4.52% 4.52% 4.52% 27.39% 4.52% 4.52% 4.52% 4.52% 
USF 129 90.91% 8.28% 25.03% 8.34% 8.34% 8.28% 8.34% 8.34% 8.34% 8.34% 8.34% 
USF 130 90.91% 9.35% 21.96% 9.35% 9.35% 4.95% 12.06% 4.95% 9.35% 9.35% 9.35% 
USF 131 90.85% 5.31% 33.64% 5.74% 5.31% 5.31% 23.44% 5.31% 5.31% 5.31% 5.31% 
USF 132 90.81% 8.15% 25.54% 8.15% 8.15% 8.15% 9.23% 8.15% 8.15% 8.15% 8.15% 
USF 133 90.73% 5.27% 32.68% 6.77% 5.27% 3.37% 29.08% 5.27% 3.63% 5.27% 3.37% 
USF 134 90.73% 5.56% 32.62% 5.56% 6.26% 5.56% 22.20% 5.56% 5.56% 5.56% 5.56% 
USF 135 90.66% 3.24% 31.46% 10.23% 5.07% 3.24% 30.13% 3.24% 5.07% 5.07% 3.24% 
USF 136 90.65% 8.25% 24.75% 8.75% 8.25% 8.25% 8.75% 8.25% 8.25% 8.25% 8.25% 
USF 137 90.64% 5.29% 34.13% 5.29% 5.29% 5.29% 23.56% 5.29% 5.29% 5.29% 5.29% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 138 90.48% 5.44% 31.62% 5.44% 7.50% 5.44% 22.81% 5.44% 5.44% 5.44% 5.44% 
USF 139 90.39% 3.78% 32.84% 8.54% 4.84% 3.78% 27.93% 4.84% 3.78% 4.84% 4.84% 
USF 140 90.38% 12.04% 12.96% 12.96% 12.04% 1.34% 12.96% 5.66% 5.97% 12.04% 12.04% 
USF 141 90.29% 7.93% 23.78% 7.93% 10.37% 7.93% 10.37% 7.93% 7.93% 7.93% 7.93% 
USF 142 90.25% 5.31% 30.91% 8.47% 5.31% 5.31% 23.44% 5.31% 5.31% 5.31% 5.31% 
USF 143 90.23% 5.04% 31.27% 5.04% 8.65% 5.04% 24.80% 5.04% 5.04% 5.04% 5.04% 
USF 144 90.19% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 145 90.14% 4.57% 35.10% 5.75% 4.57% 4.57% 27.13% 4.57% 4.57% 4.57% 4.57% 
USF 146 90.10% 4.82% 35.53% 4.82% 4.82% 4.82% 25.88% 4.82% 4.82% 4.82% 4.82% 
USF 147 89.89% 6.12% 29.71% 8.06% 6.12% 3.06% 26.17% 3.06% 6.12% 6.12% 5.48% 
USF 148 89.71% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 149 89.67% 4.98% 35.06% 4.98% 4.98% 4.98% 25.09% 4.98% 4.98% 4.98% 4.98% 
USF 150 89.58% 5.27% 34.18% 5.27% 5.27% 5.27% 23.63% 5.27% 5.27% 5.27% 5.27% 
USF 151 89.53% 5.30% 33.76% 5.64% 5.30% 5.30% 23.50% 5.30% 5.30% 5.30% 5.30% 
USF 152 89.49% 5.04% 33.13% 6.79% 5.04% 5.04% 24.80% 5.04% 5.04% 5.04% 5.04% 
USF 153 89.46% 5.16% 33.71% 5.16% 5.98% 3.48% 25.90% 5.16% 5.16% 5.16% 5.16% 
USF 154 89.46% 8.10% 25.69% 8.10% 8.10% 8.10% 9.48% 8.10% 8.10% 8.10% 8.10% 
USF 155 89.35% 4.81% 35.58% 4.81% 4.81% 4.81% 25.96% 4.81% 4.81% 4.81% 4.81% 
USF 156 89.33% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 157 89.31% 2.85% 41.44% 2.85% 2.85% 2.85% 35.74% 2.85% 2.85% 2.85% 2.85% 
USF 158 89.22% 6.44% 28.86% 6.44% 8.25% 3.82% 25.66% 3.82% 3.82% 6.44% 6.44% 
USF 159 89.22% 3.22% 40.33% 3.22% 3.22% 3.22% 33.88% 3.22% 3.22% 3.22% 3.22% 
USF 160 89.08% 10.25% 14.75% 14.75% 10.25% 0.97% 14.75% 10.25% 10.25% 10.25% 3.53% 
USF 161 89.07% 10.25% 19.26% 10.25% 10.25% 4.08% 11.11% 10.25% 10.25% 10.25% 4.08% 
USF 162 89.07% 4.50% 36.51% 4.50% 4.50% 4.50% 27.52% 4.50% 4.50% 4.50% 4.50% 
USF 163 89.06% 5.69% 32.13% 5.69% 6.50% 5.69% 21.56% 5.69% 5.69% 5.69% 5.69% 
USF 164 89.02% 11.42% 13.58% 13.58% 11.42% 1.40% 13.58% 1.40% 10.78% 11.42% 11.42% 
USF 165 88.81% 5.98% 31.03% 7.01% 5.98% 3.20% 22.89% 5.98% 5.98% 5.98% 5.98% 
USF 166 88.72% 7.64% 15.83% 15.83% 10.70% 1.04% 15.83% 1.04% 10.70% 10.70% 10.70% 
USF 167 88.60% 7.90% 23.69% 10.52% 7.90% 7.90% 10.52% 7.90% 7.90% 7.90% 7.90% 
USF 168 88.57% 2.88% 41.37% 2.88% 2.88% 2.88% 35.61% 2.88% 2.88% 2.88% 2.88% 
USF 169 88.52% 4.35% 34.91% 5.37% 5.37% 4.35% 24.17% 5.37% 5.37% 5.37% 5.37% 
USF 170 88.48% 7.84% 23.53% 10.78% 7.84% 7.84% 10.78% 7.84% 7.84% 7.84% 7.84% 
USF 171 88.47% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 172 88.46% 5.27% 34.20% 5.27% 5.27% 5.27% 23.66% 5.27% 5.27% 5.27% 5.27% 
USF 173 88.45% 4.96% 35.12% 4.96% 4.96% 4.96% 25.19% 4.96% 4.96% 4.96% 4.96% 
USF 174 88.44% 10.59% 14.41% 14.41% 10.59% 0.95% 14.41% 10.59% 2.88% 10.59% 10.59% 
USF 175 88.36% 4.81% 35.58% 4.81% 4.81% 4.81% 25.96% 4.81% 4.81% 4.81% 4.81% 
USF 176 87.90% 7.89% 23.66% 7.89% 10.57% 7.89% 10.57% 7.89% 7.89% 7.89% 7.89% 
USF 177 87.90% 7.86% 23.58% 10.70% 7.86% 7.86% 10.70% 7.86% 7.86% 7.86% 7.86% 
USF 178 87.86% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 179 87.84% 4.87% 35.38% 4.87% 4.87% 4.87% 25.64% 4.87% 4.87% 4.87% 4.87% 
USF 180 87.81% 5.07% 34.80% 5.07% 5.07% 5.07% 24.66% 5.07% 5.07% 5.07% 5.07% 
USF 181 87.65% 3.79% 24.09% 11.96% 10.15% 3.79% 11.96% 10.15% 3.79% 10.15% 10.15% 
USF 182 87.59% 4.62% 36.13% 4.62% 4.62% 4.62% 26.89% 4.62% 4.62% 4.62% 4.62% 
USF 183 87.57% 5.56% 30.70% 5.56% 8.19% 4.48% 24.36% 5.56% 4.48% 5.56% 5.56% 
USF 184 87.54% 4.35% 36.95% 4.35% 4.35% 4.35% 28.25% 4.35% 4.35% 4.35% 4.35% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 185 87.51% 9.73% 20.82% 9.73% 9.73% 1.37% 9.73% 9.73% 9.73% 9.73% 9.73% 
USF 186 87.42% 4.07% 35.63% 6.24% 4.07% 4.07% 29.67% 4.07% 4.07% 4.07% 4.07% 
USF 187 87.38% 4.72% 33.03% 4.72% 7.54% 4.72% 26.42% 4.72% 4.72% 4.72% 4.72% 
USF 188 87.35% 4.31% 34.80% 4.31% 6.57% 4.31% 28.44% 4.31% 4.31% 4.31% 4.31% 
USF 189 87.33% 5.08% 34.77% 5.08% 5.08% 5.08% 24.62% 5.08% 5.08% 5.08% 5.08% 
USF 190 87.27% 5.36% 33.10% 6.19% 5.36% 5.36% 23.22% 5.36% 5.36% 5.36% 5.36% 
USF 191 87.18% 5.37% 33.01% 6.25% 5.37% 5.37% 23.13% 5.37% 5.37% 5.37% 5.37% 
USF 192 87.15% 5.12% 29.95% 9.80% 5.12% 3.09% 26.42% 5.12% 5.12% 5.12% 5.12% 
USF 193 87.08% 4.35% 36.96% 4.35% 4.35% 4.35% 28.26% 4.35% 4.35% 4.35% 4.35% 
USF 194 87.03% 5.45% 31.45% 7.64% 5.45% 5.45% 22.73% 5.45% 5.45% 5.45% 5.45% 
USF 195 86.98% 3.69% 35.83% 5.24% 5.24% 3.69% 25.36% 5.24% 5.24% 5.24% 5.24% 
USF 196 86.81% 6.10% 31.26% 6.53% 6.10% 3.22% 25.25% 6.10% 3.22% 6.10% 6.10% 
USF 197 86.80% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 198 86.76% 3.73% 32.56% 9.98% 3.73% 3.73% 31.33% 3.73% 3.73% 3.73% 3.73% 
USF 199 86.63% 3.99% 38.04% 3.99% 3.99% 3.99% 30.06% 3.99% 3.99% 3.99% 3.99% 
USF 200 86.48% 5.03% 34.90% 5.03% 5.03% 5.03% 24.84% 5.03% 5.03% 5.03% 5.03% 
USF 201 86.44% 3.03% 40.90% 3.03% 3.03% 3.03% 34.83% 3.03% 3.03% 3.03% 3.03% 
USF 202 86.31% 5.06% 34.81% 5.06% 5.06% 5.06% 24.68% 5.06% 5.06% 5.06% 5.06% 
USF 203 86.22% 9.38% 15.62% 15.62% 9.38% 1.03% 15.62% 9.38% 5.21% 9.38% 9.38% 
USF 204 86.02% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 205 85.92% 3.70% 35.92% 5.19% 5.19% 3.70% 25.54% 5.19% 5.19% 5.19% 5.19% 
USF 206 85.87% 6.30% 31.11% 6.30% 6.30% 5.59% 19.94% 6.30% 5.59% 6.30% 6.30% 
USF 207 85.77% 5.40% 33.79% 5.40% 5.40% 5.40% 22.98% 5.40% 5.40% 5.40% 5.40% 
USF 208 85.58% 7.36% 22.08% 13.20% 7.36% 7.36% 13.20% 7.36% 7.36% 7.36% 7.36% 
USF 209 85.50% 4.13% 35.44% 6.30% 4.13% 4.13% 29.33% 4.13% 4.13% 4.13% 4.13% 
USF 210 85.41% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 211 85.36% 5.42% 33.53% 5.42% 5.63% 5.42% 22.90% 5.42% 5.42% 5.42% 5.42% 
USF 212 85.28% 5.28% 34.16% 5.28% 5.28% 5.28% 23.59% 5.28% 5.28% 5.28% 5.28% 
USF 213 85.18% 4.77% 35.68% 4.77% 4.77% 4.77% 26.13% 4.77% 4.77% 4.77% 4.77% 
USF 214 85.11% 5.35% 32.99% 6.32% 5.35% 5.35% 23.27% 5.35% 5.35% 5.35% 5.35% 
USF 215 84.99% 4.98% 35.07% 4.98% 4.98% 4.98% 25.11% 4.98% 4.98% 4.98% 4.98% 
USF 216 84.99% 5.61% 33.16% 5.61% 5.61% 5.61% 21.93% 5.61% 5.61% 5.61% 5.61% 
USF 217 84.90% 5.35% 32.42% 6.89% 5.35% 5.35% 23.25% 5.35% 5.35% 5.35% 5.35% 
USF 218 84.71% 6.19% 31.42% 6.19% 6.19% 2.06% 31.42% 2.06% 2.06% 6.19% 6.19% 
USF 219 84.68% 4.92% 33.35% 4.92% 6.81% 4.92% 25.41% 4.92% 4.92% 4.92% 4.92% 
USF 220 84.64% 6.50% 18.50% 18.50% 6.50% 5.50% 18.50% 6.50% 6.50% 6.50% 6.50% 
USF 221 84.59% 3.08% 40.77% 3.08% 3.08% 2.68% 35.42% 2.68% 3.08% 3.08% 3.08% 
USF 222 84.58% 5.02% 33.35% 5.02% 6.60% 5.02% 24.88% 5.02% 5.02% 5.02% 5.02% 
USF 223 84.47% 5.52% 33.44% 5.52% 5.52% 5.52% 22.40% 5.52% 5.52% 5.52% 5.52% 
USF 224 84.35% 5.33% 32.00% 7.34% 5.33% 3.30% 27.41% 5.33% 3.30% 5.33% 5.33% 
USF 225 84.21% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 226 84.15% 4.75% 35.75% 4.75% 4.75% 4.75% 26.25% 4.75% 4.75% 4.75% 4.75% 
USF 227 84.15% 1.91% 29.01% 9.54% 9.54% 1.91% 9.92% 9.54% 9.54% 9.54% 9.54% 
USF 228 84.14% 11.07% 13.95% 11.07% 13.91% 1.44% 13.91% 1.44% 11.07% 11.07% 11.07% 
USF 229 84.11% 7.00% 27.55% 7.00% 8.45% 2.84% 19.17% 7.00% 7.00% 7.00% 7.00% 
USF 230 83.99% 12.50% 12.50% 12.50% 12.50% 0.82% 12.50% 0.82% 10.86% 12.50% 12.50% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 231 83.93% 5.65% 33.06% 5.65% 5.65% 3.41% 24.01% 5.65% 5.65% 5.65% 5.65% 
USF 232 83.90% 4.98% 35.07% 4.98% 4.98% 4.98% 25.12% 4.98% 4.98% 4.98% 4.98% 
USF 233 83.84% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 234 83.76% 5.03% 34.90% 5.03% 5.03% 5.03% 24.84% 5.03% 5.03% 5.03% 5.03% 
USF 235 83.55% 5.49% 32.36% 6.66% 5.49% 5.49% 22.54% 5.49% 5.49% 5.49% 5.49% 
USF 236 83.23% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 237 83.20% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 238 82.88% 10.17% 19.48% 10.17% 10.17% 4.65% 10.17% 10.17% 10.17% 10.17% 4.65% 
USF 239 82.81% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 240 82.75% 9.64% 21.08% 9.64% 9.64% 1.38% 11.48% 9.64% 9.64% 9.64% 8.21% 
USF 241 82.72% 4.27% 34.83% 6.63% 4.27% 4.27% 28.63% 4.27% 4.27% 4.27% 4.27% 
USF 242 82.71% 9.56% 21.31% 9.57% 9.56% 2.20% 9.57% 9.56% 9.56% 9.56% 9.56% 
USF 243 82.51% 5.85% 32.26% 6.04% 5.85% 3.33% 25.79% 5.85% 5.85% 5.85% 3.33% 
USF 244 82.45% 7.09% 27.96% 7.85% 7.09% 2.88% 27.17% 2.88% 2.88% 7.09% 7.09% 
USF 245 82.19% 8.23% 25.30% 8.23% 8.23% 8.23% 8.84% 8.23% 8.23% 8.23% 8.23% 
USF 246 82.06% 3.71% 35.96% 5.17% 5.17% 3.71% 27.09% 3.71% 5.17% 5.17% 5.17% 
USF 247 82.03% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 248 81.88% 5.08% 33.25% 6.58% 5.08% 5.08% 24.58% 5.08% 5.08% 5.08% 5.08% 
USF 249 81.81% 4.17% 29.13% 12.52% 4.17% 4.17% 29.13% 4.17% 4.17% 4.17% 4.17% 
USF 250 81.74% 4.95% 35.16% 4.95% 4.95% 4.95% 25.26% 4.95% 4.95% 4.95% 4.95% 
USF 251 81.67% 5.30% 34.11% 5.30% 5.30% 5.30% 23.52% 5.30% 5.30% 5.30% 5.30% 
USF 252 81.54% 5.26% 34.22% 5.26% 5.26% 5.26% 23.69% 5.26% 5.26% 5.26% 5.26% 
USF 253 81.37% 4.29% 37.14% 4.29% 4.29% 4.29% 28.57% 4.29% 4.29% 4.29% 4.29% 
USF 254 81.30% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 255 81.11% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 256 80.85% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 257 80.69% 7.69% 26.92% 7.69% 7.69% 7.69% 11.53% 7.69% 7.69% 7.69% 7.69% 
USF 258 80.61% 5.92% 32.25% 5.92% 5.92% 5.92% 20.42% 5.92% 5.92% 5.92% 5.92% 
USF 259 80.45% 12.50% 12.50% 12.50% 12.50% 0.82% 12.50% 10.86% 0.82% 12.50% 12.50% 
USF 260 80.28% 2.72% 41.33% 2.98% 2.98% 2.72% 35.64% 2.72% 2.98% 2.98% 2.98% 
USF 261 80.11% 5.43% 30.04% 5.43% 9.10% 3.10% 25.18% 5.43% 5.43% 5.43% 5.43% 
USF 262 80.11% 3.48% 33.72% 9.33% 3.48% 3.48% 32.62% 3.48% 3.48% 3.48% 3.48% 
USF 263 80.01% 2.47% 37.64% 2.47% 7.42% 2.47% 37.64% 2.47% 2.47% 2.47% 2.47% 
USF 264 79.73% 5.96% 32.12% 5.96% 5.96% 5.96% 20.19% 5.96% 5.96% 5.96% 5.96% 
USF 265 79.71% 5.26% 34.23% 5.26% 5.26% 5.26% 23.72% 5.26% 5.26% 5.26% 5.26% 
USF 266 79.53% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 267 79.46% 5.29% 34.14% 5.29% 5.29% 5.29% 23.57% 5.29% 5.29% 5.29% 5.29% 
USF 268 79.40% 4.84% 35.49% 4.84% 4.84% 3.66% 28.18% 3.66% 4.84% 4.84% 4.84% 
USF 269 79.20% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 270 79.10% 5.15% 33.13% 6.56% 5.15% 3.42% 25.97% 5.15% 5.15% 5.15% 5.15% 
USF 271 79.01% 4.02% 35.57% 4.02% 6.40% 4.02% 29.92% 4.02% 4.02% 4.02% 4.02% 
USF 272 78.93% 7.48% 27.56% 7.48% 7.48% 1.81% 18.26% 7.48% 7.48% 7.48% 7.48% 
USF 273 78.83% 5.75% 32.76% 5.75% 5.75% 3.38% 23.64% 5.75% 5.75% 5.75% 5.75% 
USF 274 78.58% 4.93% 35.22% 4.93% 4.93% 4.93% 25.37% 4.93% 4.93% 4.93% 4.93% 
USF 275 78.47% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 276 78.36% 4.30% 37.09% 4.30% 4.30% 3.82% 28.97% 4.30% 4.30% 4.30% 4.30% 
USF 277 78.23% 5.56% 33.33% 5.56% 5.56% 3.44% 24.34% 5.56% 5.56% 5.56% 5.56% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 278 78.15% 5.51% 33.46% 5.51% 5.51% 5.51% 22.44% 5.51% 5.51% 5.51% 5.51% 
USF 279 78.13% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 280 78.12% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 281 78.05% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 282 77.92% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 283 77.80% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 284 77.74% 4.76% 35.73% 4.76% 4.76% 4.76% 26.22% 4.76% 4.76% 4.76% 4.76% 
USF 285 77.68% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 286 77.59% 11.74% 14.79% 11.74% 11.74% 1.52% 11.74% 1.52% 11.74% 11.74% 11.74% 
USF 287 77.57% 3.44% 33.41% 6.57% 6.57% 3.44% 20.26% 6.57% 6.57% 6.57% 6.57% 
USF 288 77.47% 5.53% 33.42% 5.53% 5.53% 5.53% 22.36% 5.53% 5.53% 5.53% 5.53% 
USF 289 77.42% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 290 77.20% 4.03% 35.37% 6.58% 4.03% 4.03% 29.87% 4.03% 4.03% 4.03% 4.03% 
USF 291 77.03% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 292 76.72% 4.65% 36.04% 4.65% 4.65% 4.65% 26.73% 4.65% 4.65% 4.65% 4.65% 
USF 293 76.65% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 294 76.65% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 295 76.63% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 296 76.28% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 297 76.14% 4.67% 36.00% 4.67% 4.67% 3.71% 27.62% 4.67% 4.67% 4.67% 4.67% 
USF 298 75.76% 7.76% 26.73% 7.76% 7.76% 7.76% 11.21% 7.76% 7.76% 7.76% 7.76% 
USF 299 75.59% 3.48% 33.74% 3.48% 9.30% 3.48% 32.61% 3.48% 3.48% 3.48% 3.48% 
USF 300 75.54% 9.90% 20.29% 9.90% 9.90% 1.33% 17.63% 1.33% 9.90% 9.90% 9.90% 
USF 301 75.48% 7.78% 26.66% 7.78% 7.78% 7.78% 11.09% 7.78% 7.78% 7.78% 7.78% 
USF 302 75.37% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 303 75.01% 9.55% 21.36% 9.55% 9.55% 1.40% 10.42% 9.55% 9.55% 9.55% 9.55% 
USF 304 74.94% 5.06% 32.44% 5.06% 7.45% 3.34% 28.14% 5.06% 3.34% 5.06% 5.06% 
USF 305 74.57% 2.79% 41.63% 2.79% 2.79% 2.73% 36.16% 2.73% 2.79% 2.79% 2.79% 
USF 306 74.36% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 307 74.14% 5.66% 20.70% 11.82% 11.82% 1.36% 11.82% 1.36% 11.82% 11.82% 11.82% 
USF 308 73.92% 7.27% 21.80% 7.27% 13.66% 7.27% 13.66% 7.27% 7.27% 7.27% 7.27% 
USF 309 73.87% 9.41% 21.77% 9.41% 9.41% 6.18% 9.41% 6.18% 9.41% 9.41% 9.41% 
USF 310 73.68% 9.73% 20.82% 9.73% 9.73% 1.37% 9.73% 9.73% 9.73% 9.73% 9.73% 
USF 311 73.25% 1.70% 25.90% 11.20% 11.20% 1.70% 12.99% 1.70% 11.20% 11.20% 11.20% 
USF 312 72.73% 3.40% 32.99% 10.20% 3.40% 3.40% 32.99% 3.40% 3.40% 3.40% 3.40% 
USF 313 72.59% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 314 71.77% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 315 71.12% 8.19% 25.43% 8.19% 8.19% 8.19% 9.05% 8.19% 8.19% 8.19% 8.19% 
USF 316 70.93% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 317 70.21% 4.70% 35.89% 4.70% 4.70% 4.70% 26.48% 4.70% 4.70% 4.70% 4.70% 
USF 318 70.15% 5.41% 33.76% 5.41% 5.41% 5.41% 22.94% 5.41% 5.41% 5.41% 5.41% 
USF 319 69.69% 3.40% 32.99% 10.20% 3.40% 3.40% 32.99% 3.40% 3.40% 3.40% 3.40% 
USF 320 68.80% 3.97% 38.08% 3.97% 3.97% 3.93% 30.23% 3.97% 3.93% 3.97% 3.97% 
USF 321 68.16% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 322 67.92% 3.97% 38.09% 3.97% 3.97% 3.97% 30.15% 3.97% 3.97% 3.97% 3.97% 
USF 323 67.20% 5.71% 32.86% 5.71% 5.71% 3.39% 23.76% 5.71% 5.71% 5.71% 5.71% 
USF 324 67.11% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
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Table C1 The DEA scores and optimal virtual weights of USFs (continued) 
USF  DEA 
score 
µ1y1 µ2y2 µ3y3 µ4y4 µ5y5 µ6y6 µ7y7 µ8y8 µ9y9 µ10y10 
USF 325 66.67% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 326 66.38% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 327 66.10% 4.63% 36.10% 4.63% 4.63% 4.63% 26.83% 4.63% 4.63% 4.63% 4.63% 
USF 328 65.90% 4.66% 36.03% 4.66% 4.66% 4.66% 26.72% 4.66% 4.66% 4.66% 4.66% 
USF 329 65.88% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 330 65.70% 9.56% 21.32% 9.56% 9.56% 2.20% 9.56% 9.56% 9.56% 9.56% 9.56% 
USF 331 63.56% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 332 63.14% 9.56% 21.32% 9.56% 9.56% 2.20% 9.56% 9.56% 9.56% 9.56% 9.56% 
USF 333 62.60% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 334 62.56% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 335 62.24% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 336 61.99% 12.04% 13.87% 12.04% 12.04% 0.91% 12.04% 0.91% 12.04% 12.04% 12.04% 
USF 337 61.80% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 338 61.59% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 339 59.61% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 340 59.59% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 341 59.00% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 342 58.58% 8.33% 25.00% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 8.33% 
USF 343 58.44% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 344 57.52% 6.44% 30.67% 6.44% 6.44% 6.44% 17.78% 6.44% 6.44% 6.44% 6.44% 
USF 345 54.73% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 346 52.16% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 347 51.47% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 348 48.91% 3.40% 32.99% 3.40% 10.20% 3.40% 32.99% 3.40% 3.40% 3.40% 3.40% 
USF 349 47.52% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 350 44.78% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 351 43.97% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 352 41.90% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 353 41.33% 2.74% 41.77% 2.74% 2.74% 2.74% 36.28% 2.74% 2.74% 2.74% 2.74% 
USF 354 39.69% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
USF 355 37.97% 5.07% 34.78% 5.07% 5.07% 3.59% 27.61% 3.59% 5.07% 5.07% 5.07% 
USF 356 32.26% 3.94% 38.19% 3.94% 3.94% 3.94% 30.31% 3.94% 3.94% 3.94% 3.94% 
 
